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Abstract 
 
 
The initiation, duration and resolution of an appropriate immune response is vital for 
defending the host against invading pathogens, toxins and cancerous cells. Such 
immune responses are reliant on the cooperative action of multiple cell types and the 
co-ordinated regulation of gene expression programs, which direct immune function. 
Inducible gene expression upon immune activation is determined by the complex 
interaction between transcription factors, the chromatin structure and chromatin 
modifying/remodelling factors at the regulatory regions of immune genes. The NF-κB 
transcription factor c-Rel is a key regulator of gene expression programs within the 
immune system. c-Rel regulates expression of cytokines and transcription factors 
during immune cell activation and is essential for the correct function of immune cells 
from divergent cell lineages.  These differentiated cells are highly specialised and have 
a diverse range of functions requiring precise regulation of their gene expression 
profiles for targeted responses. This study explores the role of c-Rel in divergent 
lymphocyte and macrophage lineages.  
 
c-Rel has previously been shown to instigate chromatin remodelling events required for 
activation of the GM-CSF gene in T cells. Activation involves the depletion of hyper-
acetylated histones from the promoter region of the gene, mediated by the chromatin 
remodelling protein BRG1. This study shows that activation of the GM-CSF gene is 
also c-Rel dependent in macrophages, however the gene promoter is not marked by 
acetylated chromatin and no loss of H3 is detected in association with activation.  These 
findings suggest that whilst the GM-CSF gene is expressed in both T cells and 
macrophages, activation is regulated by fundamentally different mechanisms in the two 
cell types. The hypothesis underlying this study is that during the process of 
differentiation lineage specific chromatin structure is established at inducible gene 
promoters and that this chromatin structure largely dictates the cooperative regulation 
xiii 
 
of gene expression through interaction with transcription factors, structural proteins and 
chromatin remodelling enzymes.  
 
Using genome-wide data sets, a cohort of immune genes which are regulated by c-Rel 
were identified. These genes were further categorised into BRG1 independent and 
dependent genes. The activation requirements of these genes were examined in both T 
cells and macrophages to determine whether the switch in regulatory control identified 
for the GM-CSF gene is a common feature of genes that are co-expressed by these cell 
types, and to characterise the mechanisms underlying this fundamental difference in 
regulation. Data presented in this thesis demonstrates that several genes undergo 
switches in the requirements for gene expression between the two cell types. The 
analysis of chromatin structure indicates that these differences in activation kinetics are 
reflective of the basal chromatin accessibility established at the genes promoter regions. 
Furthermore, the extent of chromatin remodelling across promoter regions correlates 
with the magnitude of the gene transcription response. Additionally, gene expression 
analysis of macrophage and T cells derived from c-Rel
-/-
 mice suggest that c-Rel can act 
as a represser as well as an activator of gene transcription.  
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1 Regulation of inducible gene expression in the immune 
system 
 
1.1 Introduction to immune gene regulation 
 
The initiation, duration and resolution of an appropriate immune response is vital for 
defending the host against invading pathogens, toxins and cancerous cells. Such 
immune responses are reliant on the cooperative action of multiple cell types and the 
coordinated regulation of gene expression programs, which direct immune function. 
Expression programs are driven by networks of transcription factors which bind to their 
cognate binding sites in the regulatory regions of genes encoding transcription factors, 
cytokines and other proteins required for an immune response (Wilson, Rowell & 
Sekimata 2009). Control of gene transcription is therefore essential for proper immune 
cell function, but rather than being reliant on transcription factor binding alone, an 
intricate and multi-layered system of transcriptional regulation is in place in eukaryotes 
(Lim et al. 2013; Venters & Pugh 2009). 
 
Cytokines are small signalling proteins secreted by cells of both the innate and adaptive 
immune system which modulate the immune response and enable signalling between 
cell types (Cohen, Bigazzi & Yoshida 1974; Ghosh, May & Kopp 1998). Cytokine 
proteins are not usually constitutively expressed, nor stored as pre-formed molecules 
within the cell. Instead, in response to appropriate signals cytokine production is reliant 
on the transcription and translation of new cytokine proteins before cell secretion can 
take place (Abbas, Lichtman & Pillai 2007). During an immune response cytokine gene 
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expression is switched on rapidly before returning to low basal levels during immune 
resolution (Holloway, Rao & Shannon 2002). 
 
Immune cells, including T cells and macrophages, produce a broad array of cytokines 
during an immune response. The type of cytokines produced is determined not only by 
the cell type, but also the stimulus and cellular environment. As a multitude of cytokine 
genes may be expressed at one time they often affect the synthesis and function of other 
cytokine genes, as well as the activity and proliferation of other immune cells.  Partial 
redundancy exists in which some cytokines elicit similar effects. Cytokines may also 
act synergistically or antagonistically to one another and therefore the initiation, 
duration and resolution of the immune response will be reliant on the precise balance of 
pro-inflammatory and anti-inflammatory cytokines being expressed at the appropriate 
time (Abbas, Lichtman & Pillai 2007). It is now becoming increasingly appreciated that 
the control of cytokine gene expression is essentially modulated by the interaction of 
transcription factors with the chromatin platform established at the gene regulatory 
regions (Aung et al. 2006; Brettingham-Moore et al. 2008; Lim et al. 2013; Natoli 
2009). 
 
The activation kinetics of individual inducible genes within the immune system is 
important for a co-operative immune response. Inducible immune gene expression is 
recognised as occurring in two waves depending on the activation requirements of the 
individual genes (Hargreaves, Horng & Medzhitov 2009; Herschman 1991). The “first 
responders” to activation signals are also referred to as immediate-early genes or 
primary responders as an increase in gene transcription may be observed within minutes 
of stimulation and does not require the synthesis of new proteins to occur (Fowler, Sen 
& Roy 2011; Herschman 1991; Ramirez-Carrozzi et al. 2009). Late responders to 
activation signals or secondary response genes display delayed activation kinetics and 
are reliant on de novo protein synthesis before increased gene transcription can occur 
(Ramirez-Carrozzi et al. 2009; Yamamoto & Alberts 1976). Many transcription factors 
are encoded by primary response genes which are required for subsequent activation of 
secondary response genes (Fowler, Sen & Roy 2011). A further group of genes are 
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classified as delayed primary response genes (Tullai et al. 2007). Like immediate-early 
primary response genes, delayed primary response genes are expressed independent of 
protein synthesis but in contrast they display delayed activation kinetics (Tullai et al. 
2007). Whilst these different classes of gene responses have been recognised for a long 
time the mechanisms underlying these differences in gene response are yet to be fully 
explored.  
 
1.1.1 Immune cell differentiation 
 
During the process of haematopoiesis, cells of the immune system acquire attributes 
which underwrite their specific function.  The progressive loss of pluripotency and the 
process of lineage commitment occur in association with distinct changes in gene 
expression and cell surface markers. This process may be triggered and/or modified by 
a number of cues including both extracellular factors such as the cytokine environment 
and interactions with surrounding cells as well as intrinsic mechanisms like 
transcription factor up regulation and availability, in addition to epigenetic determinants 
(Cedar & Bergman 2011; Georgopoulos, Moore & Derfler 1992; Laiosa, Stadtfeld & 
Graf 2006; Rieger et al. 2009). 
 
The haematopoietic system gives rise to a number of divergent mature immune cell 
types from a common hematopoietic stem cell (HSC). HSCs were first identified as 
Thy
lo
Lin
-
Sca-1
+
 cells isolated from the bone marrow (Spangrude, Heimfeld & 
Weissman 1988). HSCs give rise to progeny that progressively lose self-renewal 
capacity, producing a variety of lineage committed progenitor cells and eventually 
differentiate into mature cell types with highly specialised roles (Akashi et al. 2000; 
Kawamoto, Ohmura & Katsura 1998; Lacaud, Carlsson & Keller 1998; Spangrude, 
Heimfeld & Weissman 1988). Haematopoiesis is highly complex. Prevailing early 
interpretations suggest that the initial step of differentiation involves the commitment to 
either the common lymphoid progenitor (CLP) or the common myeloid progenitor 
(CMP) (Akashi et al. 2000; Kondo, Weissman & Akashi 1997). Although another 
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progenitor population is reported to be lymphoid primed multipotent progenitors 
(CMPP) which precede the CLP cells and whilst committed to the lymphoid lineage 
retain the ability to give rise to granulocyte macrophage progenitors (GMP) (Cedar & 
Bergman 2011). Subsequent commitment of common myeloid progenitors to either the 
megakaryocyte/erythrocyte or granulocyte/macrophage lineages occur via mutually 
exclusive events (Akashi et al. 2000). The lymphoid lineage gives rise to both B cells 
and the T cell subsets which undergo further cell fate decisions (Yang, Bell & 
Bhandoola 2010).  It is now recognised that lineage restriction is not necessarily as 
rigid as first thought, with more opportunity for cross-over between the divergent 
myeloid and lymphoid lineages as transcriptional programs are extensively shared and 
extend across lineage-potential boundaries (Laurenti et al. 2013). Myeloid potential 
persists even as lymphoid progenitors are branching towards T and B cells (Wada et al. 
2008).  
 
Mature cell types have highly specialised functions and a coordinated response between 
the different cell types is required for immune homeostasis. The two main cell types 
examined in this thesis are the CD4 positive (CD4+) T cells, also referred to as helper T 
cells, of the lymphoid lineage and macrophage cells of the myeloid lineage. Despite 
early divergence in the haematopoietic pathway and functionally distinct roles, CD4+ T 
lymphocytes and macrophages must coordinate and initiate immune responses in a 
cooperative manner. CD4+ T cells aid in cellular immunity by activating other T cells 
and macrophages as well as contributing to humeral immunity by triggering antibody 
production in B cells (Abbas, Murphy & Sher 1996). Macrophage cells are an integral 
part of the immune system not only recognising and phagocytosing foreign particles 
and malignant tumour cells but also play an essential role in processing foreign antigen 
for presentation to T cells (Gordon 1995; Gordon & Taylor 2005). As such, cells of 
these two highly divergent lineages retain the ability to induce the transcription of a 
number of shared immune modulating genes. 
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1.1.2 Transcription factor regulation  
 
Gene expression patterns are largely governed by the availability and activation of 
transcription factors. Transcription factors assemble at specific DNA regulatory regions 
in association with other transcription factors and DNA binding proteins to form multi 
protein-DNA complexes that interact with RNA polymerase to control gene 
transcription (Kadonaga 1998). Several families of transcription factors have emerged 
as key regulators of immune cell differentiation as well as immune responses. Whilst 
some are lineage specific and differentially regulated themselves, such as Foxp3 in T 
regulatory (Treg) cells (Wei et al. 2009), others are expressed in most cells of the 
immune system. These include the Nuclear Factor of Activated T cells (NFAT) and 
Nuclear Factor – kappa B (NF-κB) families (Ghosh, May & Kopp 1998; Naito et al. 
2011; Rao, Luo & Hogan 1997). Transcription factors respond to cell signalling events 
and once activated and in the nucleus they are able to recognise and associate with 
specific DNA sequences. The combination of transcriptional activators or repressors 
present determines if gene transcription occurs. Some transcription factors, such as the 
ubiquitous Specificity Protein 1 (SP1), are found predominately within the nucleus 
(Briggs et al. 1986). Others, including NF-κB are held in an inactive state in the 
cytoplasm and require the correct signalling before translocation to the nucleus and 
subsequent transcription factor-DNA interaction can occur. In addition, the abundance 
of a transcription factor within the cell can be further modified to control gene 
expression. Increased transcription and translation of transcription factor proteins 
occurs in response to cellular activation events as has been reported for both the NFAT 
and NF-κB family proteins (Rao et al. 2003; Shaw et al. 1988). 
 
1.1.3 NF-κB transcription factors 
 
The NF-κB transcription factors were first extensively characterised in B cell 
development controlling Igκ gene transcription (Pastinen & Hudson 2004; Sen & 
Baltimore 1986; Singh et al. 1986). It has since been shown that the NF-κB 
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transcription factors are not restricted to the B cell lineage and in fact are now 
recognised as central mediators of a broad range of cellular processes, particularly in 
both the innate and adaptive immune response (Baeuerle & Henkel 1994; Ghosh, May 
& Kopp 1998; Hayden & Ghosh 2008). In addition, the role of NF-κB is not limited to 
the immune system, having been documented as regulators in most cell types in the 
body (Ghosh, May & Kopp 1998). 
 
The five NF-κB family members; NF-κB1 (p105/p50), NF-κB2 (p100/p52), Rel-A 
(p65), Rel-B and c-Rel share a conserved rel homology domain (RHD) which not only 
interacts with the inhibitory IκB family members but also enables DNA binding as well 
as the formation of dimers between NF-κB family members (Blank, Kourilsky & Israel 
1992; Ghosh et al. 1995; Ghosh, May & Kopp 1998). Active NF-κB transcription 
factors are able to regulate target gene transcription through DNA binding as both 
homo and heterodimers. The capacity of different NF-κB dimers to regulate unique sets 
of genes introduces a significant level of selectivity into the NF-κB activation pathway 
(Smale 2012). The C-terminal domains are less conserved across the different NF-κB 
family members. c-Rel along with Rel-A and Rel-B harbour transactivation domains 
within the C-terminal region (Ballard et al. 1992; Ryseck et al. 1992; Schmitz et al. 
1994). NF-κB1 and NF-κB2 on the other hand contain inhibitory domains and differ 
from the other NF-κB members as they are synthesised as larger precursor proteins 
(p105 and p100). The p105 and p100 precursor proteins are retained in the cytoplasm 
and are subject to ubiquitin/proteasome mediated processing prior to generation of the 
mature NF-κB subunits p50 and p52, which are able to translocate to the nucleus and 
interact with DNA (Fan & Maniatis 1991; Thanos & Maniatis 1995). Following nuclear 
translocation, the capacity of NF-κB proteins to mediate transcription events may be 
further modulated by post-translational modifications, including phosphorylation 
(Hayden & Ghosh 2008; Oeckinghaus, Hayden & Ghosh 2011). These nuclear 
modifications largely determine the strength and duration of the NF-κB transcriptional 
response (Chen & Greene 2004).  
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The NF-κB family of transcription factors are ubiquitously expressed with the 
exception of c-Rel which is predominately expressed in cells of the haematopoietic 
system, including both the myeloid and lymphoid lineages (Brownell et al. 1987; 
Carrasco, Weih & Bravo 1994; Weih, Carrasco & Bravo 1994). The importance of c-
Rel in immune regulation is further emphasised by the finding that c-Rel knockout mice 
although viable, are immune deficient with impaired function of both macrophages and 
lymphocytes (Gerondakis et al. 1996; Kontgen et al. 1995).  
 
1.1.4 Cell signalling events leading to NF-κB activation 
 
Mature cell types express different cell surface receptors and utilise different 
intracellular signalling cascades to enable the orchestration of targeted responses to 
specific stimuli. The signalling cascade initiated by immune activation largely 
determines which transcription factors are activated and available in the nucleus to 
direct gene expression. NF-κB proteins can be activated in both T cells and 
macrophages, although via different signalling pathways, as depicted in Figure 1.1. 
 
T cell activation requires two signals; binding of the T cell receptor (TCR) by MHC 
molecules and antigen alongside co-stimulation of molecules such as CD28 by the 
antigen presenting cell to help sustain and amplify TCR signalling (Acuto & Cantrell 
2000; Acuto & Michel 2003). Activation via the TCR initiates an intracellular cascade 
of downstream signalling events involving activation of protein kinase and calcium 
signalling pathways. These include tyrosine and serine/threonine kinases and 
phosphatases, protein kinase C (PKC) and calcineurin (Lim et al. 2013). PKC activation 
results in nuclear translocation of a range of transcriptional activators, including the 
NF-κB transcription factors. Ultimately the signalling cascade initiates gene expression 
responses required for proliferation and differentiation of cells to mount an immune 
response (Acuto & Cantrell 2000). 
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Macrophages are heterogeneous cells varying significantly in phenotype and 
functionality with localisation (Gordon & Taylor 2005). As a crucial component of the 
innate immune system, macrophages recognise and respond to conserved, pathogen 
associated molecular patterns (PAMPs) through interaction with members of the toll 
like receptor (TLR) family. One such potent activator of macrophage immune 
responses is lipopolysaccharide (LPS), a major component of the bacterial outer 
membrane of gram-negative bacteria (Palsson-McDermott & O'Neill 2004). LPS is 
bound to LPS-binding proteins and recognised by toll like receptor 4 (TLR4) which, 
upon activation, triggers two waves of signalling. The first, MyD88 dependent 
signalling pathway activates early NF-κB responses via MyD88 and Mal, whilst the 
second MyD88 independent pathway also activates late NF-κB responses (Palsson-
McDermott & O'Neill 2004). Analysis of NF-κB subunit binding through a 
combination of ChIP and microarray analysis in human monocyte cells found that NF-
κB family transcription factors bound 157 genes in unstimulated cells and that in 
response to LPS stimulation this increased to 326 genes (Schreiber et al. 2006). 
 
1.1.5 NF-κB activation pathways  
 
Divergence in the NF-κB activation signalling pathway is one of the mechanisms by 
which NF-κB activation is able to influence gene expression in a spectrum of biological 
functions. Two distinct signalling pathways have been described extensively, termed 
the canonical and non-canonical pathways (Karin & Ben-Neriah 2000). Whilst general 
divergences between the pathways are well accepted, many of the mechanisms 
underlying pathway regulation remain elusive.  
 
The canonical pathway of activation is dependent on the Inhibitor of Nuclear Factor 
Kappa-B Kinase Subunit beta (IKKβ) and NF-κB Essential Modulator (NEMO) 
subunits of the IκB kinase (IKK) complex, as defined by Oeckinghaus, Hayden and 
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colleagues (2011). This pathway is activated in response to most physiological 
activators of NF-κB signalling and as such, may be activated in response to T cell 
activation and macrophage TLR signalling. Pathway activation ultimately results in 
degradation of the classical IκB inhibitor proteins and nuclear translocation of pre-
existing NF-κB dimers due to the unmasking of the nuclear translocation sequence (Beg 
et al. 1992). IκB degradation is mediated through the activation of the IKK complex 
containing the two catalytically active kinases IKKα and IKKβ and the regulatory 
subunit, NEMO (Yamaoka et al. 1998). The recruitment and activation of the IKK 
complex is itself reliant on the assembly of appropriate adaptor protein complexes.  
 
NF-κB1 has a twofold influence on NF-κB activation. In the unprocessed p105 form it 
is able to associate with other NF-κB subunits tethering them in the cytoplasm. In the 
processed form p50 is able to translocate to the nucleus and exert gene regulatory 
function (Rice, Mackichan & Israel 1992). The degradation of p105 occurs by a 
separate pathway and is dependent upon signal-dependent proteolysis. Protein 
degradation releases p50 homodimers as well as p50 containing heterodimers such as 
p50-c-Rel. This process is mediated by the same canonical pathway, as it requires the 
same IKK complex components  (Heissmeyer et al. 1999). 
 
The non-canonical or alternative pathway describes the activation of p100 into the 
mature p52 form of NF-κB2. This pathway typically regulates p52-Rel-B dimers. The 
non-canonical pathway is activated independently of the NEMO and IKKβ components 
of the IKK complex with IκB phosphorylation mediated by IKKα proteins 
(Oeckinghaus, Hayden & Ghosh 2011). Activation of IKKα phosphorylation activity is 
dependent on NF-κB inducing kinase (NIK) which itself is subject to intricate 
regulation via members of the TRAF family of proteins (Adhikari, Xu & Chen 2007; 
Oeckinghaus, Hayden & Ghosh 2011).    
 
It has been proposed that the NF-κB family of transcription factors exert two waves of 
activation following appropriate cell signalling events (Saccani, Pantano & Natoli 
2001). NF-κB proteins enter the nucleus rapidly following appropriate activation 
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signals and a number of NF-κB response genes are able to respond by increasing 
transcription immediately. The second round of gene activation occurs up to 90 minutes 
post NF-κB translocation (Rao et al. 2003; Saccani, Pantano & Natoli 2001). Different 
NF-κB family members have been shown to translocate to the nucleus with different 
kinetics. Translocation kinetics are cell type dependent and often reflective of their 
relative abundance in the cytoplasm prior to stimulation. For example in T cells, Rel-A 
which is expressed at higher basal levels in the cytoplasm rapidly increases in the 
nucleus within 30 minutes of immune stimuli. A second round of translocation is 
observed as increased synthesis of new Rel-A protein replenishes cytoplasmic Rel-A  
(Brettingham-Moore 2006). In contrast c-Rel has relatively low basal cytoplasmic 
levels and an increase in nuclear c-Rel is not observed in T cells until after 2 hours of 
immune stimuli (Brettingham-Moore 2006; Rao et al. 2003). 
 
 Rather than the two rounds of gene activation being attributed to the two waves of NF-
κB translocation, this is thought to be due to the differing activation requirements of the 
genes themselves, highlighting that gene activation is a highly regulated process 
involving multiple control points, as depicted in Figure 1.2 (Saccani, Pantano & Natoli 
2001). This may be due to post-translational modification of the NF-κB proteins 
themselves following translocation or the delay in synthesis of other activation 
requirements, such as co-activators or repressors. Transcription may also require the 
interaction of chromatin modifiers or remodelling complexes to modify the chromatin 
structure at NF-κB target sites prior to assembly of the complete transcription initiation 
complex (Natoli 2009). 
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1.2 Chromatin architecture and immune gene regulation 
 
As immune responses are transient and involve the coordinated activity of a number of 
immune cell types, the majority of immune response genes are inducible and many are 
cell-type specific. Inducible genes are usually maintained in a repressed state with  
minimal or no basal gene transcription. However, in specific immune cell types, 
immune genes are primed to enable rapid increases in gene expression in response to 
appropriate activation signals. Post initiation, a transient period of high level 
transcription is seen before returning to basal levels as the immune response progresses 
(Holloway, Rao & Shannon 2002). The role of chromatin in mediating these responses 
is now being unravelled through the study of chromatin structure at single gene loci in 
response to activation signals, as well as through genome-wide analysis of chromatin 
structure. Such studies are revealing how nucleosome positioning, histone modification 
and histone variant composition contribute to cell-type and signal-specific gene 
expression patterns. 
 
Within each eukaryotic cell, DNA is packaged into a highly dynamic chromatin 
structure. Chromatin is a nucleoprotein complex in which the DNA double helix is 
integrated into regularly spaced nucleosomes, the basic structural unit of chromatin 
(Kornberg 1974). Each nucleosome consists of an octamer of core histone proteins, 
containing two each of H2A, H2B, H3 and H4 (Kornberg & Lorch 1999). Histone 
chaperone proteins deposit H3/H4 tetramers on newly replicated DNA. A second 
chaperone protein then adds H2A/H2B dimers and modifies the completion of 
nucleosome assembly (Lorch, Maier-Davis & Kornberg 2006). This nucleosome 
structure is then further compacted into a higher order 30nm chromatin fibre and 
ultimately assembled into the chromosome (Tremethick 2007). Histone 1 (H1) proteins 
are linker histones structurally unrelated to the core histones, which occupy 
approximately 20bp within the linker regions of DNA, located in between nucleosomes. 
H1 proteins have an essential role in mediating chromatin condensation and stability 
(McBryant, Adams & Hansen 2006). While the assembly of DNA into chromatin is 
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essential for the ordered storage of large amounts of genetic information within the cell 
nucleus, it is clear that chromatin also provides an additional layer of regulatory 
information superimposed upon the DNA sequence (Gardner, Allis & Strahl 2011). 
This information may be generated by the precise positioning of nucleosomes, chemical 
modification and physical remodelling of the histones, and also by the incorporation of 
variant histone proteins.  
 
Two distinct regions of chromatin have been identified within the cell nucleus termed 
heterochromatin and euchromatin (Cheutin et al. 2003; Tamaru 2010). Heterochromatin 
regions are typically regions where the chromatin fibre is highly condensed and are 
usually associated with transcriptionally silent genes. Euchromatin on the other hand is 
less condensed and hence allows greater accessibility of the underlying DNA to gene 
transcription initiation complexes. The maintenance of euchromatin and 
heterochromatin regions is highly complex and rather than being maintained as a static 
structure, it allows plasticity between the two states and visible changes in the two 
compartments are seen in response to stimuli (Tamaru 2010; Zhao et al. 1998). It now 
appears that there are many intermittent chromatin states that may be modified by 
histone variants, histone modifications and chromatin remodelling complexes (Luger, 
Dechassa & Tremethick 2012).   
 
1.2.1 Nucleosome positioning and changes in nucleosome occupancy 
 
The chromatin structure established at the regulatory regions of immune genes partially 
dictates the response of the gene to stimuli and hence contributes to the effectiveness of 
an immune response. During the process of immune cell differentiation, lineage 
specific chromatin structure is established along with lineage specific gene expression 
patterns. Variation in chromatin structure between different cell lineages may be 
visualised as the appearance of lineage specific DNase hypersensitive (DH) sites 
(Cockerill 2011; Hawwari et al. 2002). DH sites represent regions of DNA that are 
more sensitive to nucleases such as DNase and MNase. Such sites have long been 
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appreciated to coincide with regulatory elements of genes. Further, the appearance of 
DH sites has been well documented to coincide with the activation of inducible genes. 
Inducible DH sites typically represent regions of chromatin which have been 
remodelled to be more accessible to transcription factors and regulatory molecules 
(Cockerill 2004, 2011; Takemoto et al. 2000). Changes in gene transcription are 
commonly associated with changes in chromatin structure and inducible DH sites have 
been described at the regulatory regions of a number of different cytokine genes in 
immune cells in response to appropriate activation signals. Data from both single gene 
and genome-wide studies suggest that the promoter region of many inducible genes is 
encompassed within a nucleosome, and that nucleosome rearrangement or disassembly 
is required to enable the transcription machinery to access the gene promoter and 
facilitate gene activation (Workman 2006). At a single gene level, such chromatin 
changes have been well described during activation of many inducible genes. The 
Granulocyte Macrophage – Colony Stimulating Factor (GM-CSF) gene and closely 
linked Interleukin 3 (IL-3) gene have been well characterised by DH mapping in T cells 
in order to identify key regulatory elements (Cockerill 2004). Both genes appear to be 
regulated by proximal promoters located immediately upstream of the transcriptional 
start site in addition to three enhancers that are identifiable by the induction of DH sites 
in response to stimulation (Cockerill et al. 1993). Similarly at the interleukin 2 (IL-2) 
gene, DH sites appear in both the proximal and distal regulatory regions upon 
stimulation (Ward et al. 1998). Further studies revealed that inducible DH sites at the 
GM-CSF and IL-2 promoters result from an increase in accessibility of the promoters, 
due to the depletion of histones from regions of the promoter corresponding to one 
(GM-CSF) or two (IL-2) nucleosomes, in response to activation signals (Brettingham-
Moore et al. 2008; Chen et al. 2005; Holloway et al. 2003; Rao, Procko & Shannon 
2001). Likewise, MNase1 analysis of the IL-12 p40 promoter has demonstrated that 
selective remodelling of a single positioned nucleosome covering the promoter 
accompanies its activation in macrophages (Weinmann, Plevy & Smale 1999). 
 
Genome-wide analysis of histone occupancy and positioning suggest that the 
remodelling events observed at these individual cytokine promoters are a relatively 
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common feature of inducible genes. Genome-wide maps of nucleosome positioning in 
both resting and activated CD4+ T cells have recently been generated using direct 
sequencing (Schones et al. 2008), and these data suggest that nucleosomes are highly 
phased relative to the transcriptional start site (TSS) of expressed genes, but that 
phasing is not seen at unexpressed genes (Schones et al. 2008). Nucleosome phasing 
appears to be influenced by surrounding histone features such as the incorporation of 
histone variants and the presence of poised or elongating Pol II at the TSS (Schones et 
al. 2008). Furthermore, data from this study suggest that many inducible genes are in a 
permissive basal state in terms of nucleosome positioning but that significant 
nucleosome reorganisation occurs following TCR stimulation, with a decrease in 
histone density preferentially occurring at the promoters of activated genes. 
Remodelling appears to alter the chromatin surrounding the promoters of inducible 
genes so that they are more accessible to the transcription machinery (Schones et al. 
2008).  
 
1.2.2 Histone modification signatures 
 
While changes in nucleosome occupancy are clearly important in regulating gene 
expression, the modification state of these nucleosomes also influences gene activity. 
Each of the core histone proteins consists of an inner globular domain into which the 
DNA is embedded and an N terminal tail region of between 14 and 28 amino acids, 
which extends beyond the nucleosome complex (McBryant, Adams & Hansen 2006). 
The histone proteins are subject to a range of modifications, occurring primarily on the 
histone tails. There have now been more than a dozen forms of histone modification 
described, the most extensively studied being acetylation and methylation (Barski et al. 
2007; Gardner, Allis & Strahl 2011; Kouzarides 2007; Tan et al. 2011).  
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1.2.2.1 Histone Acetylation 
 
Acetylation of histones on lysine residues is strongly correlated with active gene 
transcription (Strahl & Allis 2000), although the particular mechanisms by which 
histone acetylation facilitates gene expression have yet to be fully elucidated. Initially 
the correlation between histone acetylation and increased gene transcription was 
attributed to acetylation neutralising the positive charge of lysine residues within the 
histone. This is thought to reduce the affinity between the histone tails and the 
negatively charged DNA on surrounding nucleosomes, thus loosening the overall 
chromatin structure and enabling transcription from the underlying DNA (Grunstein 
1997; Shogren-Knaak et al. 2006). Acetylation marks may also serve as recognition 
sites for bromodomain containing protein complexes. Bromodomains recognise 
acetylated lysine residues and are contained within a number of chromatin modifying 
complexes and transcriptional regulators such as histone acetyltrasferases, histone 
methyltransferases and chromatin remodelling complexes. Thus histone acetylation 
may mark regions of chromatin for downstream modification and subsequent chromatin 
remodelling events (de la Cruz et al. 2005).  
 
1.2.2.2 Histone Methylation 
 
Histone methylation can occur on either arginine residues, which may be mono- or di- 
methylated, or lysine residues which may be mono-, di- or tri- methylated (Rice et al. 
2003). Histone methylation is somewhat more complicated than acetylation as it is 
associated with both activation and repression of gene expression. The effect of 
methylation is determined by the precise location of the amino acid residue on which 
the methylation occurs, and the number of methylation groups added (Barski et al. 
2007). This observation led to the proposal of the so-called “histone code” hypothesis, 
in which histone tail modifications act as receptors to be recognised and bound by other 
proteins which further modify chromatin structure (Gardner, Allis & Strahl 2011; Strahl 
& Allis 2000). For example, histone 3 lysine 27 (H3K27) di- and tri-methylation is well 
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documented as being a repressive histone modification required for mediating gene 
silencing. H3K27me2/3 is recognised and bound by polycomb repressor complex 2 
(PCRC2), a methyltransferase which further catalyses the addition of repressive histone 
modifications, thus maintaining gene silencing throughout processes such as DNA 
replication (Xu et al. 2010).  
 
Histone H3 methylation at lysine 4 (H3K4) is associated with euchromatic regions. Tri-
methylation at this position generally localises at the 5’ gene regulatory regions, near to 
the transcriptional start site. This methylation mark correlates with actively transcribed 
genes (Bernstein et al. 2005; Santos-Rosa et al. 2002). A number of proteins have been 
found to recognise and interact with H3K4me3 including several chromatin 
remodelling proteins. The yeast homologue of the human ISWI chromatin remodelling 
enzyme, Isw1p has been shown to mediate chromatin remodelling events to make the 
regulatory region of genes marked by H3K4me3 more permissible to transcription 
initiation (Santos-Rosa et al. 2003). In addition, the chromodomain-helicase-DNA-
binding protein 1 (CHD1) has also been shown to associate with H3K4me3 and recruit 
factors required for efficient RNA transcription post initiation, thereby facilitating 
transcription through positioned nucleosomes (Sims et al. 2007). These studies suggest 
that the H3K4me3 acts as a recognition site to enable the assembly of other co-
activators and transcription machinery, permitting gene transcription to occur.  
 
1.2.3 Histone modifications in inducible immune gene expression 
 
The functional role of many of the histone modifications remains elusive, although it is 
clear that such modifications can have a profound effect on the overall chromatin 
structure and function. Recent data, particularly that generated using genome-wide 
technologies such as ChIP-chip and ChIP-sequencing, has begun to shed new light on 
the distribution and role of permissive and repressive histone modifications in 
regulating gene expression (Barski et al. 2007; Lim et al. 2009; Roh, Cuddapah & Zhao 
2005; Schones et al. 2008; Wang et al. 2008). This work has begun to define chromatin 
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signatures that are associated with particular gene states, providing insight into how 
different chromatin architectures interact with extracellular signals and regulate gene 
expression, as reviewed by Lim et al. (2013).  
 
Early studies investigating histone acetylation patterns associated with the IL-4 and 
IFN-γ genes during T cell differentiation using Chromatin Immunoprecipitation (ChIP) 
assays, indicated that specific histone acetylation patterns where generated at the gene 
loci during differentiation, establishing permissive chromatin environments (Avni et al. 
2002). Differentiation of naïve T cells down the Th1 or Th2 lineage results in cells 
which express either IFN-γ or IL-4 respectively (Mosmann & Coffman 1989), 
correlating with the accumulation of histone acetylation at the active locus (Wei et al. 
2009). Acetylation marks are often associated with actively transcribed genes. Genome-
wide analysis of histone acetylation in T cells described an association of 
H3K9ac/K14ac with regulatory regions, including both promoters and enhancers, with 
the acetylation levels correlating well with gene expression. The discovery that 
promoter regions are often occupied by highly acetylated histones in comparison to the 
rest of the genome and the finding that promoters containing unmethylated CpG islands 
are often marked by highly acetylated histones, led to the proposition of ‘acetylation 
islands’. It was hypothesised that histone hyper-acetylation functions as a mechanism to 
prevent DNA methylation and hence is correlated with genes being maintained in an 
inducible state (Roh, Cuddapah & Zhao 2005). Subsequent ChIP-chip experiments in T 
cells revealed that inducible genes exhibit higher levels of acetylation as well as 
permissive methylation marks when compared to non-expressive genes, suggesting that 
permissive histone modifications may act to prime genes for transcriptional response 
upon activation (Lim et al. 2009). Furthermore, it was found that early response genes 
have significantly greater acetylation than delayed response genes, suggesting that the 
histone modifications may determine not only the ability of a gene to respond to 
activating signals, but also the kinetics of the gene response (Hargreaves, Horng & 
Medzhitov 2009). Histone acetylation has generally been associated with gene 
transcription and this has largely been confirmed by genome-wide studies. One such 
genome-wide study profiled 18 different acetylated lysine residues on the four core 
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histones and demonstrated that all were associated with gene transcription (Wang et al. 
2008). However there are also reports of particular histone acetylation marks being 
associated with gene silencing. For example, H4K12ac has been demonstrated to have a 
role in transcriptional silencing in heterochromatin in yeast (Braunstein et al. 1996).  
 
In contrast to histone acetylation, which is largely associated with gene transcription, 
histone methylation is associated with either activation or repression depending on the 
particular modification. Genome-wide analysis of the distribution of H3K27me3 and 
H3K9 methylation suggest these are repressive histone modifications as they are more 
prevalent at silenced genes compared to active promoters (Barski et al. 2007). The 
association of these marks with a repressive role was confirmed in a further study, 
along with H3K27me2 and H4K20me3 (Wang et al. 2008). However, in addition to 
marking promoters of inactive genes these modifications are also present in intergenic 
regions (Barski et al. 2007; Roh et al. 2006). In contrast, H3K4 methylation appears to 
be a permissive methylation mark, with H3K4me3 enriched at the TSS of active genes, 
and H3K4me1/2 enriched across the transcribed regions of active genes (Barski et al. 
2007). Similarly, H3K36me3 and H3K79 methylation are associated with actively 
transcribed genes, although H3K36me3 is enriched at the 3’ end, while H3K79 
methylation is enriched at the 5’ end of these genes. Furthermore, while di- and tri-
methylation of H3K9, H3K27 and H4K20 are associated with gene repression the 
mono-methylation of these residues is enriched at active genes (Barski et al. 2007).  
 
1.2.4 Bivalent histone modifications 
 
Specific histone modifications are clearly associated with gene activation or gene 
repression. However, genome wide studies have also identified genes which carry so-
called ‘bivalent’ marks and are marked by both active (H3K4me3) and repressive 
(H3K27me3) histone modifications (Azuara et al. 2006; Bernstein et al. 2006; 
Mikkelsen et al. 2007). Bivalent modifications are thought to enable a gene to be held 
in a non-transcribed state by the repressive markers, while it is also primed to respond 
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to appropriate signals by the permissive marks. Bivalent histone modifications were 
initially thought to be a unique feature of stem cells and to contribute to the 
pluripotency, but have subsequently been observed in differentiated cells. It has 
therefore been suggested that this bivalent chromatin state may be involved in 
regulating genes that respond to developmental and environmental signals in many cell 
types (Araki et al. 2009; Barski et al. 2007; Cui et al. 2009; Lim et al. 2009; Rodriguez 
et al. 2008).  
 
1.2.5 Histone modification enzymes 
 
The modification state of histones is maintained by the activity of groups of modifying 
enzymes. Acetylation levels are determined by the opposing activity of histone acetyl-
transferases (HAT)s and histone deacetylases (HDAC)s, whilst methylation 
modifications are mediated by histone methyl-transferases (HMTs) and demethylases 
(Couture & Trievel 2006; Smith & Denu 2009). Thus the activity of modifying 
enzymes determines the level of permissive and repressive markers at each gene. 
Recent ChIP-sequencing studies in T cells have profiled the association of HATs with 
gene promoters (Wang et al. 2009). Combined analysis with gene expression data 
reveals that, as may be expected, a high level of HAT activity correlates with higher 
levels of acetylation, in addition to elevated gene transcription. In addition HAT 
binding is positively correlated with the binding of Pol II at active genes (Wang et al. 
2009). Surprisingly, ChIP-sequencing revealed that HDACs are also correlated with 
active gene transcription, with only a small fraction associated with silent genes. These 
results suggest that rather than having a primary role in maintaining a silent state, the 
main role of HDACs may be the removal of acetyl groups added by HATs at active 
genes. HDACs are recruited to actively transcribed genes by interaction with elongating 
Pol II and may therefore play an important role in resetting chromatin following 
remodelling (Wang et al. 2009). Examining the binding of HATs and HDACs to 
transcriptionally silent genes reveals that these genes are also subject to constant 
acetylation and deacetylation cycles mediated by the transient and unstable binding of 
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HATs and HDACs. Thus like ‘bivalent’ chromatin marks, the activity of HATs and 
HDACs at repressed genes primes these genes for future activation (Wang et al. 2009). 
Furthermore, activity of HATs and HDACs at ‘primed’ genes appears to be further 
modulated by the presence of other chromatin modifying factors including permissive 
H3K4 methylation and the histone variant protein H2A.Z  (Wang et al. 2009). 
 
1.2.6 Chromatin remodelling complexes 
 
In addition to the proteins that modify histones, a group of chromatin remodelling 
complexes (CRCs) have been described. CRCs utilise the energy released by ATP 
hydrolysis to physically alter chromatin structure through changes in the association 
between histone proteins and the DNA double helix. CRC activity may result in 
changes in nucleosome conformation, position, composition and occupancy and are 
often associated with specific histone modifications (Li, Carey & Workman 2007). 
These mechanisms provide another layer of complexity to gene regulation by dictating 
the accessibility of regulatory regions of DNA to transcription factors. The sliding and 
partial or full disassembly of the core nucleosome proteins by chromatin remodelling 
complexes may disrupt the DNA/histone protein interaction, allowing transcription 
factors to access and bind DNA regulatory regions and initiate transcription. Likewise 
re-assembly of the nucleosome complex may conclude gene transcription (Kornberg & 
Lorch 2007). It has been proposed that remodelling enzymes may be targeted to 
specific DNA regions through interaction with transcription factors, non-coding RNA, 
specific histone modifications and/or DNA damage (de la Serna, Ohkawa & Imbalzano 
2006). CRCs may be classified into subfamilies by the sequence homology of their 
ATPase subunit. These families are called SWI/SNF (SWItch/Sucrose Non-
Fermentable), ISWI (Imitation SWItch), CHD1 (chromodomain helicase DNA binding 
protein) and INO80 (INOsitol requiring) (Lusser & Kadonaga 2003). CRC sub-families 
have both complementary and opposing roles depending on the cell type and chromatin 
environment.  
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CRCs frequently mediate the changes in chromatin accessibility required for 
transcriptional activation of inducible genes. Utilising ATP-hydrolysis, CRCs 
reposition, assemble or dismantle nucleosome complexes from the regulatory regions of 
genes (Lusser & Kadonaga 2003; Saha, Wittmeyer & Cairns 2006). However 
chromatin remodelling is not required for activation of all genes. Genes that respond 
rapidly to immune stimuli often exhibit high sensitivity to nucleases at regulatory 
regions prior to stimulation. Further analysis revealed that this is due to low 
nucleosome occupancy at nuclease susceptible promoters (Ramirez-Carrozzi et al. 
2009). Genes that have low basal nucleosome occupancy are therefore proposed to 
increase gene expression independent of chromatin remodelling as the promoter is 
subject to less nucleosome interference with transcription factor association.  
 
Lymphocyte activation is accompanied by visible changes in the chromatin architecture 
which are associated with the stable association of SWI/SNF complexes with the 
nucleus/chromatin within 10 minutes of cell stimulation (Zhao et al. 1998). Genome-
wide analysis of BRG1 (an ATPase component of the SWI/SNF complex) binding in 
non-stimulated and stimulated T cells in conjunction with mRNA gene expression 
analysis reveals that BRG1 is important for the response to cell activating signals and 
that BRG1 binding is positively correlated with gene transcription (De et al. 2011). 
Knockout of the BRG1 gene is embryonically lethal during the implantation stage 
however, conditional knockdown in fibroblast cells does not affect survival in culture 
suggesting that BRG1 is required for development but not general cell viability 
(Bultman et al. 2000). Furthermore, conditional knockdown of BRG1 has demonstrated 
BRG1 is required for multiple stages of T cell development as BRG1 is required for 
effective intracellular signalling events (Chi et al. 2003; Gebuhr et al. 2003). 
Knockdown of the BRG1/BRM complex in murine macrophages has shown that a 
subset of inducible genes require SWI/SNF for activation in macrophages also 
(Ramirez-Carrozzi et al. 2009). The recruitment of BRG1 to SWI/SNF dependent genes 
is reported to be mediated by the presence of permissive histone acetylation marks (De 
et al. 2011). In this case, for chromatin remodelling to occur via the recruitment of 
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BRG1 a specific chromatin environment must be established at the gene prior to 
recruitment.  
 
SNF2H is an ISWI chromatin remodelling complex which is also abundantly expressed 
in immune T cells. Knockdown of SNF2H revealed that SNF2H has a regulatory role at 
a number of cytokine genes, typically repressing gene transcription, but at some 
cytokine genes such as IL-3, increasing transcription (Precht, Wurster & Pazin 2010). 
SNF2H appears to mediate changes in chromatin structure by directly binding in 
association with its partners, including ACF1, to regulatory sites. However cell 
stimulation appears to have minimal influence on SNF2H binding, which remains 
comparatively uniform across cytokine loci. Knockdown experiments have 
demonstrated that SNF2H is crucial in mediating development and as there is little 
evidence of dynamic recruitment of the remodeller, it appears that SNF2H association 
with chromatin at cytokine genes may be initiated during differentiation (Precht, 
Wurster & Pazin 2010).  
 
Mi2/NuRD complexes interact with DNA-binding proteins such as Ikaros which are 
implicated in repression, as well as HDACs and have been shown to contribute to 
transcriptional repression. However the complex has also been implicated in 
transcriptional activation (Ramirez-Carrozzi et al. 2006). In macrophage cells, the 
Mi2β/NuRD complex associates with pro-inflammatory cytokine genes in a similar way 
to the BRG1 SWI/SNF remodeller. Knockdown of Mi2β revealed that Mi2β acts as an 
antagonist of gene transcription, moderating the response of late primary and early 
secondary response genes.  When BRG1 is depleted the association of Mi2β with 
cytokine genes is also depleted, suggesting that Mi2β is dependent on BRG1 for 
recruitment to regulatory regions to occur (Ramirez-Carrozzi et al. 2006).  
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1.2.7 Histone variants  
 
Chromatin structure can also be modified by the incorporation of variants of the 
canonical core histone proteins. Variants are so named as they are variations of the 
major histone proteins. They may vary in only a single amino acid or exhibit more 
significant alterations in composition. The histone variant H2A.Z is a replacement 
histone for H2A, the sequence of which varies significantly from that of canonical H2A  
(Bonenfant et al. 2006). H2A.Z appears to have a key role in chromatin structure 
determination (Creyghton et al. 2008). In human CD4+ T cells, H2A.Z is associated 
with promoter regions both up and downstream of transcription start sites. Integration 
of the H2A.Z histone appears to be associated with gene activity (Barski et al. 2007).  
H3.3 is another frequently reported histone variant, but in contrast to H2A.Z, H3.3 is 
highly structurally similar to H3 (Szenker, Ray-Gallet & Almouzni 2011). The 
integration of H3.3 into nucleosomes is strongly associated with gene transcription and 
it is thought to destabilise nucleosome structure (Jin et al. 2009; Kafer et al. 2010; 
Sutcliffe et al. 2009; Szenker, Ray-Gallet & Almouzni 2011). Not only are histone 
variants associated with regulating gene expression, they have also been implicated in 
DNA repair and X inactivation. Variant histone proteins have also been shown to be 
enriched at target genes in embryonic stem cells and appear to be necessary for lineage 
commitment to occur (Creyghton et al. 2008). 
 
1.3 Immune gene activation in divergent cell types 
 
The advent of genome-wide technologies to study chromatin architecture has provided 
remarkable insight into the multitude of chromatin factors which mediate gene activity, 
including histone modifications, activity of histone modifying enzymes and recruitment 
of chromatin remodelling complexes as well as the incorporation of histone variants 
(Araki et al. 2009; Barski et al. 2007; De et al. 2011; Ramirez-Carrozzi et al. 2009). 
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Such analysis has provided general “rules” for deciphering chromatin signatures 
associated with particular gene states, as summarised in Figure 1.3. In addition, 
genome-wide data is available for association of transcription factors to regions of 
DNA both before and after immune stimuli (Bunting et al. 2007) as well as the 
association of poised and recruited RNA polymerase II (Barski et al. 2009). Genome-
wide studies continue to be complimented by gene-centric studies which are uncovering 
the key mechanisms that regulate gene expression, and how particular chromatin 
features interact with modifying proteins and transcription factors to impact gene 
activity. Despite the insights that we have gained over recent years several questions 
remain unanswered including how conserved the regulatory mechanisms are across 
different cell types. 
 
The inducible expression of the inflammatory cytokine, Granulocyte Macrophage – 
Colony Stimulating Factor (GM-CSF) has been studied extensively in T cells where 
gene activation has been shown to require co-operative interaction with both the NF-κB 
transcription factor, c-Rel and the BRG1 chromatin remodelling complex (Brettingham-
Moore et al. 2008; Poke et al. 2012). GM-CSF expression is not restricted to the T cell 
lineage, with expression also inducible in response to stimuli in several other cell types 
including macrophages (Cockerill 2004; Shannon et al. 1997). Several other inducible 
cytokine genes are also expressed in both T cells and macrophages which may be 
regulated by similar mechanisms to GM-CSF.  
 
The hypothesis underlying this study is that during the process of differentiation lineage 
specific chromatin structure is established at inducible gene promoters and that this 
chromatin structure largely dictates the cooperative regulation of gene expression 
through interaction with transcription factors, structural proteins and chromatin 
remodelling enzymes.  
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1.4 Research Project Aims: 
 
The aim of this study was to examine how different cell types are able to induce 
transcription of the same cytokine genes utilising different mechanisms and to examine 
the role of c-Rel in facilitating this. The specific aims were to: 
 
1) Characterise the different activation requirements of the GM-CSF gene in 
macrophages in comparison to T cells, and investigate the mechanisms involved 
in the different cell types. 
 
2) Utilise genome-wide data to identify c-Rel dependent genes that have inducible 
expression in both T cells and macrophages and to determine whether c-Rel 
dependent genes are regulated by fundamentally different mechanisms in the 
two cell types. 
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2 Materials and Methods 
 
2.1 Cell culture 
 
2.1.1 Tissue culture 
 
RAW 264.7 macrophage and EL4 T cell lines were purchased from the American 
Tissue Culture Collection and were cultured in Gibco® RPMI 1640 medium 
(Invitrogen
TM
, U.S.A) supplemented with fetal bovine serum (10%; JRH Biosciences, 
Australia), penicillin (100U/mL)/streptomycin (100µg/mL, Sigma-Aldrich, U.S.A). 
EL4 T cells were maintained between 2x10
5
 and 1x10
6
 cells per mL with passaging 
every 24hrs. RAW 264.7 macrophages were subcultured every 3 days by cell scraping 
and re-plating at 1:4. Cells were incubated in a humidified atmosphere at 37°C with 5% 
CO2.  
 
2.1.1.1 Treatment of cultured cells 
 
Cell lines and primary cells were treated with the following reagents as indicated in 
Table 2.1.  
 
Table 2.1: Cell treatments 
 
Reagent Stock concentration Treatment 
lipopolysaccharide from salmonella 
typhosa (LPS, Sigma-Aldrich, 
U.S.A). 
1mg/mL in RPMI  10μg/mL for variable 
times as indicated. 
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phorbol 12-myristate 13-acetate 
(PMA, Boehringer Mannheim, 
Australia). 
 
 1mg/mL in DMSO 20ng/mL, for variable 
times as indicated. 
Calcium ionophore A23187 (I, 
Sigma-Aldrich, U.S.A). 
 
10mM in DMSO 1µM, for variable 
times as indicated. 
Cyclohexamide (CHX, Millipore, 
Germany). 
 
100mg/mL in ethanol 10 µM for 30 minutes. 
Pentoxyfylline (PTX, Sigma-
Aldrich, U.S.A). 
 
Stored as powder and 
made up fresh by 
dissolving directly in 
medium 1 hour prior 
to treatment. 
 
6mg/mL for 30 
minutes. 
 
 
Unless otherwise specified EL4 T cells were stimulated using 20ng/mL phorbol 12-
myristate 13-acetate (PMA, Boehringer Mannheim, Australia) and 1µM calcium 
ionophore (A23187; Sigma-Aldrich, U.S.A). RAW 264.7 cells were stimulated using 
10ng/mL bacterial lipopolysaccharide (LPS) isolated from Salmonella Typhosa (Sigma-
Aldrich, U.S.A).  
 
2.1.2 Isolation of primary cells 
 
Ethics approval was sought and gained from the University of Tasmania Animal Ethics 
Committee (ethics number: A0011434). Primary cells were obtained from male 
C57/BL6 mice and c-Rel
-/-
 mice aged 6-8 week. c-Rel
-/-
 mice were obtained from the 
lab of H.C Liou (Liou et al. 1999) and re-derived at the John Curtin School of Medical 
Research, Australian National University (JCSMR, ANU). Experiments were 
undertaken at JCSMR, ANU (ethics numbers: ASD 197 and ASD 173). 
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2.1.2.1 CD4+ T cells 
 
CD4+ T cells were isolated using the MACS CD4+ T cell isolation kit (Miltenyi 
Biotec, Germany) as per the manufacturers’ directions. Briefly, mice were euthanised 
by CO2 asphyxiation and spleens were isolated. Splenocytes were dissociated by 
passage through a 70µM cell strainer (Becton Dickinson Biosciences, Australia). 
Mononuclear cells were collected utilising density gradient centrifugation through 
Lympholyte-M (Cedarlane, Canada) in accordance with the manufacturer’s directions. 
Cells were then incubated with antibody-conjugated magnetic beads against CD4 
(Miltenyi Biotec, Germany). CD4+ cells were selected by magnetic separation, 
according to the manufacturers’ directions. Purified cells were maintained in Gibco® 
DMEM supplemented with fetal bovine serum (10%; JRH Biosciences, Australia), 
penicillin (100U/mL) /streptomycin (100µg/mL, Sigma-Aldrich, U.S.A).  
 
2.1.2.2 Murine Embryonic Fibroblasts (MEFs) 
 
Murine embryonic fibroblasts were obtained from E14 C57/BL6 embryos. Embryos 
were decapitated and the liver removed. Remaining embryonic tissue was finely minced 
using a scalpel blade and suspended in 10mL of 1 x PBS (MP Biomedicals, U.S.A) 
with trypsin (0.2%, Sigma-Aldrich, U.S.A). Cells were incubated in trypsin for 10 
minutes at room temperature before being pelleted by centrifugation (300g for 5 
minutes). Cells were resuspended in 2mL 1 x PBS (MP Biomedicals, U.S.A) and 
dissociated through a 70 µM cell filter (Becton Dickinson Biosciences, Australia) with 
excess 1X PBS (MP Biomedicals, U.S.A) before being pelleted by centrifugation (300g 
for 5 minutes) and re-suspended in 10mL DMEM (Invitrogen
TM
, U.S.A)  at 37°C and 
transferred to 25cm
2 
flasks (Becton Dickinson Biosciences, Australia). Following 24 
hours incubation, adherent fibroblasts were further subcultured every 3 days as cells 
reached approximately 90% confluence. To subculture, adherent cells were washed in 1 
x PBS (MP Biomedicals, U.S.A) before 3 minute incubation in 5mL 0.05% trypsin in 
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PBS (Sigma-Aldrich, U.S.A) at 37°C. Flasks were tapped to ensure dissociation of 
adherent cells and 5mL of DMEM medium was added before cells were pelleted by 
centrifugation (300g for 5 minutes). Cells were resuspended in fresh DMEM 
(Invitrogen
TM
, U.S.A) and re-plated 1:4.   
 
2.1.2.3 Bone Marrow Derived Macrophages (BMDM) 
 
Mice were euthanised by CO2 asphyxiation. Bone marrow cells were flushed with 
DMEM (Invitrogen
TM
, U.S.A) from mice tibias and femurs using a 23 gauge needle and 
syringe. Cells were then dissociated through a 70 µM cell filter (Becton Dickinson 
Biosciences, Australia) with excess 1X PBS (MP Biomedicals, U.S.A) before being 
pelleted by centrifugation (300g for 5 minutes) and re-suspended in 10mL DMEM at 
37°C and transferred to 25cm
2 
flasks (Becton Dickinson Biosciences, Australia). Cells 
were incubated overnight (37°C, 5% CO2) to allow fibroblast cells to adhere to the 
flask. Following 24 hours of incubation non-adherent cells were seeded into new flasks 
in fresh DMEM with murine macrophage colony stimulating factor, M-CSF 
(100ng/mL, Sigma-Aldrich, U.S.A) at a density of 1x10
7
 cells per 25cm
2
 flask and 
returned to the incubator for 5 days to allow differentiation into adherent 
monocyte/macrophage cells. Differentiation was determined by morphological changes 
as well as flow cytometry with anti-CD11b (Becton Dickinson Biosciences, Australia). 
 
2.1.2.4 Flow cytometry  
 
Successful isolation of primary cell populations was confirmed by flow cytometry 
using the CyAn
TM
 ADP Analyzer (Beckman Coulter, U.S.A).  An aliquot of cells was 
washed in 1x PBS (MP Biomedical, U.S.A) and either left unstained as a control or 
incubated for 1 hour with appropriate antibody. Anti-CD11b-FITC (Becton Dickinson 
Biosciences, Australia) was used to detect monocyte/macrophage cells whereas Anti-
CD4-FITC (Becton Dickinson Biosciences, Australia) was used for CD4+ T cells. 
Stained cells were analysed alongside an unstained control as well as both negative and 
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compensation control beads incubated with the same antibody. These protocols 
typically generate cell populations of over 90% purity. 
 
2.2 Gene expression analysis by Reverse Transcription quantitative 
Polymerase Chain Reaction (RT-qPCR) 
 
2.2.1 RNA extraction 
 
RNA was extracted from a minimum of 2.5 x10
6
 cells per treatment. Pelleted cells were 
resuspended in TRI reagent (500µL, Sigma-Aldrich, U.S.A) and incubated at room 
temperature for 5 minutes. Chloroform (100µL) was added and the tube contents mixed 
by vigorous shaking for 15 seconds. Following incubation (10 minutes, room 
temperature) the tubes were pelleted by centrifugation at 12,000g for 15 minutes. The 
clear upper layer was transferred to a fresh 1.5mL microcentrifuge tube and isopropanol 
(250µL) was added and mixed gently by inversion to precipitate the RNA. The RNA 
was precipitated at -20°C for a minimum of 1 hour. Following precipitation RNA was 
pelleted by centrifugation at 12,000g for 20 minutes at 4°C.   RNA pellets were washed 
with 700µL of 70% ethanol prior to air-drying.  Dried pellets were resuspended in 
DEPC treated water (Sigma-Aldrich, U.S.A), quantified by spectrophotometery and 
RNA quality and integrity determined by agarose gel electrophoresis (2.2.2) before 
being stored at -80°C.   
 
2.2.2 RNA quantification 
 
RNA was quantified using the NanoDrop® ND- 1000 UV- vis spectrophotometer 
(Nanodrop® Technologies, U.S.A). Optical density was measured at an absorbance of 
260nm and RNA concentration was determined (1 OD = 40µg/µL).   
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RNA integrity was confirmed by electrophoresis through a 1% agarose gel in 1x TAE 
and visualised using SYBR® safe DNA gel stain (Invitrogen Corporation, U.S.A). 
Molecular weight standards HindIII λ (New England Biolabs, U.S.A) and HyperLadder 
II (Bioline, UK) were electrophoresed alongside the RNA for sizing comparison. 
 
2.2.3 Preparation of cDNA 
 
Total  RNA (1µg) was subjected to DNase I treatment for 30 minutes at 37°C using 1 
unit of DNase I (Invitrogen
TM
, U.S.A) in 1x First Strand Buffer (Invitrogen
TM
, U.S.A). 
DNase I was then inactivated at 75°C for 5 minutes. Oligo dT (0.1nmol; Invitrogen
TM
, 
U.S.A) was then added and the reaction was incubated at 70°C for 10 minutes. The 
sample was then subjected to reverse transcription using Superscript Reverse 
Transcriptase III enzyme (100 units, Invitrogen
TM
, U.S.A) in 1x First Strand Buffer 
(Invitrogen
TM
, U.S.A) supplemented with DTT (0.1M, Invitrogen
TM
, U.S.A) and 
dNTPs (0.5mM, Promega Corporation, U.S.A). The reaction was incubated at 42°C for 
50 minutes, following which the enzyme was inactivated at 70°C for 15 minutes. cDNA 
was stored at -20°C.  
 
2.2.3.1 qPCR  
 
cDNA was diluted to a concentration of 10ng/µL and 5µL (50ng) was used for each 
qPCR reaction. Gene expression was determined using the primer sets detailed in Table 
2.2. Expression levels were determined from Ct values and a 5 point standard curve for 
each primer set and normalised to the “house-keeping” gene GAPDH.  qPCR utilised 
HotStarTaq DNA Polymerase and SYBR Green I dye (QuantiTect® SYBR® Green 
master mix; Qiagen, Netherlands). A reaction volume of 25µL was used to analyse 
50ng of DNA (or cDNA) in 5µL volume. Each reaction consisted of: QuantiTect® 
SYBR® Green master mix (12.5µL), RNase-Free water (4.5µL), forward primer (5 
µM, 1.5µL), reverse primer (5µM, 1.5µL). For no template control reactions, the 
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volume of DNA was substituted for additional RNase-Free water. The samples were 
subjected to the following cycling using the Corbett Rotor- Gene
TM
 2000
 
Real-Time 
Cycler (Corbett Research Pty Ltd, Australia); 1X 95°C 15 minutes, 40X 94°C 15 
seconds followed by 60°C for 60 seconds (acquiring to Cycling A on CH1) and a final 
melt analysis starting at 60°C ramping to 95°C, increasing by 1ºC each 5 seconds 
(acquiring to Melt A on CH1). Analysis was performed using the software provided 
(Corbett Research Pty Ltd, Australia).  
 
 
Table 2.2: Primers for analysis of gene expression by RT-qPCR 
 
Name Sequence (5’ to 3’) Fragment Size (bp) 
mGAPDH  
F:  AAGTATGATGACATCAAGAAGGTGGT 
R:  AGCCCAGGATGCCCTTTAGT 
 
 
67 
mGM-CSF  
F:  AAGGTCCTGAGGAGGATGTG 
R:  GAGGTTCAGGGCTTCTTTGA 
 
 
140 
mIL-23A 
 
 
F: GGTGCTTATAAAAAGCCAGACC 
R: AATAATGTGCCCCGTATCCA 
 
 
112 
mIL-10 
 
 
F: GTGAAAATAAGAGCAAGGCAGTG  
R: GATCATCATGTATGCTTCTATGCAG 
    
 
 
128 
mIL-6 
 
 
F: GTTCTCTGGGAAATCGTGGA 
R: TTTCTGCAAGTGCATCATCG 
 
 
85 
mTnfsf9 
(Ramirez-Carrozzi et al. 
2009) 
 
 
F: GCCCCAACACTACACAACAG 
R: GCTGTGCCAGTTCAGAGTTG 
 
 
95 
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mIL-1a 
 
 
F: AGCAGCCTTATTTCGGGAGT 
R: GTGCAAGTGACTCAGGGTGA 
 
94 
mIL-13 
(Wurster & Pazin 2008) 
 
F: AGACCAGACTCCCCTGTGCA 
R: TGGGTCCTGTAGATGGCATTG 
 
 
123 
mIL-21 
(Chen et al. 2010) 
 
F: TCAGCTCCACAAGATGTAAAGGG 
R: GGGCCACGAGGTCAATGAT 
 
 
121 
mIL-22 
 
 
F: CAACTTCCAGCAGCCATACA  
R: GTTGAGCACCTGCTTCATCA 
 
  
157 
mIL-24 
 
 
F: TTAGGACCCTAGCAGGAGCA 
R: AGAACCACCCCTGTCACTTG 
 
 
163 
 
 
2.3 Western blot analysis of protein localisation 
 
Table 2.3: Primary and secondary antibodies used for western blot analysis 
 
Affinity Host Type Dilution Supplier (cat. No)  
Anti - NFκB p65 (C-20) Goat Polyclonal 1 : 1000 Santa Cruz 
Biotechnology 
(sc-272X) 
Anti - c-Rel (C) Rabbit Polyclonal 1 : 1000 Santa Cruz 
Biotechnology 
(sc-71) 
Anti – Sp1 Rabbit Polyclonal 1 : 1000 Santa Cruz 
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Biotechnology 
(sc-59) 
Anti – Histone H3 Rabbit Polyclonal 1 : 10,000 Abcam (ab1791) 
Anti – β-actin Mouse Monoclonal 1: 10,000 Sigma-Aldrich 
(A2228) 
2° Anti – goat HRP Rabbit Polyclonal 1 : 1000 Dako (P0160) 
2° Anti – rabbit HRP Goat Polyclonal 1 : 1000 Dako (P0448) 
 
 
2.3.1 Preparation of nuclear and cytoplasmic protein extracts 
 
Nuclear and cytoplasmic extracts were prepared from a modified method (Schreiber et 
al. 1989). Briefly, cells (up to 1x10
7
)  were pelleted (500g, 5 minutes, 4°C) and washed 
in 10mL of ice-cold 1x PBS (MP Biomedicals, U.S.A) before being resuspended in 
lysis buffer (1 mL containing; 10mM Tris (pH 7.4), 10mM NaCl, 3mM MgCl2, 0.1mM 
EDTA (pH 8.0),  0.5% Igepal) and incubated on ice for 5 minutes. Nuclei were pelleted 
by centrifugation (500g, 3 minutes, 4°C) and the supernatant (cytoplasmic extract) was 
transferred to a fresh tube. Nuclei were washed once in Igepal free buffer (1ml 
containing; 10mM Tris (pH 7.4), 10mM NaCl, 3mM MgCl2, 0.1mM EDTA (pH 8.0)) 
before being resuspended in nuclei lysis buffer (25µL containing; 400mM  NaCl, 
7.5mM  MgCl2, 0.2mM EDTA (pH 8.0), 1mM DTT) with added Complete EDTA-Free 
Protease Inhibitor Cocktail (Roche Applied Science, Switzerland).  Samples were 
incubated on ice for 15 minutes with regular agitation. Cell debris was pelleted at 
15,000g and the supernatant (nuclear extract) was transferred to a fresh tube.  
 
Protein extracts were quantified by Bradford assay (Bradford, 1976). Briefly, extracts 
(2µl) were diluted 1:5 with MilliQ® water and combined with 1mL of diluted (1:5) 
Bio-Rad Protein Assay dye reagent concentrate (Bio-Rad Laboratories, U.S.A), 
absorbance was determined at 595nM by spectrophotometery (SpectraMax® Plus
384
, 
Molecular Devices, U.S.A). Protein concentration was then determined relative to a 
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standard curve generated using a series of dilutions of Bovine Serum Albium (BSA, 
New England Biolabs, U.S.A) ranging in concentration from 0.00µg/mL to 2.00µg/mL. 
 
2.3.2 SDS-PAGE and western blotting 
 
Protein extracts (10-20μg) were prepared with 4x sample loading buffer (5µL 
containing; 240mM Tris HCl (pH 6.8), 40% glycerol, 8% SDS, 0.08% Bromophenol 
blue, 10% β-mercaptoethanol) to a total volume of 20µL and heated at 95°C for 5 
minutes. Samples (20μL) were loaded on a 12% Mini-PROTEAN® TGX TM pre-cast 
gel (Bio-Rad Laboratories, U.S.A) alongside 5 and 10µL of SpectraTM Multicolor 
Broad Range Protein Ladder (Thermo Fisher Scientific, U.S.A) with sufficient SDS-
PAGE running buffer (192mM glycine, 25mM Tris (pH 8.0) and 0.1% sodium dodecyl 
sulphate). Samples were initially electrophoresed for 15 minutes at 100 V followed by 
150 V until completion.  
 
Proteins were transferred from the gel to 0.45µM nitrocellulose membrane (Bio-Rad 
Laboratories, U.S.A) utilising a wet transfer. The transfer assembly consisted of the gel 
and membrane in direct contact surrounded by two layers of filter paper (Whatman, 
U.S.A) and a support pad on either side pressed together by the support grid. The 
apparatus was immersed in western transfer buffer (150mM glycine, 20mM Tris (pH 
8.3) and 20% methanol) and transfer facilitated by 100 V for 90 minutes at 4°C.  
 
The membrane was placed in blocking reagent (Blocking reagent (Roche Applied 
Science, Switzerland) diluted 1:10 in 1x TNT (10mM Tris (pH 8.0), 150mM NaCl, 
0.05% Tween). and incubated overnight at 4°C with shaking. The membrane was then 
incubated with primary antibody (refer to table 3 for dilutions of specific antibody) 
followed by 3x 10 minute washes with 1x TNT at room temperature. The incubation 
and wash process was subsequently repeated for the appropriate secondary antibody 
(refer to table 3 for details). The membrane was then incubated for 5 minutes with 
SuperSignal® West Pico Stable Peroxide solution (2mL, Thermo Fisher Scientific, 
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U.S.A) and Pico Luminol/Enhancer solution (2mL, Thermo Fisher Scientific, U.S.A) 
with shaking. Excess chemiluminescent reagent was removed and the membrane was 
exposed for adequate lengths of time, up to 15 minutes using the Chemi-Smart 5000 
(Vilber Lourmat, France).  
 
2.3.3 Stripping and re-probing membranes for western analysis 
 
For detection of additional proteins, membranes were washed for 10 minutes with 1X 
TNT then incubated with Restore
TM
 PLUS Western Blot Stripping Buffer (Thermo 
Fisher Scientific, U.S.A) with vigorous shaking for 15 minutes to facilitate the removal 
of antibodies attached to the membrane. The membrane was then washed twice more 
with 1X TNT (10 minutes) before being placed in 1x Blocking Reagent (Roche Applied 
Science, Switzerland) and additional probing proceeded as described above (section 
3.3).  
 
2.4 Chromatin analysis  
 
Table 2.4: Primers designed to promoter regions used for chromatin 
analysis  
 
Name Sequence (5’ to 3’) Fragment Size (bp) 
mGMA 
(Holloway et al. 2003) 
 
F: GCCTGACAACCTGGGGGAAG 
R: TGATTAATGGTGACCACAGAACTC 
116 
 
mIL23a_pro 
(Ramirez-Carrozzi et al. 
2009) 
 
F: GCCTCTAGCCACAACAACCTC 
R: ATTCCCCTCCCTACATCATCTC 
 
95 
mIL6_pro  93 
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(Ramirez-Carrozzi et al. 
2009) 
F: AATGTGGGATTTTCCCATGA 
R: GCTCCAGAGCAGAATGAGCTA 
 
mIL10_pro 
(Ramirez-Carrozzi et al. 
2009) 
 
F: GCAGAAGTTCATTCCGACCA 
R: GGCTCCTCCTCCCTCTTCTA 
 
119 
RhoD  
(Poke et al. 2012) 
 
F: ATATCTCGCGGATGCTGAAT 
R: GACAGACCAAGGCTGCTT 
136 
 
 
2.4.1 Chromatin accessibility by real time PCR (CHART-PCR) 
 
Chromatin accessibility (CHART-PCR) assays were performed as previously described 
(Rao, Procko & Shannon 2001). Briefly, cells (up to 1x10
7
 per sample) were pelleted 
(500g, 5 minutes, 4°C) and washed in 10mL of chilled 1X PBS (MP Biomedicals, 
U.S.A) before being resuspended in chilled nuclei buffer (1 mL containing; 10mM Tris 
(pH 7.5), 10mM NaCl, 3mM MgCl2, 0.1mM EDTA (pH 8.0), 0.5% Igepal, 0.15mM 
spermine and 0.5mM spermidine) and incubated on ice for 5 minutes. Nuclei were 
pelleted by centrifugation (500g, 3 minutes, 4°C) and washed once in MNase1 buffer 
(1mL containing; 10mM Tris (pH 7.5), 15mM NaCl, 60mM KCl, 0.15mM spermine 
and 0.5mM spermidine) before being resuspended in 200µl MNase1 buffer. An aliquot 
(94µL) of each sample was used for subsequent MNase1 digestion whilst an equal 
volume of each sample was used as an undigested control. Calcium chloride (1mM) 
was added to all samples.  
 
For MNase1 digestion, samples were incubated with 1 unit of MNase1 (Roche Applied 
Science, Switzerland) in MNase1 buffer (5µL) for exactly 5 minutes before the reaction 
was quenched with the addition of stop buffer (20μL containing; 0.1M EDTA (pH 8) 
and 0.05M EGTA (pH 8)). MNase1 buffer alone (5µL) was added to undigested 
controls. All samples were then diluted to 200µL with MNase1 buffer and subjected to 
DNA extraction using the QIAamp DNA Blood Mini Kit (Qiagen, Netherlands) 
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according to manufacturer’s directions. Genomic DNA (50ng per sample) was used for 
qPCR analysis (as per 2.2.3.1) with appropriate promoter primers (refer to table 2.4) 
and accessibility of DNA to MNase1 digestion was determined relative to undigested 
samples.  
 
2.4.2 Chromatin Immunoprecipitation (ChIP) 
 
ChIP analysis was performed as previously described (Chen et al. 2005). Briefly, 
proteins were cross-linked to DNA through treatment of EL4 T cells (15mL at a density 
of 5x 10
5
 cells/mL) or RAW 264.7 cells (2x 75cm
2
 flasks each with 20mL of media 
covering adherent cells at 80% confluence) with 37% formaldehyde (final 
concentration of 1%) for 10 minutes.  Cross-linking was quenched through the addition 
of glycine (final concentration of 0.125M) and incubated at room temperature for 10 
minutes. Adherent RAW 264.7 cells were recovered by scraping from the bottom of the 
flask.  Cells were pelleted by centrifugation (500g for 5 minutes) and washed twice in 
ice cold PBS (MP Biomedicals, U.S.A) with Complete EDTA-Free Protease Inhibitor 
Cocktail (Roche Applied Science, Switzerland). Cells (2.0x10
6
) were then re-suspended 
in 250µL sodium dodecyl sulphate (SDS) lysis buffer (1% SDS, 10mM EDTA, 50mM 
Tris-HCl. pH 8.1) with added Complete EDTA-Free Protease Inhibitor Cocktail (Roche 
Molecular Biochemicals, U.S.A) before being subjected to sonication using the settings 
on the Diagenode Bioruptor
®
 (Diagenode, Belgium) empirically determined to generate 
DNA fragments 200 to 1000bp in length. ChIP dilution buffer (1mL containing; 0.01% 
SDS, 1.2mM EDTA (pH 8.0), 16.7mM Tris-HCl (pH 8.1), 1% Triton X-100, 167mM 
NaCl) and salmon sperm DNA/ protein A agarose slurry (60µL; Millipore Corporation, 
Germany) were added and incubated at 4°C for 1 hour on a rotating wheel in order  to 
pre-clear samples. A total input sample was taken from the supernatant (100µL) and 
stored at -80ºC for use as a PCR control.  Aliquots (300μL) of each sample were used 
for a no antibody control and each antibody treatment. Chromatin/bead/antibody mix 
was incubated overnight with rotation (4°C). For details of antibodies and 
concentrations used refer to table 2.5. 
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Immune complexes were recovered by incubation with salmon sperm DNA/ protein A 
agarose slurry (60µL; Millipore Corporation, Germany) for 2 hours and washed in a 
series of buffers; Low Salt Buffer (1mL containing, 0.1% SDS, 2.0mM EDTA, 20mM 
Tris- HCl (pH 8.1), 1% Triton X-100, 150mM NaCl), High Salt Buffer (1mL 
containing, 0.1% SDS, 2.0mM EDTA (pH 8.0), 20mM Tris-HCl (pH 8.1), 1% Triton 
X-100, 500mM NaCl), LiCl Buffer (1mL containing, 1.0mM EDTA pH 8.0, 10mM 
Tris-HCl (pH 8.1), 250mM LiCl, 1% Igepal, 1% Deoxycholate) then twice in TE 
Buffer (1mL containing, 1.0mM EDTA pH 8.0, 10mM Tris-HCl pH 8.1). All wash 
buffers were supplemented with Complete EDTA-Free Protease Inhibitor Cocktail 
(Roche Applied Science, Switzerland). Following the final TE wash, immune 
complexes were eluted in Elution Buffer (400µL, 1% SDS, 10mM NaHCO3). 
Proteinase K (1µL, 20mg/mL; Qiagen, Netherlands) and NaCl (0.2M) were added to all 
samples and incubated overnight (65°C) to reverse cross-linking.  
 
Immunoprecipitated DNA was  purified by phenol/chloroform extraction using phase-
lock gel light 1.5mL tubes (5 Prime, Germany) and ethanol precipitated overnight at -
20°C before being washed in 70% ethanol, air-dried and resuspended in 50µL MilliQ® 
water (Millipore Corporation, Germany). DNA (5µL) was amplified by qPCR (as per 
section 2.2.3.1). Data was normalised to total input samples and analysed relative to no 
antibody controls and the silent Rhodopsin gene (refer to table 2.4 for primer 
sequences).  
 
 
Table 2.5: Antibodies used for chromatin immunoprecipitation  
 
Affinity Host Type Amount 
per IP 
Supplier (cat. No)  
Anti - NFκB p65 (C-
20) 
Goat Polyclonal 2µg Santa Cruz 
Biotechnology, 
U.S.A  (sc-272X) 
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Anti - c-Rel (C) Rabbit Polyclonal 2µg Santa Cruz 
Biotechnology, 
U.S.A (sc-71X) 
Anti – Histone H3 Rabbit Polyclonal 1.8µg Abcam, UK 
(ab1791) 
Anti – acetyl-H3 Rabbit Polyclonal 4µg  Millipore, 
Germany (06599) 
 
2.5 Cloning of promoter regions  
Upstream regions of the IL-6, IL-10 and IL-23A genes were cloned into the pXPG 
luciferase reporter plasmid (Bert et al. 2000). Primers were designed to specifically 
amplify the region approximately 1000bp upstream of the transcriptional start site of 
each gene using the National Centre for Biotechnology (NCBI) BLAST and Primer 
BLAST programs (http://blast.ncbi.nlm.nih.gov/). The New England BioLabs® (NEB) 
cutter V2.0 program (http://tools.neb.com/NEBcutter2/) was used to identify restriction 
enzymes which did not digest DNA within the promoter sequences. Xho1 and HindIII 
restriction enzymes were then selected and their recognition sequences added included 
at the 5’ end of the primer sequences as indicated by underline in Table 2.6.  Random 
nucleotides were then added on to the 5’ end of the restriction enzyme sites to enhance 
digest efficiency.  
 
 
Table 2.6: Promoter cloning primers 
 
Name Sequence (5’ to 3’) Fragment Size (bp) 
 
IL-6  
 
F: TGCTACTCGAGGAGCTTCAAACACAAG 
 
R: TGCTACAAGCTTGCGGTTTCTGGAATTG 
  
1062 (+23) 
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IL-10 
 
F: TGCTACTCGAGCATTCCCTGGTCAACA 
 
R: TGCTACAAGCTTTAGTGCAAGAGCAAGT 
 
 
1042 (+23) 
 
IL-23A 
 
F: TGCTACTCGAGGACGTCCAGATGGTGC 
 
R: TGCTACAAGCTTTAACTCTGTAGTCCGA 
 
 
1046 (+23) 
 
 
2.5.1.1 PCR amplification of promoter regions 
 
Genomic DNA (50ng) was isolated from EL4 T cells using the QIAamp DNA Blood 
Mini Kit (Qiagen, Netherlands) and used as a template for the PCR amplification of the 
promoter regions. A 25µL Go-Taq® Green (12.5µL. Promega Corporation, U.S.A) 
reaction was employed with 0.2µM primers (Table 2.5). DNA was amplified using a 
Veriti® 96 Well Thermal Cycler (Applied Biosystems
TM
, U.S.A) under the following 
cycling conditions: 1X 95ºC for 3 minutes, 35X 95ºC for 15 seconds followed by 56ºC 
30 seconds and 72ºC for 1 minute. Following the last cycle samples were held at 72ºC 
for 10 minutes. 
 
Annealing temperature was ascertained by gradient PCR for each primer pair. An 
annealing temperature of 56ºC was used for the IL-6 cloning primers whilst a 
temperature of 54ºC was selected for the IL-10 and IL-23A promoter cloning primers.  
 
PCR product specificity was confirmed by electrophoresis through a 1% agarose gel in 
1x TAE and PCR products were visualised using SYBR® safe DNA gel stain 
(Invitrogen
TM
, U.S.A). Molecular weight standards HindIII λ (New England Biolabs, 
U.S.A) and HyperLadder II (Bioline, Australia) were electrophoresed alongside the 
PCR product for size comparison. Products were purified using the GFX
TM
 DNA and 
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Gel Band Purification kit (GE Healthcare, UK) according to the manufacturer’s 
directions.  
 
2.5.1.2 Ligation 
 
PCR products were ligated into the pXPG plasmid vector (Bert et al. 2000) which was 
first prepared using the Plasmid Maxi Kit (Qiagen, Netherlands). Both PCR products 
and vector were digested overnight with the Xho1 and HindIII restriction enzymes, 
followed by purification with the GFX
TM
 DNA and Gel Band Purification kit (GE 
Healthcare, UK). Ligations were performed using 50ng of vector and a 3:1 insert: 
vector ratio using 1µL of both T4 DNA Ligase and T4 Ligase buffer (New England 
BioLabs, U.S.A) in a 10µL reaction. Ligations were incubated overnight at room 
temperature.  
 
2.5.1.3 Plasmid transformation 
 
One Shot® TOP 10 Chemically Competent E. coli cells (Invitrogen
TM
, U.S.A) were 
transformed with the ligated DNA according to the manufacturers’ instructions. The E. 
coli cells (25µL) were thawed on ice. Ligated DNA (5µL) was added and incubated at 
on ice for 30 minutes. The cells were then heat-shocked at 42ºC for 30 seconds, 
incubated on ice for 2 minutes and 250µL of pre-warmed SOC medium (Invitrogen
TM
, 
U.S.A) was added. The cells were incubated with shaking (37ºC, 1 hour) before being 
pelleted by centrifugation (15,000g, 5 minutes). Excess supernatant (170µL) was 
removed from cell pellets and the pellet was resuspended in residual SOC medium. 
Cells were then plated out on agar plates containing 50µg/mL ampicillin. Plates were 
incubated overnight at 37ºC to enable cell growth and subsequently stored at 4ºC.  
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2.5.1.4 Identification of recombinant plasmids 
 
To select colonies which were successfully transformed with the recombinant plasmids 
colonies were screened utilising PCR, restriction enzyme digest and DNA sequencing. 
 
2.5.1.5 PCR screening and restriction enzyme digest 
 
Individual colonies were picked from each plate and inoculated into 10µL of MilliQ® 
(Millipore, Germany). Colonies were re-streaked onto agar plates containing 50µg/mL 
ampicillin and allowed to grow overnight at 37ºC before being stored at 4ºC for further 
use. The inoculated water was used as a template for PCR reaction as described in 
section 2.5.1.1. The PCR products were analysed by agarose gel electrophoresis and 
colonies that contained the recombinant plasmids were used for DNA isolation using 
the Wizard
®
 Plus SV Minipreps DNA Purification System (Promega Corporation, 
U.S.A) and further analysis. A restriction enzyme digest was performed with the Xho1 
and HindIII restriction enzymes (New England BioLabs, U.S.A) on isolated DNA to 
confirm the plasmid identity. Digests were subjected to electrophoresis through a 1% 
agarose gel to confirm fragment sizes.  
 
2.5.1.6  DNA sequencing 
 
To confirm the successful generation of the recombinant plasmids identified by PCR 
screening and restriction enzyme digest (section 5.1.5.2) plasmid DNA (100ng) was 
sequenced to confirm the insert sequence. Forward and reverse primers were designed 
for the pXPG plasmid DNA so as to flank the promoter insert site. The sequencing 
reaction was carried out with either the forward primer (0.528µM) sequence: 5’ 
TCATGTCTGGATCAGCCATATC 3’ or the reverse primer (0.528µM) sequence: 5’ 
TGGAAGACGCCAAAAACATAAAG 3’. The plasmid DNA was sequenced using the 
BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems
TM
, U.S.A) in a 
Veriti® 96 Well Thermal Cycler (Applied Biosystems
TM
, U.S.A) using the following 
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reaction conditions: 1X 96ºC for 1 minute, 25X 96ºC 10 seconds, 50ºC 5 seconds and 
60ºC for 4 minutes.  
 
Sequencing reactions were purified using the CleanSEQ® beads (Agencourt® 
Bioscience Corporation, U.S.A) and resuspended in 40µL of MilliQ water. Purified 
sequencing reaction (30µL) were sequenced on the ABI
TM 
310 Genetic Analyzer 
(Applied Biosystems
TM
, U.S.A) and sequences were analysed using Sequencher 4.10.1 
DNA sequencing software (Gene Codes Corporation, U.S.A) to confirm insert 
sequence. 
 
2.6 Luciferase Reporter Assay 
 
The luciferase reporter plasmids containing the promoter regions of the IL-6, IL-10 and 
IL-23A cytokine genes cloned into pXPG were analysed for promoter activity and 
responsiveness to the NF-κB transcription factors, c-Rel and Rel-A using a luciferase 
reporter assay. 
 
2.6.1 Plasmid Preparation and Cell Transfection 
 
Each of the pXPG promoter plasmids (IL-6, IL-10 and IL-23A) were co-transfected 
with the Rel-A cFlag pcDNA3 (Addgene plasmid 20012) and c-Rel cFlag pcDNA3 
(Addgene plasmid 20013), both of which have been described previously (Sanjabi et al. 
2005). A non-active control plasmid RcCMV (Invitrogen
TM
, U.S.A) was used in the 
absence of the Rel constructs to ensure equal DNA. Transfection with the luciferase 
activity control plasmid pGL3 (Promega Corporation, U.S.A) in which luciferase 
activity is under the control of the SV40 promoter and enhancer was performed 
alongside the other transfections to monitor transfection efficiency.  
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All plasmid DNA was prepared using the Plasmid Max Kit (Qiagen, Netherlands) from 
E.coli cultures grown with shaking in L broth (100mL) with 50µg/mL ampicillin (37ºC, 
overnight). Purified plasmid DNA was resuspended in TE buffer (100µL, Invitrogen
TM
, 
U.S.A) and quantified using the NanoDrop® ND-1000 Spectrophotometer (Thermo 
Fisher Scientific, U.S.A). Plasmid DNA used for transfections was stored at -20ºC at a 
concentration of 1µg/µL.  
 
2.6.1.1 Transfection of EL4 T cells 
 
The EL4 cell line was passaged to reach a density of 5x10
5 
cells/mL at the time of 
transfection. Cells were pelleted by centrifugation (500g, 5 minutes) and resuspended at 
a concentration of 1.5x10
7
 cells/mL in pre-warmed RPMI 1640 medium (Invitrogen
TM
, 
U.S.A) supplemented with fetal bovine serum (20%; JRH Biosciences, Australia), 
penicillin (100U/mL) and streptomycin (100µg/mL, Sigma-Aldrich, U.S.A). Purified 
plasmid DNA (5µg per plasmid) was pipetted onto the wall of a 0.4mm electroporation 
cuvette (Bio-Rad Laboratories, U.S.A). Cells (300µL) were added to the plasmid DNA 
and allowed to mix for 5 minutes. Cells were electroporated at 270V with a capacitance 
of 950µFarad and a resistance of infinity using a Gene Pulser Xcell
TM
 (Bio-Rad 
Laboratories, U.S.A). Cells were recovered in 1mL of RPMI 1640 medium 
(Invitrogen
TM
, U.S.A) supplemented with fetal bovine serum (10%; JRH Biosciences, 
Australia), penicillin (100U/mL) and streptomycin (100µg/mL, Sigma-Aldrich, U.S.A). 
Following 10 minutes of recovery, cells were returned to the incubator (37ºC, 5% CO2) 
in 10mL of medium and incubated for 24 hours. Each transfection was performed in 
duplicate and combined into one flask after transfection. 
 
2.6.1.2 Transfection of RAW 264.7 cells 
 
The RAW 264.7 cell line was passaged to reach 70% confluence at the time of 
transfection. RAW 264.7 cells were transfected using a protocol described previously 
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(Smale 2010b). Briefly, adherent cells were removed with a cell scraper and pelleted 
(500g, 5 minutes). Cells were resuspended in pre-warmed RPMI 1640 medium 
(Invitrogen
TM
, U.S.A) supplemented with fetal bovine serum (20%; JRH Biosciences, 
Australia), penicillin (100U/mL)  and streptomycin (100µg/mL, Sigma-Aldrich, U.S.A) 
at a concentration of 3.75x10
7
 cells/mL Purified plasmid DNA (5µg per plasmid) was 
pipetted onto the wall of a 0.4mm electroporation cuvette (Bio-Rad Laboratories, 
U.S.A). Cells (200µL) were added to the plasmid DNA and allowed to mix for 5 
minutes. Cells were electroporated at 250V with a capacitance of 950µFarad and a 
resistance of infinity using a Gene Pulser Xcell
TM
 (Bio-Rad Laboratories, U.S.A). 
Following transfection cells were washed in 1X PBS (MP Biomedicals, U.S.A) and 
resuspended in RPMI 1640 medium (Invitrogen
TM
, U.S.A) supplemented with fetal 
bovine serum (10%; JRH Biosciences, Australia), penicillin (100U/mL) and 
streptomycin (100µg/mL, Sigma-Aldrich, U.S.A) and returned to the incubator (37ºC, 
5% CO2) in 10mL of medium and incubated for 24 hours. Each transfection was 
performed in duplicate and combined into one flask after transfection. 
 
2.6.2 Preparation of cell lysates for reporter assay 
 
At 24  hours post-transfection cells were  pelleted by centrifugation (500g, 5 minutes at 
4°C) and washed twice with ice-cold PBS before re-suspension in 100µL of cell lysis 
buffer (1X Cell Culture Lysis Reagent, Promega Corporation, U.S.A). Cell lysates were 
then transferred to a 1.5mL microcentrifuge tube and kept on ice. Tubes were vortexed 
briefly to ensure complete cell lysis and centrifuged (12,000g for 2 minutes) at room 
temperature to facilitate separation of cell debris. Supernatant was transferred to a new 
1.5mL microcentrifuge tube and stored at -80°C.  
 
2.6.3 Luciferase activity assay 
 
Protein concentration of lysates was determined by Bradford assay as outlined in 
section 3.2. Luciferase activity was analysed using the Luciferase Assay System 
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(Promega Corporation, U.S.A). Luciferase Assay Substrate was reconstituted with the 
Luciferase Assay Buffer as directed by the manufacturer. Cell lysate (30µg) was 
aliquoted into an opaque white, 96-well plate (Greiner Bio-one, Germany), in duplicate 
and the total volume made up to 100µL with 1x cell culture lysis buffer (Promega 
Corporation, U.S.A). Luciferase activity was measured following the addition of 100µL 
reconstituted Luciferase Assay Reagent (Promega Corporation, U.S.A) using a Turner 
Biosystems Veritas™ Microplate Luminometer (Turner Biosystems Incorporated, 
U.S.A). 
 
2.7 Data Analysis 
 
All basic data analysis was performed in Microsoft Excel 2010. Unless otherwise 
specified a paired Students T. Test was used to determine significance from non-
stimulated. Unless otherwise specified, p values shown are for two tailed T. Tests. A p 
value of less than 0.05 was considered significant.  
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3  Divergent activation requirements for GM-CSF gene 
expression in T cells and macrophages  
 
3.1 Introduction 
The initiation, duration and resolution of an immune response is dependent on the 
coordinated induction of immune gene expression programs. A key control point in the 
induction of cytokine gene expression is at the level of gene transcription, through the 
assembly of precise transcription initiation complexes at gene regulatory regions (Carey 
1998; Litterst et al. 2005; Ptashne & Gann 1997). However, the assembly of such 
transcription complexes must take place within the chromatin environment established 
at the gene. Thus gene responses are dependent on the interaction between transcription 
factors, transcription initiation complexes and the chromatin platform (Li, Carey & 
Workman 2007; Lim et al. 2013; Natoli 2009). The chromatin structure itself is further 
modified by interaction with histone modifying enzymes and chromatin remodelling 
complexes (Cockerill 2011; Gardner, Allis & Strahl 2011; Kouzarides 2007).  
 
The inflammatory cytokine, Granulocyte-Macrophage Colony Stimulating Factor (GM-
CSF) otherwise referred to as Colony Stimulating Factor 2 (CSF2) is produced at high 
levels in T cells following immune activation. As such, the GM-CSF gene has proved a 
valuable model with which to study how inducible gene expression is regulated both at 
the level of transcription (Himes et al. 1996; Shannon, Himes & Coles 1995) and by 
chromatin structure (Brettingham-Moore et al. 2005; Brettingham-Moore et al. 2008; 
Cakouros et al. 2001; Cockerill 2004; Holloway et al. 2003). Regulation of the rapid 
activation of GM-CSF gene expression has been attributed to a proximal promoter, 
encompassing 100bp upstream of the transcriptional start site, in addition to an 
upstream enhancer (Shannon et al. 1997). The activation of GM-CSF gene transcription 
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and the associated changes in chromatin architecture at both the promoter and enhancer 
regulatory regions of the gene, have been extensively studied in T cells. Increased gene 
transcription is induced via signalling through the T cell receptor and to co-stimulatory 
molecules which activate the protein kinase C (PKC) and calcium signalling pathways 
(Brettingham-Moore et al. 2005; Shannon et al. 1997). Whilst low basal levels of gene 
expression are permissible without chromatin remodelling, higher levels of 
transcription occur in association with changes in the chromatin architecture of the 
promoter and enhancer regions (Cockerill et al. 1993). Changes in nucleosome 
occupancy at the promoter region are detected by an increase in sensitivity of the 
promoter DNA to digestion by MNase1 (Holloway et al. 2003). This increased 
sensitivity is in part attributable to the loss of core histone proteins from the region 
indicating that increased gene transcription is enabled by chromatin remodelling events 
(Brettingham-Moore et al. 2008; Chen et al. 2005; Holloway et al. 2003; Poke et al. 
2012). Prior to remodelling, the promoter is marked by high levels of histone 
acetylation which may be recognised by and recruit activating factors to the promoter 
region. The chromatin remodelling protein, BRG1, is a member of the SWI/SNF 
complex and contains an acetylation recognising bromodomain which associates with 
the promoter region (Brettingham-Moore et al. 2005; Brettingham-Moore et al. 2008).  
 
As part of the SWI/SNF complex, BRG1 is able to utilise ATPase to disrupt 
DNA/nucleosome interaction via complete displacement, nucleosome sliding or 
unravelling, which may directly alter gene expression (Saha, Wittmeyer & Cairns 2006; 
Wurster, Precht & Pazin 2011). BRG1 is essential for embryonic development and is 
known to have an important regulatory role in T cell development (Bultman et al. 2000; 
Chi et al. 2002; Chi et al. 2003) as well as maintaining functionality of mature cells of 
the haematopoietic lineages (De et al. 2011; Ramirez-Carrozzi et al. 2006; Wurster & 
Pazin 2008). Whilst remodelling enzymes, such as BRG1, are thought to bind DNA 
non-specifically, they may be recruited to targeted regions through interaction with 
modified histones (such as histone acetylation), transcription factors or non-coding 
RNA (Hassan et al. 2001; Ho & Crabtree 2010; Lee et al. 2010; Singh et al. 2007; 
Wurster & Pazin 2008; Wysocka et al. 2006; Yudkovsky et al. 1999). BRG1 has been 
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identified as a functional regulator of the GM-CSF gene in T cells, where it is thought 
to mediate the changes in nucleosome occupancy of the promoter region, allowing the 
transcription machinery to assemble and facilitate gene transcription (Brettingham-
Moore et al. 2008; Holloway et al. 2003).  
 
The NF-κB transcription factors are key mediators of gene expression throughout the 
immune system and have a critical role in GM-CSF transcription (Cakouros et al. 2001; 
Ghosh, May & Kopp 1998; Holloway et al. 2003; Shannon, Himes & Coles 1995). c-
Rel appears to be particularly crucial for GM-CSF transcription, as c-Rel depleted T 
cells are unable to increase GM-CSF expression in response to stimulation (Gerondakis 
et al. 1996). In addition, c-Rel has been shown to be required for chromatin remodelling 
events which precede increased GM-CSF transcription (Brettingham-Moore et al. 2005; 
Poke et al. 2012). Furthermore, an interaction between the Rel-A subunit and BRG1 has 
been observed at a distal enhancer region of the GM-CSF and IL-3 locus which is also 
associated with increased gene expression (Wurster, Precht & Pazin 2011). 
 
GM-CSF expression is not restricted to the T cell lineage, with expression also 
inducible in response to stimuli in several other cell types including macrophages, mast 
cells and fibroblasts (Cockerill 2004; Shannon et al. 1997). However the activation 
requirements in other cell types are less understood. Available data suggests that in 
macrophages, rather than being dependent on BRG1 chromatin remodelling, GM-CSF 
gene activation is SWI/SNF independent. Additionally, GM-CSF gene expression has 
been classified as  independent of new protein synthesis and therefore a primary 
response gene in macrophages (Ramirez-Carrozzi et al. 2009). In contrast, in T cells 
GM-CSF is a secondary response gene with gene expression dependent on the synthesis 
of new proteins (Brettingham-Moore et al. 2005).  
 
These studies suggest that GM-CSF gene activation is regulated by fundamentally 
different mechanisms in macrophages compared to T cells. Therefore the aim of this 
chapter is to characterise the activation requirements of the GM-CSF gene in 
macrophage cells in comparison to T cells.  
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3.2 Results 
 
3.2.1 GM-CSF gene expression is induced in T cells and macrophages 
 
To confirm that GM-CSF gene transcription is inducible in both T cells and 
macrophages and to establish cell models in which to investigate the mechanisms of 
GM-CSF gene regulation, gene responses were analysed by RT-qPCR using RNA 
extracted from both murine cell lines and primary cells prepared from male C57/BL6 
mice. In the EL4 T cell line (Figure 3.1.A) an increase in GM-CSF mRNA levels is 
observed in response to 4 hours of treatment with PMA and calcium ionophore (PI), 
(p<0.01). Treatment with PI activates the protein kinase C and calcium signalling 
pathways respectively, which operate downstream of T cell receptor signalling 
(Takahama & Nakauchi 1996; Tsuboi et al. 1994). Similarly, CD4+ T cells prepared 
from mouse splenocytes produced increased GM-CSF mRNA levels in response to 4 
hours of PI treatment (Figure 3.1.B, p<0.05). In contrast, in RAW 264.7 macrophages 
exposed to PI for 4 hours there was no discernible increase in GM-CSF transcript levels 
(Figure 3.2.A). The bacterial cell wall component, lipopolysaccharide (LPS) is 
routinely used to illicit immune responses in macrophage cells as it signals through Toll 
Like Receptor 4 (TLR4), and has previously been documented to induce GM-CSF gene 
expression (Li et al. 2012; Ramirez-Carrozzi et al. 2006). In keeping with this, RAW 
264.7 macrophage cells stimulated for 4 hours with LPS displayed increased GM-CSF 
mRNA levels (Figure 3.2.B, p= 0.050). Primary macrophage cells were derived from 
C57/BL6 mouse bone marrow cells differentiated by culturing in M-CSF conditioned 
medium. Following 5 days of differentiation >90% of cells stained positive for the 
monocyte/macrophage marker CD11b (Figure 3.3.A). Treatment of these cells with 
LPS for 4 hours also produced a significant increase in GM-CSF mRNA levels (Figure 
3.3.B. p<0.05). The relative levels of GM-CSF mRNA are greater in T cells when 
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compared to macrophages. This is not attributable to differences in the house-keeping 
gene GAPDH to which expression was normalised. Rather this is a reflection of lower 
absolute GM-CSF mRNA levels induced in macrophage cells.  
 
3.2.2 Kinetics of GM-CSF activation is similar in T cells and macrophage cells 
 
The kinetics of GM-CSF gene activation were analysed in T cells and macrophages in 
order to determine if this is reflective of the switch between a secondary to a primary 
response gene as reported in the literature. Changes in GM-CSF mRNA levels were 
monitored over a 24 hour time course in both EL4 T cells and RAW 264.7 macrophage 
cells following stimulation. Cells were collected for RNA extraction both prior to 
stimulation (NS) as well over a 24 hour period post stimulation. Basal transcript levels 
were low in T cells (Figure 3.4.A) and not detectible in macrophage cells (Figure 
3.4.B). In response to stimulation an increase in GM-CSF mRNA levels was observed 
in both cell types, however the amplitude of maximal expression varied between 
individual experiments as well as between cell types. Therefore in order to effectively 
compare the kinetics of the response between the two cell types, gene expression was 
normalised to expression at 4 hours, which was set to 100 in each case (unadjusted data 
is available in Appendix B, page 178). The 4 hour time point was selected as at this 
time, a significant increase in GM-CSF mRNA levels was observed in both cell types. 
As previously documented in T cells, GM-CSF mRNA levels increased in response to 
PI treatment and a peak in GM-CSF transcription was observed after 8 hours of PI 
treatment and had decreased by 24 hours (Brettingham-Moore et al. 2005; Brettingham-
Moore et al. 2008), as depicted in Figure 3.4.A. A similar activation profile was 
observed in RAW 264.7 macrophage cells, with mRNA levels peaking at 8 hours and 
decreasing by 24 hours post stimulation (Figure 3.4.B). As no discernible difference in 
activation kinetics of GM-CSF was observed between the two cell types, subsequent 
experiments utilised the 4 hour time point for stimulation.  
 
59 
 
 
60 
 
3.2.3 GM-CSF gene transcription and reliance on new protein synthesis 
 
While no difference in activation kinetics was observed, previous work has suggested 
that GM-CSF is a secondary response gene in T cells (Brettingham-Moore et al. 2005), 
but a primary response gene in macrophages (Ramirez-Carrozzi et al. 2009). In order to 
confirm this divergence between the two cell types, gene expression responses were 
studied in EL4 T cells and RAW 264.7 macrophages. Gene transcription was examined 
in the presence of the protein synthesis inhibitor cycloheximide (CHX) to determine the 
reliance on the translation of new proteins for induction of GM-CSF gene expression. 
Cells were either left un-treated or pre-treated with CHX for 30 minutes. Following pre-
treatment cells were either left unstimulated or stimulated with PI (EL4 T cells) or LPS 
(RAW 264.7 cells) for 4 hours.  
 
In T cells, the increase in GM-CSF mRNA levels in response to stimulation was 
reduced in the presence of CHX (Figure 3.5.A; p<0.05). In contrast, CHX treatment of 
RAW 264.7 cells enhances the transcriptional response to LPS (Figure 3.5.B; p= 
0.212), with enhanced transcription observed as soon as 1 hour post stimulation (data 
not shown). These results demonstrate that whilst GM-CSF mRNA levels are inducible 
in both T cells and macrophages, the requirements for GM-CSF gene transcription vary 
between the two cell types. The divergence in CHX dependence may be reflective of 
differences in proteins required for gene activation or differences in the basal levels of 
these proteins in the different cell types. To determine if this response is unique to the 
RAW 264.7 macrophage cell line, the activation response in the presence of CHX was 
also determined in primary bone marrow derived macrophages (BMDMs). 
 
BMDM cells have a similar transcription profile to the RAW 264.7 macrophage cells 
with increased GM-CSF mRNA levels in the presence of LPS (p<0.01). CHX treatment 
alone increased GM-CSF mRNA levels, whilst superinduction of GM-CSF mRNA was 
observed with combined CHX and LPS treatment (Figure 3.6.A). These results confirm 
that the RAW 264.7 macrophage data is not limited to the immortalised cell line alone 
and can be replicated in primary cultured macrophages.  
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Fibroblast cells are also documented as producing GM-CSF in response to immune 
stimuli (Shannon et al. 1997). In order to confirm this, murine embryonic fibroblasts 
(MEFs) were extracted from day 14 mouse embryos. Cultured MEF cells were treated 
with CHX and LPS as described for the BMDM. An increase in GM-CSF mRNA levels 
in response to LPS stimuli was observed in MEFs (Figure 3.6.B. p= 0.175). In the 
presence of CHX the GM-CSF mRNA levels were significantly enhanced (p<0.05) 
indicating that GM-CSF superinduction in the presence of CHX is not limited to 
macrophage cells.   
 
Therefore, in T cells GM-CSF is classified as a secondary response gene, reliant on de 
novo protein synthesis prior to increased gene transcription. In contrast, in macrophage 
and fibroblast cells GM-CSF is a primary response gene with increased expression in 
response to stimulation independent of new protein synthesis.  
 
3.2.4 NF-κB nuclear localisation differs in T cells compared to macrophages 
 
The c-Rel transcription factor is a key member of the NF-κB family and has been 
recognised as being of particular importance in BRG1 chromatin remodelling events 
observed at the GM-CSF promoter in T cells (Brettingham-Moore et al. 2005; Poke et 
al. 2012). As GM-CSF gene expression is thought to be SWI/SNF independent in 
macrophages (Ramirez-Carrozzi et al. 2009), different availability/requirement for c-
Rel may be associated with the switch from being reliant on new protein synthesis in T 
cells to being independent of protein synthesis in macrophages. Prior to activation the 
NF-κB family transcription factors are tethered in the nucleus by the inhibitory IκB 
proteins. Upon activation, a series of phosphorylation and ubiquitination events occur 
leading to the degradation of IκB proteins and unmasking of the NF-κB nuclear 
translocation sequence. NF-κB transcription factors are then shuttled into the nucleus 
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where interactions with DNA and transcription machinery may take place (Karin & 
Ben-Neriah 2000). 
 
To determine whether differences in NF-κB activation in the two cell types explains the 
differences in protein synthesis dependence, western blot analysis was performed on 
cytoplasmic and nuclear protein extracts prepared from both untreated and CHX treated 
EL4 T cells and RAW 264.7 macrophages both non-stimulated (NS) and stimulated (PI 
and LPS). Blots were probed with antibodies against the c-Rel and Rel-A family 
members as well as the constitutively nuclear transcription factor, SP1 and β-actin as 
loading controls (Figure 3.7).  
 
In EL4 T cells, Rel-A was detectible in the cytoplasm and at low levels in the nucleus 
prior to stimulation (Figure 3.7.A). PI treatment increased the amount of Rel-A detected 
in both the nuclear fraction and the cytoplasmic fraction (Figure 3.7.A). In the presence 
of CHX, PI treatment results in an increase in nuclear Rel-A, indicating translocation of 
Rel-A to the nucleus is not reliant on the synthesis of new proteins. However, no 
increase in Rel-A is discernible in the cytoplasmic extract suggesting that the increase 
in cytoplasmic Rel-A in response to PI stimulation is the product of new Rel-A 
synthesis. In comparison, c-Rel is detectible at low levels in the EL4 T cell cytoplasmic 
fraction in the non-stimulated samples but undetectable in the nucleus (Figure 3.7.A). 
An increase in nuclear c-Rel is detected upon PI treatment however this response is 
inhibited in EL4 T cells pre-treated with CHX (Figure 3.7.A). These data suggested that 
in EL4 T cells the c-Rel transcription factor requires protein synthesis for nuclear 
activation as only very low levels are present in the cytoplasm prior to stimulation. It 
would therefore be expected that genes over which c-Rel exhibits regulatory control, 
such as GM-CSF, will be affected by CHX treatment in T cells.  
 
The house-keeping protein, β-actin was used as a loading control for all samples whilst 
transcription factor Sp1, which is constitutively present in the nucleus, was used as a 
nuclear loading control for the western analysis. In EL4 T cell extracts β-actin is 
detectible in all nuclear and cytoplasmic fractions although at slightly lower levels in  
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the CHX treated samples indicating that the synthesis of β-actin is inhibited by CHX. 
The nuclear loading control, Sp1, was absent from the cytoplasmic fractions indicating 
no nuclear contamination.  
 
In the extracts prepared from RAW 264.7 cells, Rel-A is detectible in both the nuclear 
and cytoplasmic fractions in all treatments (Figure 3.7.B). An increase in Rel-A in 
response to LPS stimulation is observed, however not to the level seen in T cells. In 
contrast to what was seen in T cells, nuclear localisation does not appear to be reliant 
on the synthesis of new proteins (Figure 3.7.B). In RAW 264.7 macrophage cells an 
increase in nuclear c-Rel occurs in response to 4 hours of LPS treatment and an 
increase in cytoplasmic c-Rel is also observed (Figure 3.7.B). Nuclear localisation is 
still observed in the presence of CHX (Figure 3.7.B). Further, in the presence of CHX 
alone an increase in nuclear c-Rel is observed suggesting that in RAW 264.7 cells, c-
Rel translocation is permitted in the absence of new protein synthesis.  
 
In the RAW 264.7 extracts, β-actin is detectible at comparable levels between all 
nuclear and cytoplasmic fractions suggesting that an equal quantity of protein was 
loaded per well. The nuclear loading control, Sp1, is more variable. In contrast to what 
was observed in the T cell fractions, a greater amount of Sp1 is detected in the RAW 
264.7 nuclear fractions which were not pre-treated with CHX (both NS and LPS 
treated). If CHX treated nuclear samples do not contain less protein then this further 
supports the observation that CHX enhances the nuclear localisation of c-Rel in 
macrophages but inhibits c-Rel translocation in T cells.  
 
These results support the hypothesis that the differences in protein synthesis 
requirements of the GM-CSF gene may be partially explained by the different effect of 
CHX treatment on c-Rel localisation in T cells compared to macrophages. In T cells 
CHX treatment inhibited both the synthesis of new cytoplasmic c-Rel and the nuclear 
localisation of c-Rel in response to PI stimulation. In macrophage cells, nuclear 
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localisation of c-Rel in response to LPS stimulation was not perturbed by CHX 
treatment.  
 
3.2.5 C-Rel is required for GM-CSF activation in T cells and macrophages 
 
Given that c-Rel is regulated differently in the two cell types the requirement for c-Rel 
for GM-CSF transcription was determined using the c-Rel inhibitor pentoxifylline 
(PTX) (Wang et al. 1997). Cells were either left untreated or pre-treated with PTX for 
30 minutes. Following pre-treatment cells were either left non-stimulated (NS) or 
stimulated for 4 hours with either PI (EL4 T cells) or LPS (RAW 264.7 macrophages).  
 
In EL4 T cells a significant increase in GM-CSF gene expression was observed in the 
absence of c-Rel inhibition (Figure 3.8.A; p<0.05). In the presence of PTX this was 
significantly reduced (Figure 3.8.A; p<0.05) confirming that c-Rel is required for GM-
CSF gene transcription in T cells. In RAW 264.7 cells an increase in GM-CSF mRNA 
levels is observed in the absence of PTX, although the amplitude of this response was 
variable (Figure 3.8.B; p= 0.169). In the presence of PTX a significant increase in GM-
CSF mRNA levels is observed in response to LPS stimulation (Figure 3.8.B; p<0.01). 
The amplitude of this response is reduced, although not statistically significantly, due to 
the variation in the non-PTX treated control. These results suggest that whilst an 
increase in GM-CSF gene expression can be induced in the absence of c-Rel, c-Rel is 
required for higher levels of transcription. The effect of PTX on GM-CSF gene 
expression provides further support for a role for c-Rel in GM-CSF gene activation in T 
cells. However the inhibition of GM-CSF expression in PTX treated macrophages is not 
conclusive as c-Rel inhibition did not significantly reduce GM-CSF expression. 
Therefore further investigation was required to confirm that the divergence in c-Rel 
nuclear localisation observed in the western blot analysis accounts for the divergent 
CHX response observed between the two cell types.   
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To confirm these results, an alternative approach the role of c-Rel in activation of GM-
CSF gene expression was examined in a knockout mouse model. CD4+ T cells and 
BMDM cells were purified from c-Rel
-/-
 mice (Liou et al. 1999) and gene transcription 
responses examined in comparison to wild type C57/BL6 (WT) cells. T cells were co-
stimulated with PI and CD28 which induced a significant increase in GM-CSF mRNA 
levels in WT cells (Figure 3.9.A; p<0.05). While an increase in GM-CSF mRNA levels 
was detected in c-Rel
-/-
 T cells (Figure 3.9.A; p= 0.121), the gene response was 
significantly reduced compared to WT T cells (p<0.05), demonstrating that in the 
absence of c-Rel the inducible expression of GM-CSF is limited. This supports the 
hypothesis that c-Rel is an important transcription factor required for GM-CSF 
expression. 
 
BMDM cells were treated with LPS to activate GM-CSF gene expression, which 
induced a high level of GM-CSF mRNA in WT cells (Figure 3.9.B), although this was 
highly variable and did not reach statistical significance (p= 0.156). BMDM derived 
from c-Rel
-/-
 mice also produced increased levels of GM-CSF mRNA in response to 
LPS treatment (Figure 3.9.B; p= <0.05) but these levels were consistently lower than 
that which was observed in the WT cells. These data are consistent with what was 
found utilising PTX c-Rel inhibition and confirm that c-Rel has an integral role in GM-
CSF gene transcription responses in both T cells and macrophages.   
 
3.2.6 GM-CSF promoter chromatin accessibility 
 
Association between c-Rel and the GM-CSF promoter has previously been shown to be 
required for chromatin remodelling across the previously defined promoter region in T 
cells (Brettingham-Moore et al. 2005; Poke et al. 2012). The requirement for chromatin 
remodelling complex assembly and activation prior to gene transcription events may 
explain the requirement for new protein synthesis prior to gene activation. Therefore 
changes in  
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chromatin accessibility in response to stimulation were examined in the presence and 
absence of protein synthesis inhibition in T cells and macrophages using a previously 
described CHART-qPCR technique (Rao, Procko & Shannon 2001). This assay has 
previously been used in T cells to demonstrate that chromatin remodelling occurs 
across the GM-CSF promoter region in association with increased GM-CSF mRNA 
levels (Holloway et al. 2003). 
 
In unstimulated T cells the promoter region is slightly accessible (uncut/cut ratio >1). 
Upon stimulation, EL4 T cells exhibit an increase in GM-CSF promoter accessibility to 
MNase1 (Figure 3.10.A) as has previously been described (Brettingham-Moore et al. 
2005; Holloway et al. 2003). In the presence of CHX, this increase in accessibility is 
not observed (Figure 3.10.A). These results indicate that new protein synthesis is 
required to mediate the chromatin remodelling events which facilitate the increased 
promoter accessibility and subsequent GM-CSF transcription events.  
 
In RAW 264.7 macrophage cells an increase in promoter accessibility is observed upon 
LPS stimulation (Figure 3.10.B; p<0.05) however the magnitude of this change is not as 
substantial as what was observed in T cells. In contrast to T cells, in the presence of 
CHX a significant increase in promoter accessibility of similar magnitude to that 
observed in the absence of CHX is induced (p<0.05). Importantly, these changes in 
accessibility also correlate with the changes in mRNA levels detected in RAW 264.7 
cells (Figure 3.5.B).  
 
In macrophage cells negative accessibility (uncut/cut value ratio <1, is detected in the 
unstimulated cells (Figure 3.10.B). This indicates that the non-digested samples contain 
less intact genomic DNA than those subjected to MNase1 digestion. It is conceivable 
that this may occur when the accessibility of the promoter is very close to zero as only 
at this level of accessibility would small errors in qPCR efficiency be unmasked and 
detectible as negative accessibility. Negative accessibility data has previously been 
published and reported as a mathematical artefact most likely attributable to error in  
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DNA quantitation and it was found to be neither reproducible nor biologically 
significant (Liang et al. 2006).  
 
These data confirm that increased promoter accessibility occurs in conjunction with 
increased gene transcription.  In EL4 T cells, treatment with PI for 4 hours results in an 
increase in GM-CSF promoter accessibility, but this increase is abolished by CHX 
treatment suggesting that chromatin remodelling events are reliant on newly 
synthesised proteins. In RAW 264.7 macrophage cells an increase in promoter 
accessibility is seen in response to LPS stimulation. Although significant, this increase 
was not as substantial as that observed in T cells, which correlates with the smaller 
increase in GM-CSF transcription observed in macrophages. Furthermore the increase 
in chromatin accessibility in macrophages occurs in the presence of CHX protein 
synthesis inhibition suggesting that the small change in chromatin accessibility 
observed in macrophage cells has different requirements to that observed in T cells.  
 
3.2.7 Chromatin structure at the GM-CSF promoter 
 
Basal chromatin structure established across gene regulatory regions has considerable 
influence over the activation requirements for gene expression. To further examine the 
changes in chromatin accessibility described above and with the purpose of determining 
if the GM-CSF promoter shares similar basal chromatin structure in T cells and 
macrophages, chromatin immunoprecipitation assays (ChIP) were performed. 
Association between the core histone protein H3 and H3 acetylation with the upstream 
GM-CSF enhancer, a region 1.1 kb 5’ of the GM-CSF promoter and the inactive 
rhodopsin promoter were examined alongside the GM-CSF promoter and have been 
reported previously in T cells (Poke et al. 2012). 
 
Core histone protein H3 was examined to give an estimation of the relative nucleosome 
occupancy of the DNA region of interest and to determine if this is reflective of the 
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relative chromatin accessibility. In non-stimulated EL4 T cells the GM-CSF promoter 
region shows a similar level of H3 association to that of the GM-CSF enhancer and the 
region 1.1 kb 5’ (Figure 3.11.A). Following 4 hours of PI stimulation, H3 associated 
with the GM-CSF promoter is depleted (p<0.05) whilst no significant loss of H3 is 
observed from the control regions (Figure 3.11.A). This loss of H3 is indicative of 
chromatin remodelling events occurring at the promoter region (Figure 3.10.A).  
 
Regions of chromatin which undergo chromatin remodelling events are frequently 
marked by chromatin modifications such as histone acetylation which may be 
recognised by further modifying enzymes as well as chromatin remodelling complexes 
(Dhalluin et al. 1999). In T cells, the GM-CSF promoter is specifically marked by 
higher levels of H3 acetylation than the control regions (Figure 3.11.B). This 
acetylation is lost upon 4 hours of PI stimulation (p<0.05) which correlates with the 
loss of core H3 proteins from the promoter (Figure 3.11.A). Notably the levels of H3 
acetylation detected at the inactive rhodopsin promoter region are markedly lower and 
do not vary with stimulation as is consistent with inactive chromatin structure.  
 
In non-stimulated RAW 264.7 macrophage cells the GM-CSF promoter displays a 
similar level of core histone protein H3 to the GM-CSF enhancer and control region as 
well as to the distal inactive rhodopsin promoter (Figure 3.12.A). Upon LPS 
stimulation a decrease in H3 association is observed although this is not significant and 
a comparable loss in H3 is seen across all of the control regions including the rhodopsin 
promoter (Figure 3.12.A). These data suggest that there is no significant depletion of 
H3 from the promoter region in macrophages such as is observed in T cells. In 
macrophage cells the GM-CSF promoter H3 acetylation levels are comparable to those 
is detected at the inactive rhodopsin promoter (Figure 3.12.B) indicating that the 
promoter is not marked by higher acetylation levels. In addition no change in H3 
acetylation is observed at any of the regions examined in response to LPS stimulation. 
Therefore, it would appear that the GM-CSF promoter is not marked for activation by 
H3 acetylation in macrophages as it is in T cells and in addition any chromatin  
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remodelling events that are observed in association with GM-CSF activation in 
macrophage cells are brought about independent of H3 loss.  
 
These results independently confirm the changes in chromatin structure at the promoter 
region observed in the chromatin accessibility assays. In T cells significant loss of 
acetylated H3 proteins from the promoter region results in an increase in promoter 
accessibility which is permissive for increased gene transcription. In macrophages this 
loss of H3 was not observed in response to stimulation. This is reflective of the small 
increase in promoter accessibility and gene transcription triggered by stimulation. In 
addition the promoter region is not marked by histone acetylation indicating that the 
basal chromatin environment established at the GM-CSF promoter is different in T cells 
compared to macrophages. 
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3.3 Discussion 
 
The data presented here demonstrates that immune genes may be expressed in multiple 
cell types and display similar activation kinetics, however the mechanisms regulating 
gene activation can be fundamentally different in the divergent cell types. While the 
GM-CSF gene is activated with similar kinetics in T cells and macrophages, this 
appears to involve two clear mechanistic differences. Firstly, in T cells the GM-CSF 
gene is classified as a secondary response gene based on its reliance on new protein 
synthesis, whereas in macrophages GM-CSF is a delayed primary response gene with 
increased expression independent of new protein synthesis. While the data presented 
clearly shows that c-Rel is required for GM-CSF transcription in both cell types, the 
divergence in response type may be partially explained by a difference in the 
requirement for protein synthesis for c-Rel nuclear localisation in the two cell types. 
Secondly, the chromatin remodelling events which increase accessibility of the GM-
CSF promoter in response to stimulation, and accompany transcriptional activation of 
the gene, occur by fundamentally different mechanisms in T cells compared to 
macrophages.  
 
3.3.1 Protein synthesis requirements – Primary versus secondary responses 
 
The requirement for new protein synthesis for increased gene transcription has widely 
been used to classify genes as primary and secondary response genes (Fowler, Sen & 
Roy 2011; Hargreaves, Horng & Medzhitov 2009; Yamamoto & Alberts 1976). These 
differing requirements have previously been found to reflect differences in activation 
kinetics. However the data presented in this chapter revealed that despite having similar 
activation kinetics, in T cells GM-CSF is categorised as a secondary response gene 
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reliant on de novo protein synthesis for increased gene transcription whereas in 
macrophages GM-CSF expression is independent of new protein synthesis, as 
previously documented (Brettingham-Moore et al. 2005; Ramirez-Carrozzi et al. 2009).  
 
The data presented here shows that, not only is gene transcription permissible in the 
presence of CHX in macrophage cells, the amplitude of mRNA transcript levels was in 
fact elevated. Enhanced mRNA levels in response to CHX treatment have previously 
been reported for other inducible immune genes (Roger, Out, Jansen, et al. 1998). This 
is conceivably due to the non-specific nature of blocking translation or a regulatory 
mechanism in response to transcription initiation signals but no resultant translation of 
proteins occurring. Plausibly this enhanced expression may be due to off-target effects 
of CHX blocking the synthesis of inhibitory proteins which down regulate gene 
expression. However, this phenomenon, termed superinduction, has previously been 
reported for other genes and has largely been attributed to enhanced mRNA stability in 
the presence of CHX. Enhanced IL-6 mRNA stability has previously been examined by 
inhibiting transcription of new mRNA through treatment of cells with actinomycin. 
mRNA half-life was then determined by northern blot analysis of RNA at a number of 
different time points (Roger, Out, Jansen, et al. 1998; Roger, Out, Mukaida, et al. 
1998). This supports the notion that no new synthesis of transcriptional activators is 
required for increased gene transcription to occur, confirming the previous 
classification of GM-CSF as a primary response gene i.e. independent of CHX in 
macrophages (Ramirez-Carrozzi et al. 2009).  
 
Interestingly, when the GM-CSF transcriptional response was examined in murine 
embryonic fibroblasts (MEFs), the superinduction response in the presence of CHX is 
also observed. This raises the possibility that the divergence in CHX response may be 
stimulus driven as both the MEF cells and macrophages were stimulated with LPS via 
the TLR4 MyD88 signalling pathway. In T cells increased mRNA transcription was 
triggered by directly activating the protein kinase C and calcium signalling pathways 
downstream of the TCR through treatment of cells with PMA and calcium ionophore. 
The murine EL4 T cell line is unable to respond to LPS as it does not have the 
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appropriate intact cell surface receptors and the murine RAW 264.7 cell line did not 
produce a discernible increase in GM-CSF expression in response to PI stimulation. 
Therefore this divergence was unable to be examined by using the same stimuli for both 
cell types. LPS is routinely used to activate macrophage cells and has previously been 
reported to be a potent activator of GM-CSF  (Li et al. 2012; Thorens, Mermod & 
Vassalli 1987) in addition to the other macrophage growth and differentiation factor, 
macrophage colony stimulating factor (M-CSF) (Becker, Devlin & Haskill 1989). 
Signalling through TLR4 activates a series of downstream signalling cascades including 
the protein kinase C pathway that is activated by PMA (Sweet & Hume 1996). 
However additional signalling events must be required as LPS was able to trigger 
increased expression of GM-CSF whereas PI stimulation was not.  
 
Whilst the different stimulus and signalling cascade is worthy of consideration, it is 
unlikely that this accounts for all of the difference in response between cell types. 
Activation of naïve T cells results in the slow differentiation into cytokine producing 
effector cells, whereas stimulation via the same cell surface signalling events in 
memory T cells triggers much more rapid cytokine expression suggesting that even 
though initial signalling events are the same, distinct regulatory mechanisms can exist 
downstream of the activation signals (Cuddapah, Barski & Zhao 2010). Furthermore, 
different populations of macrophages produce different activation profiles for immune 
genes, including for GM-CSF, in response to the same stimuli (Grigoriadis et al. 1996). 
This suggests that specific populations of cells are able to respond to the same stimuli 
in different ways in order to produce a targeted immune response. 
  
Both the PKC and TLR4 signalling pathways trigger activation of NF-κB proteins 
(Figure 1.1). Data from this study suggest that c-Rel nuclear activation has different 
requirements for protein synthesis in T cells compared to macrophages. Western blot 
analysis showed that c-Rel nuclear translocation is inhibited by CHX treatment in T 
cells but is still permissive in CHX treated macrophage cells suggesting that a 
divergence in c-Rel activation may account for the divergence in CHX response. c-Rel 
was shown to undergo translocation from the cytoplasm to the nucleus in response to PI 
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stimulation in T cells and LPS stimulation in macrophages. This increase in c-Rel levels 
in the nucleus is not detected in the presence of CHX in T cells and increased synthesis 
of c-Rel in the cytoplasmic fraction is abolished suggesting that CHX inhibits c-Rel 
synthesis and activation. In contrast, in macrophage cells an increase in c-Rel nuclear 
localisation in response to LPS is sustained in the presence of CHX. Additionally CHX 
treatment alone appears to enhance nuclear localisation of c-Rel in macrophage cells. 
Enhanced c-Rel nuclear localisation in the presence of protein synthesis inhibition 
suggests that in macrophage cells the continued synthesis of a c-Rel inhibitory molecule 
is required to maintain cytosolic localisation. In contrast fellow NF-κB family 
transcription factor, Rel-A is constitutively expressed and does not display evidence of 
inhibition in the presence of CHX in T cells. These results further suggest that the 
divergence in CHX dependence is due to divergence in c-Rel regulation, which may be 
either cell type or stimulus specific.  
 
The role of c-Rel in mediating GM-CSF gene responses was further confirmed with the 
pharmacological c-Rel inhibitor, pentoxifylline (PTX) as well as in cells derived from 
c-Rel
-/-
 mice. Results from both of these models demonstrate a critical role for c-Rel in 
GM-CSF activation in both T cells and macrophages.  
 
3.3.2 Chromatin structure and remodelling 
 
Data presented in this chapter suggest that both the basal chromatin structure 
established across the GM-CSF promoter and remodelling events in response to cell 
activation differ between T cells and macrophages. Firstly, prior to activation, the 
promoter region is marked by high levels of histone acetylation in T cells but not 
macrophages. Additionally, following T cell activation significant loss of acetylated H3 
proteins from the GM-CSF promoter region results in an increase in promoter 
accessibility which is permissive for increased gene transcription. In contrast, in 
macrophages no such loss of H3 was observed in response to stimulation. In addition 
only a small increase in accessibility was observed at the promoter region in stimulated 
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macrophages. As changes in chromatin accessibility reflective of chromatin 
remodelling are often associated with increased gene transcription (Cockerill 2011) this 
may reflect of the smaller increase in GM-CSF gene transcription triggered by 
stimulation in macrophages compared to T cells. Previous work has identified c-Rel as 
an important regulator for chromatin remodelling events which occur in T cells at the 
GM-CSF promoter to permit increased gene transcription (Brettingham-Moore et al. 
2005). 
 
The basal chromatin state at the GM-CSF promoter appears to be different between the 
two cell types examined. This is likely to be established during the process of cell 
differentiation. In early T cell development in the thymus, the IL-3/GM-CSF locus is 
retained in an epigenetically silent state marked by repressive histone modifications 
(Mirabella et al. 2010). Chromatin mediated repression of potent pro-inflammatory 
cytokines assists in preventing inappropriate inflammatory responses. Effectively GM-
CSF gene transcription in response to activation of the PKC and calcium signalling 
pathway is abolished  (Mirabella et al. 2010). During the process of differentiation into 
mature T cell lineages, cells progressively acquire active chromatin modifications and 
gene inducibility increases (Mirabella et al. 2010). This suggests that chromatin 
structures established during differentiation from a common precursor can dictate the 
transcriptional response of the GM-CSF gene. In T cells, GM-CSF gene activation 
occurs in association with BRG1 mediated nucleosome remodelling (Brettingham-
Moore et al. 2008). Evidence of this is seen in the loss of highly acetylated H3 histones 
from the GM-CSF promoter region in response to PI stimulation. Histone acetylation 
marks regions of DNA for subsequent gene expression and is able to recruit chromatin 
remodelling complexes (Hassan et al. 2001) so may explain how the chromatin 
established at the GM-CSF promoter primes the gene for subsequent inducible gene 
expression.  
 
In macrophage cells a similar level of basal H3 occupancy (about 20% T.I) is detected 
at the GM-CSF promoter however the promoter region is not marked by high levels of 
acetylation and no significant loss of histone protein H3 was seen upon LPS 
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stimulation. This may be a reflection of the difference in magnitude of the 
transcriptional response induced by LPS in macrophage cells compared to PI 
stimulation of T cells, or may indicate that only a small population of the macrophage 
cells are responding to stimuli compared to the T cells. It is probable that a more 
significant increase in gene expression and also a greater increase in chromatin 
accessibility may be induced with increasing concentrations of LPS as it has previously 
been reported that LPS is internalised rapidly in macrophages and rapidly broken down 
enzymatically (Sweet & Hume 1996; Ulevitch & Tobias 1995). However E. coli 
derived LPS has been used at only 1μg/mL to induce GM-CSF expression in RAW 
264.7 macrophages (Li et al. 2012). The type of LPS used throughout these experiments 
has previously been shown to induce immune gene expression in the J774 macrophage 
cell line at 10μg/mL, at the same concentration used throughout these experiments 
(Ramirez-Carrozzi et al. 2009).  
 
In T cells a significant increase in promoter accessibility was seen in response to 
stimulation which is reflective of the loss of nucleosome proteins from this region. This 
response is significantly reduced in the presence of CHX suggesting that the synthesis 
of new proteins is required for chromatin remodelling events at the GM-CSF promoter 
in T cells. In contrast, in macrophages a small increase in promoter accessibility is 
observed in response to LPS stimulation despite no evidence of significant loss of H3 
proteins. This increase in accessibility in response to stimulation was observed both in 
the presence and absence of CHX, indicating that no new protein synthesis is required 
to enable this level of chromatin remodelling. If c-Rel is required to mediate chromatin 
remodelling events in macrophages as it is in T cells then the increased nuclear 
localisation of c-Rel in CHX treated macrophages may explain why chromatin 
remodelling is permissible in CHX treated macrophages. Alternatively it may indicate 
that the low level chromatin remodelling may take place utilising an alternative 
mechanism in macrophage cells. The lower level of increased accessibility in 
macrophage cells appears to occur without significant loss of H3 proteins from the 
promoter region. This may be due to only partial disassembly/sliding of the 
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nucleosome, which may utilise a Mi2 or ISWI family chromatin remodeller as opposed 
to the SWI/SNF BRG1 remodelling enzyme utilised in T cells.  
 
3.3.3 Conclusions 
 
The data presented in this chapter shows that in T cells the GM-CSF gene is a 
secondary response gene marked by high levels of histone acetylation. Upon 
stimulation an increase in promoter accessibility is facilitated by loss of core histone 
protein H3 from the promoter region. This increase in accessibility enables high levels 
of gene transcription to take place. This chromatin remodelling and associated gene 
transcription requires new protein synthesis. Despite having similar activation kinetics 
in macrophages, GM-CSF expression is independent of new protein synthesis and 
therefore classified as a delayed primary response gene. Only a small change in 
promoter accessibility is observed in association with increased gene transcription and 
does not involve significant loss of H3 from the promoter region. This suggests that 
lower levels of transcription may be permissible without significant chromatin 
remodelling. Previously it has been shown that treatment of T cells with ionophore 
alone triggers low level GM-CSF transcription without chromatin remodelling events 
(Brettingham-Moore et al. 2005). Additionally the promoter region is not marked for 
remodelling by high levels of histone acetylation in macrophages as it is in T cells.  
 
Despite divergence in the activation requirements between the two cell types the NF-κB 
transcription factor c-Rel is shown to be required for GM-CSF expression in both cell 
types. These results highlight that the interaction between basal chromatin environment, 
transcription factor availability and chromatin remodelling events are important for the 
inducible activation of immune genes, and together allow genes to respond to immune 
signals by different mechanisms in different cell types.  
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4 Inducible cytokine gene expression  
 
4.1 Introduction 
 
The role of chromatin architecture established during the process of differentiation in 
mediating lineage commitment and mature cell type capabilities is increasingly being 
appreciated (Cedar & Bergman 2011; Falvo et al. 2013; Georgopoulos 2002; Zhang et 
al. 2012). In fact, the transcription factors involved in mediating cell fate do so not only 
through the recruitment of the transcription machinery to transcriptional start sites but 
also through interactions with chromatin modifying complexes that are important for 
establishing lineage specific chromatin architecture (Laiosa, Stadtfeld & Graf 2006; 
Vahedi et al. 2012). This raises the possibility that genes which are expressed in 
multiple cell types utilising similar transcription factors may produce a unique response 
due to the different chromatin architecture established at that gene during the process of 
differentiation (Smale 2010a).  
 
Genome-wide studies utilising technologies such as ChIP-on-chip and ChIP-seq have 
rapidly advanced our understanding of how chromatin landscapes are associated with 
gene regulation. We now have an understanding of typical patterns of histone 
modification which are associated with gene promoters, enhancers, gene bodies and 
transcribed regions (Barski et al. 2007; Lim et al. 2009; Lim et al. 2013). High levels of 
H3 and H4 acetylation as well as H3K4 methylation are detected at promoter regions of 
actively transcribed genes (Roh et al. 2006; Roh, Cuddapah & Zhao 2005; Saccani, 
Pantano & Natoli 2001). Additionally, mono-methylation of H3K27, H3K9, H4K20, 
H3K79 and H2BK79 are linked to gene activation (Barski et al. 2007). In contrast, tri-
methylation of H3K27, H3K9 and H3K79 are linked to repressed genes (Barski et al. 
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2007; Roh et al. 2006). These histone modifications are dynamically added to through 
the recruitment and activity of histone–modifying enzymes (Lim et al. 2013). Genome-
wide mapping of histone acetyltransferases (HATs) and deacetylases (HDACs) has 
revealed several categories of HAT/HDAC activity which correlate with gene 
expression. HDACs are recruited not only to repressed genes but are also highly 
associated with active genes, where both HATs and HDACs have a high level of 
activity associated with RNA polymerase binding and gene transcription (Wang et al. 
2009). Genes that are primed for subsequent gene activation events are not necessarily 
marked by high levels of acetylation but both HATs and HDACs appear to bind 
transiently suggesting that acetyl groups are actively added and removed frequently 
from primed promoters ready for rapid activation (Wang et al. 2009). Furthermore the 
incorporation of histone variants such as H2A.Z in place of canonical histone proteins 
occurs at regulatory elements of DNA (Barski et al. 2007). Whilst these studies have 
been pivotal to understanding how epigenetic markers are distributed and elucidate 
general rules which govern gene regulation, the intricate interaction between different 
regulatory components at gene specific sites is often overlooked. These include how 
individual transcription factors interact with the chromatin environment. 
 
Despite early divergence in the haematopoietic pathway and functionally distinct roles, 
CD4+ T lymphocyte cells and macrophages must coordinate and initiate immune 
responses in a cooperative manner. As such, cells of the divergent lineages retain the 
ability to induce the transcription of a number of shared immune modulating cytokine 
genes in addition to the GM-CSF gene which was discussed in Chapter 3. The GM-CSF 
gene has been well characterised in T cells and its inducible gene transcription is 
documented as being dependent on the synthesis of new protein, the transcription factor 
c-Rel and the chromatin remodeller BRG1, as discussed in Chapter 3 and described 
elsewhere (Brettingham-Moore et al. 2005; Brettingham-Moore et al. 2008; Poke et al. 
2012). 
 
Both BRG1 and c-Rel have previously been identified as playing a significant role in 
immune gene regulation in macrophage cells also (Grigoriadis et al. 1996; Ramirez-
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Carrozzi et al. 2006; Schreiber et al. 2006). A study coupling ChIP for NF-κB 
transcription factors with microarray analysis of gene expression determined that, in 
human monocytic cells c-Rel binds 83 gene promoters in response to LPS stimuli, only 
10% of which were occupied prior to stimulation (Schreiber et al. 2006). This suggests 
an important role for c-Rel in regulating inducible genes. From gene expression 
analysis in cells isolated from c-Rel
-/-
 mice, c-Rel can be inferred as serving distinctly 
unique roles in regulating gene expression in different mature macrophage populations. 
Hematopoietic precursors in c-Rel
-/-
 mice retain the ability to differentiate into mature 
macrophages. However the normal mature macrophage population is somewhat 
heterogeneous and different populations of mature macrophages isolated from c-Rel
-/-
 
mice exhibit defective cytotoxic killing, nitric oxide production as well as altered 
expression of certain cytokines including GM-CSF (Grigoriadis et al. 1996) suggesting 
that c-Rel may play a different regulatory role in different macrophage populations.  
 
The GM-CSF gene is c-Rel dependent in both T cells and macrophages (Chapter 3) but 
switches from being a BRG1 dependent gene in T cells to being independent of 
SWI/SNF in macrophages (Grigoriadis et al. 1996; Poke et al. 2012; Ramirez-Carrozzi 
et al. 2009). In addition, there is a switch in the requirement for new protein synthesis 
for gene transcription between the two cell types as is discernible by gene expression 
analysis in the presence of the translation inhibitor, cycloheximide (CHX). Genome-
wide data provides a valuable resource in which to identify other cytokine and immune 
modulating genes which are regulated by c-Rel in both T cells and macrophages and 
determine if these are common features of c-Rel dependent gene expression in the two 
cell types. 
 
The aim of this chapter was to utilise genome-wide data to identify the cohort of c-Rel 
dependent genes which have inducible expression in both T cells and macrophages, and 
identify genes which share similar activation requirements to GM-CSF. Further, the aim 
of this chapter was to determine whether c-Rel dependent genes are regulated by 
fundamentally different mechanisms in the two cell types.  
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4.2 Results 
 
4.2.1 Inducible expression of potential BRG1 and c-Rel regulated genes 
 
In order to identify additional inducible immune genes that, like the GM-CSF gene, 
require BRG1 and c-Rel for gene activation in T cells and are also expressed in 
macrophage cells, bioinformatic analysis of available genome-wide data was performed 
in conjunction with Dr. Kristine Hardy (Faculty of Education, Science, Technology and 
Mathematics, The University of Canberra, Canberra, ACT, Australia). The strategy 
employed is outlined in Figure 4.1. Genome-wide c-Rel dependence was determined by 
analysis of Affymetrix gene expression array data generated by G. Chen (JCSMR, 
ANU) from wild-type and c-Rel
-/-
 CD4+ splenocytes, either unstimulated or stimulated 
with PMA and calcium ionophore (PI) for 8 hours (G Chen, K Hardy and MF Shannon, 
unpublished). Analysis of this data identified 268 genes which showed increased gene 
expression in response to PI stimulation in the WT cells compared to the c-Rel
-/-
 cells 
with a ≥ Log2 0.5 difference.  These genes were classified as c-Rel-dependent genes. 
To determine which of the c-Rel dependent cohort were likely to be BRG1 regulated, 
publically available ChIP-seq data was analysed (De et al. 2011). This data set included 
BRG1 ChIP-seq analysis of naïve T cells and also Th1, Th2 and Th17 cells before and 
after activation (De et al. 2011). Analysis of these data sets, revealed that approximately 
60% of c-Rel dependent genes in CD4+ T cells bind BRG1, with 23% displaying basal 
BRG1 binding within 1kb of their transcription start site, and 38% demonstrating 
enhanced BRG1 binding in stimulated T cells. These values are similar to other 
inducible genes, but much higher than for all genes on the array, suggesting as expected 
that BRG1 plays an important role in the regulation of inducible genes. Of the 101 
genes that gain BRG1 binding in activated cells, 72 have NF-κB motifs within 200 bp  
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of the BRG1 binding site, as identified using the Toucan program. This list represents 
genes that are potentially regulated by both the chromatin remodeller BRG1 and NF-κB 
transcription factors, including c-Rel. A set of c-Rel regulated genes which bind BRG1 
and a set of genes which did not bind BRG1 in this data set were selected for further 
analysis to determine if common features distinguish these two gene sets. 
The BRG1 independent genes, IL-6, IL-10, IL-1a and IL-22 were selected for further 
analysis, as were the BRG1-dependent genes, IL-23A, IL-21, Tnfsf9 and IFN-γ due to 
their respective roles in immune regulation. Expression of these genes was initially 
examined by RT-qPCR in primary CD4+ T cells either left untreated or treated with PI 
for 4 hours to confirm inducible expression in T cells. All genes examined showed very 
low or no basal mRNA expression and increased mRNA levels in response to PI 
stimulation (Figure 4.2). To determine if these genes were also expressed in 
macrophage cells so that regulatory mechanisms of inducible gene expression could be 
examined in the two cell types, gene expression analysis was also performed in bone 
marrow derived macrophages (BMDM) in response to LPS. As in T cells, no or low 
basal mRNA expression was observed, and in response to LPS stimulation an increase 
in mRNA levels was observed for all genes with the exception of IL-21 and IL-22 
(Figure 4.3). This indicates that, as expected, not all immune genes are expressed in 
both cell types. Whilst the majority of genes showed evidence of up regulation in 
response to stimulation, the extent of this increase was variable. GM-CSF (p<0.05) and 
IFN-γ (p<0.05) displayed the highest levels of expression in T cells (Figure 4.2), whilst 
other genes such as IL-6 (p= 0.122) showed only a small fold change in gene expression 
(Figure 4.2). In macrophage cells, IL-1a showed the highest level of expression 
(p<0.05), whilst GM-CSF also showed comparatively high levels of inducible gene 
expression (p<0.01).  
These results show that a number of immune genes are inducibly expressed in both T 
cells and macrophages in response to appropriate stimuli and may potentially share 
activation requirements with the GM-CSF gene.  
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4.2.2 Protein synthesis dependence of inducible gene sets 
 
Evidence presented in Chapter 3 indicates that GM-CSF gene induction switches 
between being inhibited in the presence of CHX in T cells to being CHX independent 
in macrophages. This raises the possibility that this “switching” may represent a 
mechanism employed by other inducible genes. To determine if this switch in 
activation requirements occurs for other cytokine genes, the influence of CHX 
treatment on cytokine gene expression both before and after stimulation was examined 
in both EL4 T cells (Figure 4.4), BMDM cells (Figure 4.5) as well as RAW 264.7 
macrophages (Figure 4.6). Like the GM-CSF gene, IL-23A appears to switch from 
being CHX dependent in EL4 T cells (Figure 4.4) to being a CHX independent gene in 
macrophages cells (Figures 4.5 & 4.6). IL-1a, Tnfsf9 and IFN-γ appear independent of 
CHX treatment in all cell types (Figures 4.4, 4.5 & 4.6).  IL-6 and IL-10 in contrast 
appear to be independent of CHX in EL4 T cells but switch to being inhibited in the 
presence of CHX in BMDM (Figure 4.5) as well as in RAW 264.7 macrophages 
(Figure 4.6), although this is less obvious as expression levels are low in this cell line. 
A summary of CHX dependence based on this data is provided in Table 4.1 along with 
BRG1 dependence inferred from the literature. From the CHX transcription response 
data the IL-6 and IL-10 genes which are BRG1 independent in T cells were selected for 
subsequent analysis alongside the IL-23A gene and the already characterised GM-CSF 
gene which are BRG1 dependent in T cells. These genes appear to switch in CHX 
dependence between the two cell types as well as switching in their requirement for the 
SWI/SNF chromatin remodelling complex. Additionally there is evidence of CHX 
dependence in both T cells and macrophages for different genes suggesting that CHX 
dependence is not determined by cell type alone. These genes are therefore ideal 
candidates to investigate the mechanisms that underlie these changes in gene regulation 
between cell types.  
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4.2.3 Activation kinetics of inducible genes in T cells compared to macrophages 
 
Previous work has suggested that both the requirement for the synthesis of new proteins 
and the requirement for chromatin remodelling may be linked to the kinetics of 
inducible gene activation (Natoli 2009; Natoli et al. 2005; Ramirez-Carrozzi et al. 2009; 
Saccani, Pantano & Natoli 2001), although this was not found to be the case for GM-
CSF (Chapter 3). Therefore the kinetics of immune gene activation in response to 
stimulation were examined in both EL4 T cells and RAW 264.7 macrophages to 
determine if these differ and whether kinetics reflect the switching in CHX dependence 
observed for the selected genes between the two cell types. As outlined in the previous 
chapter for the GM-CSF gene, because in some biological replicates basal expression 
levels were undetectable, in order to effectively compare the kinetics of the response 
between the two cell types, gene expression relative to GAPDH was normalised to 
expression at 4 hours, which was set to 100 in each case. 
 
In EL4 T cells, IL-23A transcript levels increased from 4 hours of PI stimulation. 
Within the time course examined, the highest levels of mRNA were detected at 24 
hours post stimulation (Figure 4.7.A). This is in contrast to the GM-CSF gene (Chapter 
3) where levels peaked at 8 hours and decline by 24 hours. In RAW 264.7 macrophage 
cells, an increase in IL-23A mRNA levels was observed by 1 hour following LPS 
stimulation and maintained at this level with a further increase not detected until 24 
hours (Figure 4.7.B). These results suggest that the kinetics of IL-23A gene activation 
differ between the two cell types. In T cells, induction follows a similar pattern to that 
observed for GM-CSF, however in macrophage cells the IL-23A transcript levels 
initially increased rapidly and then maintained at a constant level out to 8 hours post 
stimulation.  
 
IL-6 expression followed a similar upward trend in transcript levels in both EL4 T cells 
and RAW 264.7 macrophage cells, however there is evidence of a biphasic pattern of  
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gene transcription. A small initial peak in mRNA levels was observed at 1 hour post 
stimulation in EL4 T cells and a similar peak detected at 6 hours post stimulation in 
RAW 264.7 macrophages. These peaks were followed by a decline before maximal 
mRNA levels were detected at 24 hours (Figure 4.8.A & B). In contrast, IL-10 
expression demonstrated an initial peak at 0.5 hours of stimulation in both T cells and 
macrophages which decreased at 1 hour before increasing to a greater peak at 6 hours 
of LPS stimulation and declining again by 24 hours (Figure 4.9.A & B).  These results 
suggest that rather than cell stimulation triggering a cumulative increase in IL-6 and IL-
10 mRNA, transcription is biphasic. These profiles of activation kinetics are similar in 
T cells and macrophages indicating that whilst there is a difference in requirement for 
new protein synthesis between the two cell types, this does not necessarily result in a 
difference in activation kinetics. This is in keeping with the observations made 
following examination of the GM-CSF gene in the previous chapter, i.e that activation 
classifications of primary and secondary response genes does not necessarily reflect 
differences in activation kinetics.  
 
4.2.4 Chromatin remodelling events are associated with increased gene 
transcription at inducible genes 
 
Changes in chromatin structure at the regulatory region of genes are often required to 
facilitate subsequent inducible gene expression (Cockerill 2011). To determine if 
changes in gene expression in T cells and macrophages correlated with changes in 
chromatin accessibility at the regulatory promoters of the IL-23A, IL-6 and IL-10 
immune genes the CHART qPCR assay was utilised. This technique has previously 
been shown to be directly comparable between different genes and different cell types, 
with promoter regions of ubiquitously expressed genes showing comparable levels of 
MNase1 digestion across different cell lines while developmentally restricted genes 
demonstrated different accessibility levels (Cruickshank et al. 2008). Promoter primers 
were selected to amplify the region occupied by the +1 nucleosome which is frequently  
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removed during transcription (Schones et al. 2008) and have previously been utilised in 
the literature (refer to Table 2.4, Materials and Methods). 
 
In EL4 T cells, when the promoter regions of IL-23A, IL-6 and IL-10 were examined 
using the chromatin accessibility assay, accessibility of less than one was detected 
(Figure 4.10.A) which indicates that the non-digested samples contain less intact 
genomic DNA than the samples subjected to MNase1. As discussed in Chapter 3 this 
may be attributed to inaccuracy in the DNA quantitation and is not considered 
biologically significant (Liang et al. 2006). Prior to stimulation similar levels of basal 
promoter accessibility are seen for all genes examined. Stimulation for 4 hours with PI 
results in an increase in accessibility at both the IL-23A (p= 0.14) and IL-6 (p= 0.38) 
promoter region in EL4 T cells, although these increases were not statistically 
significant, and nor of the magnitude of that observed at the GM-CSF promoter (Figure 
4.10). In contrast the IL-10 promoter showed no increase in accessibility in response to 
stimulation. The increase in the IL-23A, IL-10 and IL-6 mRNA levels is not as large as 
that observed for the GM-CSF gene (Figure 4.4), conceivably this is because 
stimulation only induces low level transcription which is permissible without 
significant chromatin remodelling.  
 
In RAW 264.7 macrophage cells, both the IL-6 and IL-10 promoters appear to have 
relatively accessible basal chromatin structure in comparison to the GM-CSF and IL-
23A promoter regions (Figure 4.10.B), with basal accessibility greater than 1. An 
increase in promoter accessibility is then seen in response to LPS stimulation at all 
promoter regions suggesting that chromatin remodelling occurs in response to 
stimulation enabling increased gene transcription to occur. However, this change in 
accessibility is not statistically significant for the IL-6 promoter (p= 0.17). Again the 
changes observed are not of the magnitude of that seen at the GM-CSF promoter in T 
cells.  
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These results show that low levels of gene transcription are permissible with only small 
increases in chromatin accessibility. The level of chromatin remodelling taking place at 
the promoter region is not as large for IL-23A, IL-6 and IL-10 as is observed at the GM-
CSF promoter in T cells, which suggest that the extent of chromatin remodelling may 
dictate the magnitude of the mRNA transcription response. In macrophage cells the IL-
6 and IL-10 promoter regions are held in more accessible basal state than the GM-CSF 
or IL-23A promoters demonstrating that there is some variation in the inherent level of 
basal accessibility which may impact on the level of chromatin remodelling required for 
increased gene transcription.  
 
4.2.5 Regulation of cytokine gene responses by c-Rel 
 
In Chapter 3 it was demonstrated that nuclear localisation of the c-Rel transcription 
factor was inhibited in CHX treated T cells but not macrophages suggesting that c-Rel 
regulation may partially explain the divergence in gene expression responses between 
the two cell types. Genome-wide data was used to identify potential c-Rel dependent 
immune genes in T cells which were selected for this study. Therefore to confirm c-Rel 
dependence in both T cells and macrophages the c-Rel inhibitor pentoxifylline (PTX) 
was employed to examine the effect of c-Rel inhibition on inducible gene expression. 
IL-23A mRNA levels increased in response to PI treatment of EL4 T cells but this 
response was diminished in the presence of PTX (Figure 4.11.A; p= 0.178). Likewise in 
RAW 264.7 cells, a significant increase in IL-23A mRNA levels is observed in response 
to LPS treatment (Figure 4.11.B; p<0.05) but this response is inhibited in the presence 
of PTX (Figure 4.11.B; p= 0.270). These results indicate that IL-23A gene activation is 
reliant on c-Rel in both T cells and macrophages. 
 
IL-6 mRNA levels are relatively low in both un-stimulated T cells (Figure 4.12.A) and 
macrophages (Figure 4.12.B) both in the presence and absence of PTX. An increase in  
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IL-6 mRNA levels is observed in response to stimulation and is inhibited by the 
presence of PTX in both cell types, suggesting that c-Rel is also required for 
transcriptional activation of IL-6. Whilst there is no significant increase in IL-10 mRNA 
levels in response to PI treatment of T cells, PTX treatment results in a decrease in 
basal mRNA levels (Figure 4.13.A) suggesting that c-Rel is required for basal 
transcription of IL-10 gene expression in T cells. In RAW 264.7 macrophage cells, 
there is a significant increase in IL-10 mRNA levels in response to stimulation (Figure 
4.13.B; p<0.05) and this response is slightly reduced in the presence of PTX, however 
this is not significant. 
 
Thus c-Rel inhibition resulted in reduced inducible expression of IL-23A, IL-6 and IL-
10 in both T cells and macrophages suggesting that, as predicted by the genome-wide 
studies, the c-Rel transcription factor is required for activation of these genes. 
Furthermore, basal IL-10 expression was reduced in the presence of PTX suggesting 
that c-Rel is also required to maintain its basal levels of gene transcription.  
 
Pentoxifylline is a pharmacological inhibitor of c-Rel which is used clinically as a 
vasoactive anti-inflammatory drug which clearly acts on a diverse range of cell types. 
However little is known about the other signalling pathways which may be affected by 
PTX (Wang et al. 1997). In order to examine the role of c-Rel in inducible gene 
expression independent of any possible off target effects of PTX treatment, gene 
expression responses were examined using cells derived from c-Rel
-/- 
mice compared to 
C57/BL6 (WT) mice. CD4+ T cells were isolated from mice and either left un-
stimulated or stimulated with PI and CD28 for 4 hours. BMDM cells were 
differentiated from bone marrow and either left un-stimulated or stimulated for 4 hours 
with LPS. Following stimulation RNA was extracted and examined by RT-qPCR. In 
comparison to wild type cells, both CD4+ T cells and BMDM derived from c-Rel
-/-
 
mice exhibited low induction of IL-23A mRNA in response to stimulation (Figure 
4.14.A & B). IL-6 mRNA levels increased upon stimulation in WT CD4+ T cells and 
BMDM cells as expected. However, this response was greater in both cell types derived  
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from c-Rel
-/-
 cells (Figure 4.15.A & B). Similarly, while IL-10 mRNA increased in 
response to stimulation in WT cells, in c-Rel
-/-
 cells the IL-10 mRNA response was also 
enhanced with a significant difference in fold change observed for IL-10 in BMDM 
(Figure 4.16.A & B. p= <0.05).  
 
These data suggest that while c-Rel is required for activation of some genes, including 
GM-CSF (Chapter 3) and IL-23A, c-Rel has a negative regulatory role for IL-6 and IL-
10. Furthermore, the increased gene expression response in the absence of c-Rel is in 
contrast to what was observed for IL-6 and IL-10 mRNA levels in the presence of PTX, 
suggesting that the PTX effect on gene transcription may be due to the non-specific 
effects on factors other than c-Rel.  
 
4.2.6 Association of NF-κB transcription factors with immune genes 
 
With the intention of discerning if the role of c-Rel in cytokine gene regulation was 
attributable to direct interaction between the transcription factor and the promoter 
regions or through indirect mechanisms, chromatin immunoprecipitation (ChIP) was 
utilised. Association of the NF-κB transcription factors, Rel-A and c-Rel with the 
promoter regions of the immune cytokine genes both before and after stimulation in T 
cells was examined. As previously documented an increase in the association between 
both c-Rel (Figure 4.17.A) and Rel-A (Figure 4.17.B) is detectible at the GM-CSF 
promoter region upon PI stimulation (Poke et al. 2012). Both c-Rel and Rel-A also 
showed an increased association with the IL-23A promoter (Figure 4.17.A & B). In 
addition, increased association of Rel-A and c-Rel with the IL-6 promoter was observed 
upon stimulation, although no association was seen with the IL-10 promoter (Figure 
4.17.A & B). The levels of the two NF-κB proteins associated with the IL-10 promoter 
are comparable to that of the inactive Rhodopsin control region which is not expressed 
in haematopoietic cells and is not regulated by c-Rel. These data suggest that IL-10 may  
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not be regulated by direct c-Rel or Rel-A binding at the promoter region. Instead, IL-10 
could be regulated by c-Rel binding to a more distal location or via an indirect 
mechanism. To determine which of these is likely to be the case the NF-κB binding 
sites were determined bioinformatically and schematically depicted relative to the 
proximal promoter region amplified by the promoter primers (Figure 4.18). The GM-
CSF, IL-23A and IL-6 promoter regions amplified by the primer sets selected overlap 
with the putative NF-κB binding sites. In contrast the region amplified by the IL-10 
promoter primers is approximately 500bp from the region amplified. Binding of c-Rel 
at this site may be undetectable due to the level of DNA shearing employed in the ChIP 
protocol. In order to examine the association between c-Rel and the upstream NF-κB 
binding site a new primer set would need to be designed specific for this region.  
 
These results suggest that GM-CSF, IL-23A and IL-6 are regulated by c-Rel through 
direct association of c-Rel with their respective promoter regions. Gene expression 
analysis in c-Rel
-/- 
cells indicates that c-Rel has a positive influence on IL-23A 
expression and negative regulatory role in IL-6 expression. Whilst gene expression 
analysis of IL-10 also suggests that the gene is negatively regulated by c-Rel, no 
association between the promoter region and c-Rel was observed. Bioinformatic 
analysis suggests that the IL-10 NF-κB binding site is located upstream of the proximal 
promoter region, and binding at this site may therefore confer gene repression. These 
results suggest that c-Rel may be both a positive and negative regulator of immune gene 
expression.  
 
4.2.7 NF-κB transcription factors driving promoter activity  
 
To examine how both positive and negative changes in gene expression were driven by 
c-Rel binding at the gene promoter regions of the selected genes a luciferase assay was 
performed. DNA fragments were amplified that encompassed the IL-23A, IL-6 and IL-
10 5’ regions (approximately 1000bp in length) and each was ligated into the pXPG  
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reporter vector. The pXPG vector contains the luciferase gene and allows regulation of 
the luciferase gene by the cloned promoters (Bert et al. 2000). These promoter reporter 
constructs were transfected into EL4 T cells and RAW 264.7 macrophage cells along 
with c-Rel (cFlag pcDNA3) and Rel-A (cFlag pcDNA3) expression plasmids (Sanjabi 
et al. 2005). Each promoter pXPG reporter plasmid was individually co-transfected 
with Rel-A, c-Rel or a CMV control. The relative luciferase activity driven by Rel-A or 
c-Rel is shown normalised to the activity detected for the cells transfected with the 
CMV control. In transfected EL4 T cells, Rel-A drives an increase in IL-23A, IL-6 and 
IL-10 promoter activity relative to the CMV control (Figure 4.19.A). c-Rel also 
increased promoter activity above that of the CMV control for all promoter regions. 
However the magnitude of this increase is not as substantial as that driven by Rel-A 
(Figure 4.19.A). 
 
In RAW 264.7 macrophage cells, transfection of the IL-23A promoter with Rel-A 
resulted in an increase in promoter activity compared to the CMV control (Figure 
4.19.B). In contrast to what was observed in the EL4 T cells, promoter activity was 
more substantial when transfected with c-Rel (Figure 4.19.B). IL-6 promoter activity 
was decreased below that of the CMV control when co-transfected with Rel-A (Figure 
4.19.B; p= <0.05). c-Rel also had a negative effect on IL-6 promoter activity however 
this was not significantly less than the control (Figure 4.19.B). The IL-10 promoter 
activity is similar when transfected into RAW 264.7 cells to what was observed in EL4 
cells with an increase in activity driven by both Rel-A and c-Rel, but with the Rel-A 
effect being more substantial (Figure 4.19.B). Each of these transfections was 
performed as 3 individual biological replicates on separate days. Viewed individually 
the trends in promoter activity are the same, however the magnitude of the luciferase 
activity detected varied between each experiment. This variation means that the 
changes in activity are not statistically significant except in the case of the IL-6 
promoter and Rel-A repression in macrophages (Figure 4.19.B).  
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The luciferase assay analysis confirms that both the Rel-A and c-Rel transcription 
factors are able to increase transcription driven by the IL-23A promoter fragment. In 
contrast to what was observed in the c-Rel knockout cells, transfection with either Rel-
A or c-Rel increased transcription driven by the IL-10 promoter fragment in both cell 
types. IL-6 promoter activity switched between T cells and macrophages. In EL4 T 
cells either Rel-A or c-Rel transfection increased transcription from the IL-6 promoter. 
The same transfections in macrophage cells resulted in decreased transcription from the 
IL-6 promoter. These results provide further evidence that c-Rel may act as both a 
positive and negative regulator of gene expression. 
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4.3 Discussion 
 
Analysis of genome-wide data revealed that a large cohort of genes is potentially 
regulated by the co-ordinated activity of the transcription factor c-Rel and the 
chromatin remodelling complex BRG1. Although identified from data produced in 
CD4+ T cells, the majority of cytokine genes selected for further study were also 
induced in response to LPS in macrophage cells, with the highest level of gene 
expression observed for GM-CSF and IL-1a, both of which have previously been 
reported to be strong responders to LPS stimulation (Iglesias et al. 2012; Li et al. 2012).  
 
4.3.1 Selection of genes for further analysis 
 
The work in this chapter explores the mechanisms of “switching” in CHX dependence 
as this may be a common mechanism by which appropriate expression of immune 
genes is maintained. From the larger group of c-Rel dependent genes IL-23A was 
selected for more detailed analysis as it showed evidence of switching from a secondary 
response gene in T cells to a primary response gene in macrophages. IL-6 and IL-10 
were selected as they switch in the opposite direction, from primary response genes in 
T cells to secondary responders in macrophages. 
 
The correctly choreographed expression of the genes involved in mediating an immune 
response is vital for the appropriate immune resolution. The diverse range of immune 
genes activated at different times over the course of an immune response are largely 
regulated by common transcription factors such as NF-κB (Saccani, Pantano & Natoli 
2001). However despite common activation signals the timing of increased gene 
expression can vary considerably. As such, genes may be classified as early or primary 
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responders which show increased activation rapidly following immune activation while 
others which display delayed activation kinetics are referred to as late or secondary 
response genes and may be activated hours after the initiating activation signal (Natoli 
2009; Ramirez-Carrozzi et al. 2006).  
 
One method which has been used to distinguish primary from secondary response genes 
is their reliance on new protein synthesis for gene transcription (Ramirez-Carrozzi et al. 
2009; Ramirez-Carrozzi et al. 2006; Yamamoto & Alberts 1976). As demonstrated in 
Chapter 3, the GM-CSF gene switches from being a secondary response gene in T cells 
to being a primary response gene in macrophages. To determine if other immune genes 
make this switch the translation inhibitor, cycloheximide (CHX) was used to categorise 
gene expression responses in both T cells and macrophages. Whilst some of the genes 
examined in this study, such as Tnfsf9 were clearly independent of new protein 
synthesis in both cell types others show evidence of switching between the two 
categories in different cell types.  
 
Like GM-CSF, IL-23A switches from being a CHX dependent gene in T cells to being 
CHX independent in macrophage cells. This indicates that in T cells, regulatory 
proteins require synthesis before IL-23A gene expression can be mediated. These 
proteins are either not required or are already available without new protein synthesis in 
macrophages. The IL-6 and IL-10 cytokine genes both appear to undergo a switch in 
activation requirements in the opposite direction with gene expression being 
independent of new protein synthesis in T cells but dependent in macrophage cells. 
Several genes including, IL-1a and Tnfsf9 showed enhanced mRNA levels in response 
to LPS stimulation in the presence of CHX. These transcription responses do not 
require protein synthesis to occur and in addition mRNA levels of these genes are 
sustained at a higher level in the CHX samples. Superinduction of mRNA was 
discussed in Chapter 3 as it was observed in macrophage cells for GM-CSF mRNA. 
The results in this chapter suggest that mRNA superinduction is a common response to 
CHX treatment. Superinduction of IL-6 mRNA has previously been reported in lung 
epithelial cells (Roger, Out, Jansen, et al. 1998). However, neither T cells nor 
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macrophage cells treated with CHX produced a superinduction response for IL-6 
mRNA suggesting that changes in the gene transcription responses to CHX in different 
cell types is a recurrent phenomenon. This divergence in gene response may be 
reflective of differing regulatory requirements, such as transcription factors and 
chromatin modifying proteins, in different cell types.   
 
From these data, the IL-23A, IL-6 and IL-10 genes that showed evidence of switching in 
protein synthesis requirements for activation in the different cell types were selected for 
further analysis so as to increase our understanding of the mechanisms underlying these 
switches. These immune regulatory genes have quite diverse functions. The IL-23A 
gene produces the IL-23A (p19) subunit which is related to the p35 subunit of IL-12 
and has no biological activity alone (Oppmann et al. 2000). IL-23A binds with the other 
IL-12 subunit, IL-12B (p40) to form the IL-23 pro-inflammatory cytokine. The 
distinctly separate role of IL-23 from IL-12 is only beginning to be understood although 
expression has been associated with late stage and chronic inflammation as well as 
inflammatory conditions such as arthritis, autoimmune encephalitis and systemic lupus 
erythematous (Cao et al. 2006; Mus et al. 2010; Smith et al. 2012). IL-23 has been 
found to induce proliferation of CD4+ T cells (Oppmann et al. 2000) and drives the 
expansion of a pathogenic population of T cells through the up regulation of 
inflammatory cytokines including IL-17 and IL-6 contributing to autoimmune 
pathogenesis (Langrish et al. 2005). IL-6 is a potent pro-inflammatory cytokine which 
has been found to enhance IL-23 activity and co-operatively up-regulate the production 
of Th17 cells (Zhou et al. 2007). In addition, IL-6 is produced by a range of cell types 
and is frequently a therapeutic target in treating inflammatory conditions (Heinrich et 
al. 2003; Roger, Out, Jansen, et al. 1998; Wongchana & Palaga 2012). Inappropriate IL-
6 gene expression has been associated with a plethora of inflammatory conditions 
including arthritis and inflammatory bowel disease as well as several cancers (Fishman 
et al. 1998; Heinrich et al. 2003; Reinecker et al. 1993). In contrast, IL-10 forms part of 
an auto-inhibitory loop that tempers the transcription and translation of inflammatory 
cytokines such as IL-6 and IL-23A whilst potentiating TNF-α transcription (Donnelly, 
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Freeman & Hayes 1995; Fiorentino, Bond & Mosmann 1989; Liu et al. 2009; Moore et 
al. 2001). 
 
4.3.2 Activation kinetics 
 
It has previously been proposed that the requirement for new protein synthesis before 
increased gene transcription can be initiated is reflected in delayed activation kinetics, 
whereby primary response genes which can be actively transcribed without the 
synthesis of additional proteins respond more rapidly (Ramirez-Carrozzi et al. 2006). 
Activation kinetics of IL-23A gene transcription diverges between the two cell types 
which may be reflective of differing requirements for new protein synthesis. However, 
IL-6 and IL-10 demonstrated similar biphasic patterns of gene expression in both cell 
types suggesting that activation kinetics do not always correlate with the requirement 
for protein synthesis and that protein synthesis requirements may therefore not be the 
primary driver of activation kinetics.  
 
IL-23A kinetics of activation in response to stimuli occur in two distinctly different 
patterns in T cells compared to macrophages. In T cells there is a lag time between cell 
stimulation and the increase in IL-23A transcript levels with an exponential increase 
observed from 2 hours post stimulation continuing out to 24 hours. In macrophage 
cells, an increase in IL-23A mRNA levels was observed as rapidly as 30 minutes 
following LPS stimulation. This difference in activation kinetics between the two cell 
types may be partially explained by the divergence in requirement for new protein 
synthesis. In macrophages, no new protein synthesis is required and an increase in 
transcription can occur directly following stimulation. In contrast in T cells, following 
stimulation new proteins, such as transcription factors or chromatin modifiers, must 
first be synthesised before gene transcription can increase. In contrast, IL-6 expression 
is independent of new protein synthesis in T cells, but switches to being dependent on 
the synthesis of new proteins in macrophages. Despite divergence in the gene 
expression response in the presence of CHX the activation kinetics of IL-6 show a 
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similar trend in T cells and macrophages. A slight initial increase in IL-6 mRNA is 
followed by a more prolonged cumulative increase out to 24 hours post stimulation. 
This biphasic pattern of gene expression is not notably different in T cells compared to 
macrophages despite the switch in protein synthesis reliance.  
 
In both cell types a biphasic pattern of IL-10 mRNA levels is evident, this is highly 
reflective of the important role of IL-10 as a potent inhibitor of inflammation 
functioning to prevent the overproduction of inflammatory cytokines and responding to 
the cytokine environment (Fiorentino, Bond & Mosmann 1989; Moore et al. 2001). An 
increase in IL-10 mRNA is detected as soon as 30 minutes following stimulation in 
both cell types and this fluctuates throughout the time course used in this chapter. It has 
previously been documented that LPS only induces a modest IL-10 transcription 
response and that stimulation in combination with immune complexes produces a more 
robust response, this was found to be due to enhanced signalling through the MAPK 
pathway (Lucas et al. 2005). It is likely that the amplitude and activation kinetics of IL-
10 vary in response to different stimuli in order to co-ordinate the most efficient 
immune response.  
 
The results presented in this chapter clearly demonstrate that there is switching in 
activation requirements of the same gene between the two cell types examined, with 
switching between a primary to a secondary response gene in terms of the requirement 
for new protein synthesis. However this divergence is not necessarily reflected in the 
activation kinetics of the transcriptional responses to stimulation in the different cell 
types.  
 
4.3.3 Chromatin structure and remodelling 
 
Alternatively it has been hypothesised that the kinetics of mRNA induction better 
reflect the requirement for chromatin remodelling for gene activation. As such, genes 
that are rapidly transcribed are proposed to be held in a more accessible basal chromatin 
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state while genes that exhibit delayed activation kinetics are held in poised chromatin, 
requiring the recruitment and activation of chromatin remodelling complexes prior to 
increased transcription (Natoli 2009; Saccani, Pantano & Natoli 2001). Results 
presented in this chapter suggest that the basal chromatin accessibility level and the 
requirement for chromatin remodelling largely correlate with the activation kinetics of 
gene transcription.  
 
Chromatin accessibility analysis gives an indication of the relative accessibility of the 
promoter regions to MNase1 digestion which is reflective of accessibility to 
transcription complex assembly. The ratio used of ‘uncut/cut’ should give a value of 
one if the promoter is completely inaccessible, although usually a variable amount of 
basal accessibility is observed (Cruickshank et al. 2008). The extent of digestion is 
dependent on the activity and concentration of the nuclease used as well as the 
conditions of DNA digestion. Therefore while ratio values are not directly comparable 
between different studies, they should be comparable across different genes in the one 
study. In Chapter 3, increased chromatin accessibility as determined using the 
chromatin accessibility assay was shown to be reflective of chromatin remodelling and 
loss of core histone proteins from the promoter region. The primer sets used to examine 
promoter accessibility were selected to encompass the DNA sequence occupied by the 
+1 nucleosome from published literature (refer to Table 2.4, Materials and Methods). 
Nucleosome phasing at the 5’ region of genes has been previously shown to be highly 
conserved with loss of the +1 nucleosome associated with active gene transcription 
(Schones et al. 2008). 
 
CHART analysis performed in the EL4 T cells and the RAW 264.7 macrophage cells 
indicates that prior to stimulation, the IL-23A promoter region is relatively inaccessible 
to MNase1 digestion in T cells and is slightly more accessible in macrophages. 
Following 4 hours of stimulation relative accessibility was increased in both cell types, 
which correlates with increased transcription. From the time course data for IL-23A 
mRNA, it appears that increased IL-23A gene transcription occurs as early as 30 
minutes post stimulation in macrophage cells which correlates with the slightly more 
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accessible basal chromatin structure in macrophages compared to T cells. Whilst 
evidence of chromatin remodelling is observed 4 hours post-stimulation in both cell 
types, it would be interesting to look at chromatin accessibility at earlier time points in 
order to ascertain whether this increase in promoter accessibility precedes the increased 
gene transcription, as has been shown previously for the GM-CSF gene (Holloway et al. 
2003).  
 
In contrast, the IL-6 gene is held in a relatively accessible basal chromatin structure in 
macrophages with a ratio of over 1.5 prior to stimulation which is comparable to the 
activated ratio for the IL-23A gene. Following stimulation an increase in accessibility is 
observed in both cell types. The small, initial increase in mRNA levels at 1-2 hours 
post-stimuli may be permissible due to the relatively high level of accessibility of the 
chromatin structure assembled across the promoter region in non-stimulated 
macrophage cells. The more prolonged, exponential increase in IL-6 transcript levels 
seen out to 24 hours may be made possible by increases in promoter accessibility 
observed in response to 4 hours of stimulation. 
 
The rapid induction of IL-10 mRNA in response to LPS stimulation of macrophages is 
in keeping with what has previously been observed in macrophage cells where mRNA 
transcripts were detectible within minutes of immune stimulation (Zhang, Edwards & 
Mosser 2006). This prompt increase in mRNA transcript levels is conceivably 
permissible due to the relatively high level of basal IL-10 promoter accessibility (ratio 
of 1.5) which was observed in macrophage cells. An increase in DNase sensitivity at 
the promoter has previously been reported following only 15 minutes of LPS 
stimulation (Brightbill et al. 2000; Lucas et al. 2005). A small increase in IL-10 
promoter accessibility was observed following 4 hours of LPS stimulation in 
macrophages. Whilst the promoter region is located in fairly accessible chromatin prior 
to stimulation it is possible that fluctuations in promoter accessibility may be observed 
over a time course, reflective of the biphasic pattern of IL-10 activation kinetics and 
that different levels of chromatin accessibility may have been observed had it been 
measured throughout the time course. In contrast, basal levels of accessibility at the IL-
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10 promoter in T cells are low. Furthermore no increase in accessibility is observed in 
response to 4 hours of PI stimulation. This may be reflective of the low levels of IL-10 
mRNA induced by T cells. Alternatively, it is possible that the primer sets used to 
examine promoter activity were not as optimally positioned to detect promoter activity 
in both cell types. In particular the primer set chosen for the IL-10 promoter amplifies a 
region distant from both the putative NF-κB binding site and the downstream BRG1 
binding site (Figure 4.18). Further work may examine changes in promoter accessibility 
using several primer sets positioned over the length of the promoter region as well as 
remodelling over a time course.  
 
The analysis of chromatin structure suggests that the basal chromatin accessibility 
largely dictates a genes ability to respond rapidly to activation signals. In addition the 
extent of chromatin remodelling correlates with the magnitude of the transcriptional 
response. Promoter regions which are largely accessible prior to stimulation exhibit 
faster transcriptional responses than those where basal accessibility is low. This is 
consistent with the hypothesis that late or secondary responders to immune activation 
are reliant on chromatin remodelling events before increased gene transcription can 
occur. The IL-23A gene was identified as binding the SWI/SNF family chromatin 
remodelling enzyme, BRG1 in T cells but has been reported to be SWI/SNF 
independent in macrophages (Ramirez-Carrozzi et al. 2009). Contrasting this, both the 
IL-6 and IL-10 genes were identified as BRG1 independent in T cells but are reportedly 
SWI/SNF dependent in macrophage cells (Ramirez-Carrozzi et al. 2009). Although all 
the genes were found to have a putative BRG1 binding site the location of the BRG1 
binding site relative to the transcriptional start site (as depicted in Figure 4.18) varies 
between different genes. Like GM-CSF, IL-23A displayed BRG1 binding overlapping 
the amplicon just upstream of the transcriptional start site. In contrast, both IL-6 and IL-
10 have BRG1 binding sites downstream of the +1 nucleosome and the transcriptional 
start site. This downstream BRG1 binding therefore may not reflect a functional role in 
chromatin remodelling at the upstream promoter region, but rather a separate function 
of BRG1.  
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4.3.4 Regulation by the NF-κB transcription factor, c-Rel 
 
In chapter 3 the difference in CHX response was found to reflect differences in c-Rel 
nuclear translocation. This is unlikely to be the case for all immune genes as differences 
in response type are observed within the one cell type. Gene regulation by NF-κB is 
clearly complex. Data presented here show that c-Rel may act as both a positive and 
negative regulator of immune gene expression.  
 
The IL-23A promoter region contains at least three putative NF-κB binding sites, two of 
which have been found to interact with c-Rel previously (Carmody et al. 2007; Mise-
Omata et al. 2007). ChIP data from this chapter examining c-Rel and Rel-A binding in 
T cells demonstrates an increase in association of both transcription factors with the IL-
23A promoter in response to stimulation. Additionally, the IL-23A transcription 
response was inhibited in T cells and macrophages in the presence of the c-Rel inhibitor 
pentoxifylline (PTX) and in cells derived from c-Rel
-/-
 mice. This suggests that c-Rel is 
required for IL-23A gene transcription in both cell types. IL-23A expression has 
previously been found to be reduced in macrophage cells derived from c-Rel
-/-
 mice as 
well as macrophages derived from Rel-A
-/- 
mice (Mise-Omata et al. 2007). Both c-Rel 
and Rel-A have previously been found to be required for IL-23A up regulation in 
dendritic cells and changes in transcription factor binding were attributed to changes in 
immune response with age (El Mezayen et al. 2009). In c-Rel
-/-
 dendritic cells the 
production of IL-23A is significantly reduced (Carmody et al. 2007).  
 
Both EL4 T cells and RAW 264.7 macrophage cells transfected with a luciferase 
construct containing approximately 1kb of the IL-23A promoter displayed increased 
luciferase expression in the presence of Rel-A or c-Rel. Previously, RAW 264.7 cells 
transiently transfected with a reporter plasmid containing the -1180 to +110 fragment of 
the IL-23A promoter region (which encompasses the region used for reporter assays in 
this chapter) found a dose dependent response in luciferase activity with the addition of 
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c-Rel (Carmody et al. 2007). It was also found that the Rel-B protein was the only NF-
κB transcription factor that does not contribute to increased IL-23A gene expression 
(Carmody et al. 2007). This is most likely reflective of the similar DNA binding motifs 
of the NF-κB proteins (Kunsch, Ruben & Rosen 1992). In addition several other 
transcription factors including AP1, SMAD-3, ATF-2 and IRF-3 are known to interact 
with the IL-23A promoter region (Al-Salleeh & Petro 2008; Smith et al. 2012). 
Although the data presented in this chapter has demonstrated a clear role for c-Rel in 
IL-23A regulation, it is likely that c-Rel binding is just one factor which determines 
gene transcription events and transcript levels are in fact determined by c-Rel 
interaction not only with the promoter but also with associated chromatin and 
transcription factor proteins. The results presented in this chapter provide further 
support for a requirement for both c-Rel and Rel-A for IL-23A expression in 
macrophage cells as well as T cells.  
  
Analysis of c-Rel and Rel-A association with the IL-6 promoter region revealed an 
increase in association of both transcription factors with the promoter region in 
response to stimulation, suggesting that IL-6 is directly regulated by c-Rel and Rel-A 
binding. IL-6 production in response to stimulation of c-Rel
-/-
 CD4+ T cells and 
macrophages was consistently higher than that observed in the same cells isolated from 
wild type mice.  Together these results suggest that although c-Rel associates with the 
IL-6 promoter region, it has a negative regulatory role. The NF-κB family of 
transcription factors are thought to be key regulators of IL-6 expression with NF-κB 
inhibition with BAY-II abrogating expression responses in macrophage cells 
(Wongchana & Palaga 2012).  Analysis of the human IL-6 gene has identified an NF-
κB binding site, and when this site is mutated promoter activity in response to 
stimulation is diminished (Libermann & Baltimore 1990) suggesting this site is 
indispensable for IL-6 expression.  
 
In EL4 T cells transfected with the IL-6 promoter reporter construct, co-transfection 
with either of the NF-κB transcription factors Rel-A or c-Rel resulted in an increase in 
promoter driven luciferase activity when compared to the CMV control. This suggests 
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that these transcription factors positively regulated IL-6 gene transcription in T cells.  
These results would suggest that the increased transcriptional response in the absence of 
c-Rel observed in c-Rel
-/-
 cells is attributable to the c-Rel requirement of a negative 
regulator of IL-6.  Knockout of c-Rel thereby reduces the availability of this negative 
regulator, which has a greater influence on IL-6 gene transcription than the requirement 
for c-Rel for IL-6 gene transcription. Alternatively c-Rel could be a direct negative 
regulator of IL-6 expression in T cells, but only in a chromatin context not established 
during transient transfection (Jeong & Stein 1994). On the other hand c-Rel could 
mediate gene repression through interaction with other regulatory proteins which are 
not highly expressed in non-stimulated T cells. When transfected into RAW 264.7 
macrophage cells the IL-6 reporter plasmid demonstrated a significant decrease in 
luciferase activity compared to CMV in the presence of Rel-A and c-Rel which also 
appeared to have a negative influence on IL-6 promoter driven luciferase activity. This 
supports the notion that both Rel-A and c-Rel have a negative regulatory role on IL-6 
gene expression in macrophage cells mediated through direct interaction of the 
transcription factors with the promoter region. Whilst inducible IL-6 expression is 
greater in both T cells and macrophages derived from c-Rel
-/-
 mice and in the presence 
of c-Rel inhibition the mechanisms by which c-Rel negatively regulates IL-6 
transcription may vary between the two cell types.  
 
The lack of association of either c-Rel or Rel-A with the IL-10 promoter region 
suggests that these NF-κB family members do not contribute to IL-10 gene expression 
through direct binding to the promoter region. IL-10 gene transcription has previously 
been reported to be independent of NF-κB (Bondeson et al. 1999; Brightbill et al. 
2000). Although another study has shown that the NF-κB family member NF-κB1 
(p50) is able to bind to the IL-10 promoter region and activate transcription in 
macrophages cells (Cao et al. 2006). Since chromatin shearing was optimised to give 
DNA fragments of approximately 500bp in length, it is probable that the promoter 
primer set used for IL-10 promoter analysis amplified a region too distant from the NF-
κB binding site to detect changes in c-Rel binding to the promoter region.  
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The heightened IL-10 induction that was observed in the c-Rel
-/-
 CD4+ and BMDM 
cells suggest that c-Rel has a negative regulatory effect on IL-10 expression, however 
this may not be exerted though c-Rel binding to the IL-10 promoter region. As c-Rel is 
known to mediate gene expression responses of a number of immune genes as well as 
immune regulatory genes such as transcription factors these may in turn influence the 
IL-10 response through a flow on effect rather than through direct binding with the 
promoter region. It has previously been reported that IL-10 is regulated by 
transcriptional regulators that themselves are regulated by NF-κB, such as transcription 
factor STAT1 (Schreiber et al. 2006; Ziegler-Heitbrock et al. 2003). 
 
In EL4 T cells and RAW 264.7 macrophage cells transfected with the IL-10 promoter 
construct an increase in IL-10 promoter activity was observed upon co-transfection with 
either Rel-A or c-Rel. This is in conflict with the data obtained from c-Rel
-/-
 mice where 
IL-10 gene expression was enhanced in the absence of c-Rel. It is possible that in the 
absence of the associated chromatin structure assembled at the endogenous gene the 
overexpression of either Rel-A or c-Rel is able to influence IL-10 promoter activity 
though the activation of endogenous transcription factors such as STAT1 which co-
operatively drive transcription of the reporter construct. As the NF-κB family of 
transcription factors are well recognised as regulating a broad range of immune 
response genes, it is likely that the over expression of these transcription factors will 
not only interact with the co-transfected reporter plasmids but also interact with 
regulatory regions of the endogenous genes. Such interactions would potentially alter 
the expression of a number of genes which may also impact on the transcription rate of 
the reporter construct. Whilst IL-6 promoter activity in macrophages was negative in 
the presence of c-Rel, it was expected that this would also be the case when transfected 
into EL4 T cells, based on the positive effect c-Rel knockout was observed to have on 
IL-6 expression. Likewise IL-10 promoter activity may have been anticipated to 
decrease when transfected with the c-Rel plasmid. This data suggests that the divergent 
regulatory ability of c-Rel is due to interaction with other regulatory factors such as the 
chromatin structure as well as other transcription factors.  
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The NF-κB transcription factor, c-Rel is documented as having an important role in 
mediating mature macrophage and T cell function (Gerondakis et al. 2012; Gerondakis 
et al. 1996; Kontgen et al. 1995). c-Rel functioning as both a positive and negative 
regulator of cytokine gene expression in different cell types have been reported 
previously (Gerondakis et al. 1996; Grigoriadis et al. 1996). It is well established that 
mice lacking c-Rel are defective in mitogenic activation of B and T lymphocytes and 
display impaired humoural immunity and the results observed in cells isolated from c-
Rel
-/-
 mice suggest that this is due to the contribution c-Rel makes to regulating a broad 
range of cytokine genes (Gerondakis et al. 1996; Kontgen et al. 1995). Previous 
analysis has found that T cell production of cytokine genes including IL-3 and GM-CSF 
was diminished in c-Rel
-/-
 cells whilst other genes, such as IFN-γ were unaffected 
(Gerondakis et al. 1996). The work presented in this chapter indicates that c-Rel is able 
to act as both a positive and negative regulator of gene expression.  
 
The vast majority of studies looking at NF-κB activation of genes have focused on the 
Rel-A (p65) family member or the NF-κB family as a whole. It is now understood that 
the individual family members may serve distinctly different roles, in addition more 
variation is introduced by NF-κB family members binding both as homodimers and as 
heterodimers with other family members (Smale 2012). The c-Rel transcription factor 
binds as a homodimer as well as a heterodimer with the NF-κB1 (p50) subunit and Rel-
A subunit (Kunsch, Ruben & Rosen 1992). Whilst c-Rel shares an NF-κB binding 
motif with the Rel-A family member due to the homology of the DNA interacting 
region of the proteins it is evident from the differences in phenotype of the c-Rel and 
Rel-A knockout mice that they have distinct function (Baldwin 1996; Kunsch, Ruben & 
Rosen 1992; Sanjabi et al. 2005). c-Rel is able to recognise all of the binding sites that 
Rel-A is documented as interacting with, but Rel-A is unable to bind some c-Rel 
recognition sites which suggest that despite the shared DNA interaction site there is 
some specificity between the two factors (Schreiber et al. 2006). It is likely that c-Rel 
competes with other NF-κB transcription factors, including Rel-A, for binding at the 
NF-κB recognition sites. Perhaps by preventing c-Rel binding by gene knockout this 
increases the interaction of other NF-κB family members which have a greater ability to 
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drive gene expression. A further level of complexity may be added to how c-Rel 
functions to regulate gene expression by the post-translational modification of the c-Rel 
protein itself (Druker et al. 1994; Fognani et al. 2000; Martin & Fresno 2000).   
 
4.3.5 Conclusions 
 
The data presented in this chapter clearly highlights that immune cytokine genes may 
be regulated differently in different immune cells. Switching in the requirement for new 
protein synthesis for gene activation was observed between the two cell types however 
this did not adequately explain the activation kinetics of the immune genes. The basal 
chromatin structure established across the regulatory promoter regions correlates with 
the activation kinetics of gene transcription, with genes that show a rapid increase in 
gene transcription such as IL-6, held in a more permissive basal chromatin structure. In 
T cells there was evidence of remodelling for the IL-23A and IL-6 genes, however this 
was not as significant as the remodelling observed at the GM-CSF promoter and no 
evidence of remodelling was observed at the IL-10 promoter region. Chromatin 
remodelling was observed in response to stimulation for all genes in macrophage cells 
suggesting that even when the basal chromatin structure is permissive for gene 
activation, prolonged activation is sustained through permissive chromatin remodelling 
events. Whilst the c-Rel transcription factor has a pivotal role in regulating gene 
expression responses as demonstrated by the changes in gene expression response in the 
presence of the c-Rel inhibitor PTX or in cells derived from c-Rel
-/-
 mice, it can do so 
by acting as either a positive or negative regulator of gene expression.  
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5  Conclusions and Future Directions 
 
 
This thesis explores the mechanisms of gene regulation of a set of immune genes which 
fall under the control of the NF-κB transcription factor, c-Rel in both T cells and 
macrophages to determine if the regulatory mechanisms governing inducible gene 
expression differ between the two cell types. These genes were classified as either 
primary or secondary response genes based on their requirement for de novo protein 
synthesis for increased gene transcription. Results presented here clearly demonstrate 
that the requirements for inducible gene expression differ between cell types with 
switching from a primary response gene in one cell type to a secondary response gene 
in the other. This switching was not uniform in direction for all genes suggesting that 
the logic behind this switch is not attributable to a single common divergence between 
T cells and macrophages. The mechanisms underlying this switch may involve the 
cooperative interaction between a number of proteins such as transcription factors, 
chromatin structure and remodelling enzymes. Activation kinetics of immune gene 
transcription are not adequately explained by the requirement for protein synthesis, 
rather activation kinetics better reflect the basal chromatin environment established at 
the gene promoter prior to activation. Furthermore, these data demonstrate that c-Rel 
has a different regulatory effect on different immune genes, functioning as a positive or 
a negative regulator of gene expression in different contexts.  
 
Aberrant gene expression is associated with a range of immune disorders including 
inflammatory conditions such as arthritis, asthma and psoriasis as well as proliferative 
disorders like leukaemia (Heinrich et al. 2003; Langrish et al. 2005; Wills-Karp et al. 
1998; Young & Griffin 1986) and the factors that regulate immune responses are 
attractive targets for intervening in these diseases. However, targeting gene regulatory 
factors to correct aberrant gene expression also has the potential to de-regulate other 
genes. Thus a thorough understanding of the interactions between different regulatory 
factors and gene expression is required before this therapeutic avenue can be explored.  
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With the advent of genome-wide techniques such as gene expression arrays, ChIP on 
Chip and ChIP-seq assays we now have a plethora of data documenting gene 
expression in response to immune stimuli as well as the associated chromatin features. 
From this data we have gained increased understanding of the chromatin structures that 
are associated with inducible gene expression and those that mark regions of repressed 
DNA, as reviewed by Lim et al. (2013). Such studies provide a strong foundation from 
which single gene studies can build a more thorough understanding of how these 
common regulatory features interact to mediate inducible gene expression.  
 
The correct spatial and temporal activation of immune genes is crucial for the targeted 
resolution of immune responses. In order to achieve this some genes are activated more 
rapidly than others in response to the same stimuli and these have been termed primary 
and secondary responders (Ramirez-Carrozzi et al. 2006; Yamamoto & Alberts 1976). 
A possible cause for this delay in activation of some genes compared to others is the 
reliance on the synthesis of new proteins such as transcriptional activators prior to 
transcription events occurring (Fowler, Sen & Roy 2011; Ramirez-Carrozzi et al. 2009; 
Yamamoto & Alberts 1976). In this thesis gene responses were distinguished on this 
basis by examining gene expression responses in the presence and absence of 
cycloheximide (CHX), a protein synthesis inhibitor. These data demonstrated that 
several immune genes expressed in both T cells and macrophages differ in their 
requirement for new protein synthesis in the different cell types and switching between 
a primary to secondary response occurs in both directions. 
 
Activation of the GM-CSF gene in response to immune stimulation has been studied 
extensively and it is known to be differentially regulated in different cell types. This 
thesis confirms that in T cells GM-CSF is a secondary response gene whilst in 
macrophages it is a delayed primary response gene. However this does not reflect a 
difference in activation kinetics of GM-CSF gene transcription, demonstrating that the 
requirement for new protein synthesis for gene transcription is not always a good 
predictor of the kinetics of gene response. Similarly, IL-23A switches from being a 
secondary response gene in T cells to being a primary response gene in macrophage 
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cells. In contrast to GM-CSF, IL-23A displays divergent activation kinetics between the 
two cell types. An increase in IL-23A mRNA is detected within 30 minutes of 
macrophage stimulation whereas in T cells transcript levels are not increased until 4 
hours post stimulation. This delay in T cells may be partially due to the synthesis of 
new proteins required for gene activation. The switch from a primary to a secondary 
response gene was not always one directional. Both IL-6 and IL-10 gene expression was 
independent of new protein synthesis in T cells and switched to being secondary 
response genes in macrophages. Both IL-6 and IL-10 show more biphasic activation 
kinetics in both cell types suggesting that a requirement for new protein synthesis in 
macrophages but not T cells does not significantly alter the transcriptional responses. 
 
Western blot analysis of nuclear localisation of c-Rel in both macrophages and T cells 
suggests that c-Rel nuclear translocation is reliant on the synthesis of new proteins in T 
cells but not macrophages. These results suggest that the regulation of c-Rel may 
partially determine classification as a primary or secondary immune response. c-Rel is 
an attractive target for therapeutic intervention in inflammatory conditions associated 
with high levels of inflammatory cytokines mediated by c-Rel (Wada 2008; Wada et al. 
2012; Wada et al. 2007). The data presented in this thesis suggest that whilst c-Rel is a 
positive regulator of some inflammatory genes, including GM-CSF and IL-23A, it is 
also a negative regulator of others including the potent pro-inflammatory cytokine IL-6. 
Previously c-Rel has been documented as acting as both a positive and negative 
regulator in different populations of macrophage cells (Grigoriadis et al. 1996). The 
requirement for gene transcription for c-Rel can be inferred from gene transcription 
response in the presence of c-Rel inhibitors or in cells derived from c-Rel
-/-
 mice as well 
as reporter assays as has been done in this thesis. However, these data do not 
comprehensively demonstrate a direct role for c-Rel in mediating gene transcription 
levels. Whilst ChIP data in EL4 T cells suggests that c-Rel interacts with not only the 
GM-CSF promoter but also with the IL-23A and IL-6 promoter regions, further studies 
are required in order to fully elucidate the mechanisms by which c-Rel is able to 
function as both a positive and negative regulator of gene expression.  
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Previous work has shown that c-Rel association with the GM-CSF promoter is required 
to mediate chromatin remodelling events in response to immune stimulation 
(Brettingham-Moore et al. 2005). Future work should therefore examine chromatin 
remodelling events at the promoter regions in cells acquired from c-Rel
-/-
 mice to 
determine if chromatin remodelling is permissible in the absence of c-Rel. The potential 
for interaction between the c-Rel transcription factor and chromatin remodelling 
complexes would be a useful avenue to explore as it has now been reported that NF-κB 
transcription factors are required for remodelling events to occur, possibly by 
facilitating the interaction of chromatin remodelling complexes with specific DNA 
sequences (Limpert et al. 2013; Poke et al. 2012). In addition the post translational 
modification of c-Rel, such as phosphorylation may further modify c-Rel function 
(Druker et al. 1994; Fognani et al. 2000; Martin & Fresno 2000; Perkins 2006).  
 
The analysis of chromatin structure at the proximal promoters of the selected immune 
genes suggests that the basal chromatin accessibility across the promoter region largely 
dictates a genes ability to respond rapidly to activation signals. In addition the extent of 
chromatin remodelling correlates with the magnitude of the response. These findings 
support the hypothesis that the basal chromatin environment established during cell 
differentiation determines the genes response to stimuli. There is evidence to suggest 
that the chromatin structure established at the GM-CSF gene is determined through the 
process of differentiation. In the thymus the human GM-CSF gene is held in a silent 
state at the stage of TCR selection, to minimise the risk of inappropriate activation 
(Mirabella et al. 2010). During the process of T cell development the human GM-CSF 
locus is progressively activated in terms of both chromatin structure and gene 
expression (Mirabella et al. 2010). In murine CD4+ T cells, the GM-CSF promoter is 
held in a permissive chromatin structure marked by high levels of histone acetylation 
(Brettingham-Moore et al. 2008). Inducible gene expression occurs in association with 
increased promoter accessibility which is reflective of loss of core histone proteins from 
the GM-CSF promoter region (Brettingham-Moore et al. 2005; Brettingham-Moore et 
al. 2008). There is evidence that this loss of histones is mediated by the BRG1 
chromatin remodelling complex (Brettingham-Moore et al. 2005; Brettingham-Moore 
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et al. 2008) In closely related B cells the GM-CSF gene is held in a ‘repressive’ 
chromatin structure so that GM-CSF mRNA is not increased in response to stimulation 
(Brettingham-Moore et al. 2008; Sprod 2011). This supports the hypothesis that 
chromatin structure established at regulatory regions during the differentiation process 
determines the ability of the gene to respond to inducible stimuli.  Further, the work 
presented in this thesis suggests that the GM-CSF gene may be ‘primed’ for activation 
in different ways in different cell types. Whilst in macrophage cells GM-CSF gene 
activation is associated with increased promoter accessibility this was found to be 
independent of loss of core histone protein H3 from the promoter region. Interestingly, 
whilst an increase in GM-CSF mRNA levels was observed with the small change in 
chromatin accessibility seen in macrophages, the magnitude of this expression response 
was not a large as that observed in T cells where greater levels of chromatin 
remodelling are detected. This suggests that the extent of chromatin remodelling may 
dictate the degree of inducible gene expression. In macrophage cells the GM-CSF 
promoter region is not marked by high levels of histone acetylation prior to activation 
as it is in T cells. This suggests that chromatin remodelling occurs via different 
mechanisms in the two cell types as depicted in Figure 5.1. These mechanisms are yet 
to be fully elucidated and further investigation may include determining if the promoter 
region is marked by other features such as incorporation of histone variants in 
macrophage cells. Additionally, once these divergent regulatory features have been 
characterised, further work may examine how these marks are deposited and replicated 
during the process of differentiation from HSC to mature immune cell types.  
 
The incorporation of histone variants such as H2A.Z and H3.3 in exchange for 
canonical histone proteins is reported to destabilise nucleosomes (Jin et al. 2009; 
Sutcliffe et al. 2009). It is also possible that remodelling occurs via only partial 
disassembly of the promoter nucleosome so that core H3 is not depleted but perhaps the 
outer histone proteins, H2A and H2B are lost. The SWI/SNF chromatin remodelling 
complex has been shown to disassemble nucleosomes in a step-wise manner in which 
the outer H2A-H2B histone proteins are removed before a slower process removes the 
H3 and H4 proteins (Dechassa et al. 2010). It has previously been observed with the use  
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of labelled histones, that the H2A and H2B proteins are more frequently exchanged 
than the H3 and H4 proteins (Bruno et al. 2003) this may enable transcription to occur 
without complete disruption of the nucleosome, as the H2A-H2B histone dimers are 
frequently removed during the process of transcription by RNA polymerase II (Kireeva 
et al. 2002). It would be interesting to determine if gene activation is reliant on the same 
chromatin remodelling complexes in different cell types. Whilst the GM-CSF gene has 
been found to be activated by BRG1 dependent chromatin remodelling in T cells, GM-
CSF is reported as a SWI/SNF independent gene in macrophage cells (Ramirez-
Carrozzi et al. 2009). Varying the chromatin remodelling complex that mediates gene 
induction in different cell types would be one way of making gene expression responses 
cell type specific. 
 
Like GM-CSF, IL-23A is a pro-inflammatory molecule which was determined through 
genome-wide analysis to be BRG1 and c-Rel dependent in T cells. Expression analysis 
in c-Rel
-/- 
cells confirmed a requirement for c-Rel for gene transcription in both cell 
types. Following 4 hours of stimulation evidence of chromatin remodelling at the IL-
23A promoter region was seen in both T cells and macrophages correlating with 
increased gene transcription. However the extent of chromatin remodelling, as well as 
the magnitude of the transcription response are not as large as that observed for GM-
CSF in T cells. It would be useful to determine if the IL-23A promoter region is marked 
for activation by high levels of histone acetylation as the GM-CSF promoter is in T 
cells and to determine if the two genes share other chromatin marks such as active or 
repressive histone methylation. These studies may help to identify common sets of 
activation requirements for inducible immune gene expression.  
 
In contrast to GM-CSF and IL-23A, both IL-6 and IL-10 promoters are assembled into 
relatively accessible basal chromatin in macrophage cells which is most likely 
permissive to early gene transcription events. In T cells basal chromatin was more 
condensed with relative accessibility ratios closer to 1. While chromatin remodelling 
was observed in macrophage cells for the IL-23A, IL-6 and IL-10 gene promoters, basal 
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chromatin accessibility was often negative (ratio <1) in T cells, with some evidence of 
chromatin remodelling observed at the IL-23A and IL-6 promoter regions, although not 
to the same extent as is seen for GM-CSF. These data further support the notion that 
low levels of chromatin remodelling correlate with inducible transcriptional responses 
of lesser magnitude than those permissible by high levels of chromatin remodelling.  
 
This study could be expanded upon to be more informative if, rather than using just a 
single primer set to capture remodelling at a small part of the promoter region, a 
number of primer sets were employed to provide coverage up to 1kb from the 
transcriptional start site. Negative accessibility data has previously been reported as a 
mathematical artefact most likely attributable to error in DNA quantitation, and it was 
found to be neither reproducible nor biologically significant (Liang et al. 2006). 
However, negative accessibility was generally reported at only a few regions of DNA 
(amplified by specific primer sets) and when promoter DNA was examined using 
multiple primer sets, other regions showed evidence of chromatin remodelling (Liang et 
al. 2006). Additionally, mapping of hypersensitive sites both upstream and downstream 
of the TSS may be informative in regards to further control of gene transcription 
through the activation of upstream enhancer and repressor elements. GM-CSF gene 
expression has been shown to be significantly influenced by an upstream enhancer 
region (Cockerill et al. 1999; Cockerill et al. 1993). Further work may examine how 
distal regulatory regions are brought into proximity by the chromatin structure to in 
order to regulate gene expression. This work may further elucidate the significance of 
the variation in location of the putative BRG1 and NF-κB binding sites relative to the 
TSS, depicted schematically in Figure 4.18.  
 
Previous work on IL-10 activation suggests that the activation kinetics and chromatin 
remodelling may occur within the first 30 minutes of stimulation (Brightbill et al. 2000; 
Lucas et al. 2005). Whilst a time course was performed in order to examine activation 
kinetics of IL-23A, IL-6 and IL-10 mRNA levels, this could be further complemented 
by a time course to determine the chromatin accessibility associated with changes in 
mRNA levels. This may be particularly interesting for IL-6 and IL-10 where gene 
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activation has a more biphasic pattern, which may be mediated by waves of 
transcriptional activators or alternatively fluctuations in chromatin accessibility. 
 
Whilst basal chromatin structure and interaction with transcription factors and 
chromatin remodelling complexes are crucial for the correct timing of activation of 
immune genes, the re-setting of this chromatin landscape after the resolution of these 
gene responses is equally important for immune homeostasis (Poke et al. 2012). 
Histone reassembly at the GM-CSF promoter has previously been found to occur 
alongside the depletion of c-Rel from the promoter region (Poke et al. 2012). Further 
work may examine if similar mechanisms of chromatin resetting are utilised in order to 
resolve the expression of other c-Rel dependent genes.   
 
Genome-wide studies have rapidly expanded our understanding of how different 
regulatory factors are associated with immune genes both before and after stimulation. 
These studies must be expanded to encompass interaction between chromatin structure, 
chromatin modifying complexes and transcription factors in regards to gene expression. 
Data from this study suggests that association between a transcription factor or 
chromatin remodelling protein with a gene does not necessarily confer a single 
function. The schematic depiction of NF-κB binding sites and the chromatin 
remodelling protein BRG1 relative to the transcriptional start site (Figure 4.18) 
indicates that for IL-6 and IL-10 the potential BRG1 binding site is located downstream 
of the TSS, this may partially explain the difference in chromatin remodelling and 
biphasic activation kinetics for these genes. Further work may confirm the interaction 
between the different regulatory proteins at both proximal and distal regions to further 
elucidate the regulatory role of these proteins.  
 
This thesis highlights that the activation requirements of the same gene may differ 
between cell types. Expanding our understanding of the mechanistic switches in 
activation requirements and the interaction between chromatin structure, transcription 
factors and chromatin remodelling complexes will make precise targeting of such 
requirements therapeutically a more viable option.  
143 
 
 
References 
 
Abbas, AK, Lichtman, AH & Pillai, S (eds) 2007, Cellular and Molecular Immunology, 
6 edn, Saunders Elsevier, Philadelphia. 
 
Abbas, AK, Murphy, KM & Sher, A 1996, 'Functional diversity of helper T 
lymphocytes', Nature, vol. 383, no. 6603, pp. 787-793. 
 
Acuto, O & Cantrell, D 2000, 'T cell activation and the cytoskeleton', Annual Review of 
Immunology, vol. 18, pp. 165-+. 
 
Acuto, O & Michel, F 2003, 'CD28-mediated co-stimulation: A quantitative support for 
TCR signalling', Nature Reviews Immunology, vol. 3, no. 12, pp. 939-951. 
 
Adhikari, A, Xu, M & Chen, ZJ 2007, 'Ubiquitin-mediated activation of TAK1 and 
IKK', Oncogene, vol. 26, no. 22, pp. 3214-3226. 
 
Akashi, K, Traver, D, Miyamoto, T & Weissman, IL 2000, 'A clonogenic common 
myeloid progenitor that gives rise to all myeloid lineages', Nature, vol. 404, no. 6774, 
pp. 193-197. 
 
Al-Salleeh, F & Petro, TM 2008, 'Promoter analysis reveals critical roles for SMAD-3 
and ATF-2 in expression of IL-23 p19 in macrophages', Journal of Immunology, vol. 
181, no. 7, pp. 4523-4533. 
 
Araki, Y, Wang, ZB, Zang, CZ, Wood, WH, Schones, D, Cui, KR, Roh, TY, Lhotsky, 
B, Wersto, RP, Peng, WQ, Becker, KG, Zhao, K & Weng, NP 2009, 'Genome-wide 
Analysis of Histone Methylation Reveals Chromatin State-Based Regulation of Gene 
Transcription and Function of Memory CD8(+) T Cells', Immunity, vol. 30, no. 6, pp. 
912-925. 
 
Aung, HT, Schroder, K, Himes, SR, Brion, K, van Zuylen, W, Trieu, A, Suzuki, H, 
Hayashizaki, Y, Hume, DA, Sweet, MJ & Ravasi, T 2006, 'LPS regulates 
proinflammatory gene expression in macrophages by altering histone deacetylase 
expression', Faseb Journal, vol. 20, no. 9, pp. 1315-1327. 
 
Avni, O, Lee, D, Macian, F, Szabo, SJ, Glimcher, LH & Rao, A 2002, 'T-H cell 
differentiation is accompanied by dynamic changes in histone acetylation of cytokine 
genes', Nature Immunology, vol. 3, no. 7, pp. 643-651. 
 
144 
 
Azuara, V, Perry, P, Sauer, S, Spivakov, M, Jorgensen, HF, John, RM, Gouti, M, 
Casanova, M, Warnes, G, Merkenschlager, M & Fisher, AG 2006, 'Chromatin 
signatures of pluripotent cell lines', Nature Cell Biology, vol. 8, no. 5, pp. 532-U189. 
 
Baeuerle, PA & Henkel, T 1994, 'Function and activation of NF-kappa-B in the 
immune-system', Annual Review of Immunology, vol. 12, pp. 141-179. 
 
Baldwin, AS 1996, 'The NF-kappa B and I kappa B proteins: New discoveries and 
insights', Annual Review of Immunology, vol. 14, pp. 649-683. 
 
Ballard, DW, Dixon, EP, Peffer, NJ, Bogerd, H, Doerre, S, Stein, B & Greene, WC 
1992, 'The 65-kDa subunit of human NF-kappa-B functions as a potent transcriptional 
activator and a target for v-rel-mediated repression', Proceedings of the National 
Academy of Sciences of the United States of America, vol. 89, no. 5, pp. 1875-1879. 
 
Barski, A, Cuddapah, S, Cui, KR, Roh, TY, Schones, DE, Wang, ZB, Wei, G, 
Chepelev, I & Zhao, KJ 2007, 'High-resolution profiling of histone methylations in the 
human genome', Cell, vol. 129, no. 4, pp. 823-837. 
 
Barski, A, Jothi, R, Cuddapah, S, Cui, K, Roh, T-Y, Schones, DE & Zhao, K 2009, 
'Chromatin poises miRNA- and protein-coding genes for expression', Genome 
Research, vol. 19, no. 10, pp. 1742-1751. 
 
Becker, S, Devlin, RB & Haskill, JS 1989, 'Differential production of tumor necrosis 
factor, macrophage colony stimulating factor and interleukin-1 by human alveolar 
macrophages', Journal of Leukocyte Biology, vol. 45, no. 4, pp. 353-361. 
 
Beg, AA, Ruben, SM, Scheinman, RI, Haskill, S, Rosen, CA & Baldwin, AS 1992, 'I-
kappa-B interacts with the nuclear-localisation sequences of the subunits of NF-kappa-
B - a mechanism for cytoplasmic retention', Genes & Development, vol. 6, no. 10, pp. 
1899-1913. 
 
Bernstein, BE, Kamal, M, Lindblad-Toh, K, Bekiranov, S, Bailey, DK, Huebert, DJ, 
McMahon, S, Karlsson, EK, Kulbokas, EJ, Gingeras, TR, Schreiber, SL & Lander, ES 
2005, 'Genomic maps and comparative analysis of histone modifications in human and 
mouse', Cell, vol. 120, no. 2, pp. 169-181. 
 
Bernstein, BE, Mikkelsen, TS, Xie, XH, Kamal, M, Huebert, DJ, Cuff, J, Fry, B, 
Meissner, A, Wernig, M, Plath, K, Jaenisch, R, Wagschal, A, Feil, R, Schreiber, SL & 
Lander, ES 2006, 'A bivalent chromatin structure marks key developmental genes in 
embryonic stem cells', Cell, vol. 125, no. 2, pp. 315-326. 
 
Bert, AG, Burrows, J, Osborne, CS & Cockerill, PN 2000, 'Generation of an improved 
luciferase reporter gene plasmid that employs a novel mechanism for high-copy 
replication', Plasmid, vol. 44, no. 2, pp. 173-182. 
 
145 
 
Blank, V, Kourilsky, P & Israel, A 1992, 'NF-kappa-B and related proteins - rel dorsal 
homologies meet ankyrin-like repeats', Trends in Biochemical Sciences, vol. 17, no. 4, 
pp. 135-140. 
 
Bondeson, J, Browne, KA, Brennan, FM, Foxwell, BMJ & Feldmann, M 1999, 
'Selective regulation of cytokine induction by adenoviral gene transfer of I kappa B 
alpha into human macrophages: Lipopolysaccharide-induced, but not zymosan-induced, 
proinflammatory cytokines are inhibited, but IL-10 is nuclear Factor-kappa B 
independent', Journal of Immunology, vol. 162, no. 5, pp. 2939-2945. 
 
Bonenfant, D, Coulot, M, Towbin, H, Schindler, P & van Oostrum, J 2006, 
'Characterization of histone H2A and H2B variants and their post-translational 
modifications by mass spectrometry', Molecular & Cellular Proteomics, vol. 5, no. 3, 
pp. 541-552. 
 
Braunstein, M, Sobel, RE, Allis, CD, Turner, BM & Broach, JR 1996, 'Efficient 
transcriptional silencing in Saccharomyces cerevisiae requires a heterochromatin 
histone acetylation pattern', Molecular and Cellular Biology, vol. 16, no. 8, pp. 4349-
4356. 
 
Brettingham-Moore, KH 2006, 'Defining the molecular events required for GM-CSF 
gene activation in T cells', PhD thesis, University of Tasmania. 
 
Brettingham-Moore, KH, Rao, S, Juelich, T, Shannon, MF & Holloway, AF 2005, 
'GM-CSF promoter chromatin remodelling and gene transcription display distinct 
signal and transcription factor requirements', Nucleic Acids Research, vol. 33, no. 1, pp. 
225-234. 
 
Brettingham-Moore, KH, Sprod, OR, Chen, X, Oakford, P, Shannon, MF & Holloway, 
AF 2008, 'Determinants of a transcriptionally competent environment at the GM-CSF 
promoter', Nucleic Acids Research, vol. 36, no. 8, pp. 2639-2653. 
 
Briggs, MR, Kadonaga, JT, Bell, SP & Tjian, R 1986, 'Purification and biochemical-
characterization of the promoter-specific transcription factor, SPL', Science, vol. 234, 
no. 4772, pp. 47-52. 
 
Brightbill, HD, Plevy, SE, Modlin, RL & Smale, ST 2000, 'A prominent role for Sp1 
during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages', 
Journal of Immunology, vol. 164, no. 4, pp. 1940-1951. 
 
Brownell, E, Mathieson, B, Young, HA, Keller, J, Ihle, JN & Rice, NR 1987, 'Detection 
of c-Rel-related transcripts in mouse hematopoietic tissues, fractionated lymphocyte 
populations, and cell-lines', Molecular and Cellular Biology, vol. 7, no. 3, pp. 1304-
1309. 
 
146 
 
Bruno, M, Flaus, A, Stockdale, C, Rencurel, C, Ferreira, H & Owen-Hughes, T 2003, 
'Histone H2A/H2B dimer exchange by ATP-dependent chromatin remodeling 
activities', Molecular Cell, vol. 12, no. 6, pp. 1599-1606. 
 
Bultman, S, Gebuhr, T, Yee, D, La Mantia, C, Nicholson, J, Gilliam, A, Randazzo, F, 
Metzger, D, Chambon, P, Crabtree, G & Magnuson, T 2000, 'A Brg1 null mutation in 
the mouse reveals functional differences among mammalian SWI/SNF complexes', 
Molecular Cell, vol. 6, no. 6, pp. 1287-1295. 
 
Bunting, K, Rao, S, Hardy, K, Woltring, D, Denyer, GS, Wang, J, Gerondakis, S & 
Shannon, MF 2007, 'Genome-wide analysis of gene expression in T cells to identify 
targets of the NF-kappa B transcription factor c-Rel', Journal of Immunology, vol. 178, 
no. 11, pp. 7097-7109. 
 
Cakouros, D, Cockerill, PN, Bert, AG, Mital, R, Roberts, DC & Shannon, MF 2001, 'A 
NF-kappa B/Sp1 region is essential for chromatin remodeling and correct transcription 
of a human granulocyte-macrophage colony-stimulating factor transgene', Journal of 
Immunology, vol. 167, no. 1, pp. 302-310. 
 
Cao, SJ, Zhang, X, Edwards, JP & Mosser, DM 2006, 'NF-kappa B1 (p50) homodimers 
differentially regulate pro- and anti-inflammatory cytokines in macrophages', Journal of 
Biological Chemistry, vol. 281, no. 36, pp. 26041-26050. 
 
Carey, M 1998, 'The enhanceosome and transcriptional synergy', Cell, vol. 92, no. 1, 
pp. 5-8. 
 
Carmody, RJ, Ruan, QG, Liou, HC & Chen, YHH 2007, 'Essential roles of c-Rel in 
TLR-induced IL-23 p19 gene expression in dendritic cells', Journal of Immunology, 
vol. 178, no. 1, pp. 186-191. 
 
Carrasco, D, Weih, F & Bravo, R 1994, 'Developmental expression of the mouse c-Rel 
protooncogene in haematopoietic organs', Development, vol. 120, no. 10, pp. 2991-
3004. 
 
Cedar, H & Bergman, Y 2011, 'Epigenetics of haematopoietic cell development', 
Nature Reviews Immunology, vol. 11, no. 7, pp. 478-488. 
 
Chen, GB, Hardy, K, Bunting, K, Daley, S, Ma, LN & Shannon, MF 2010, 'Regulation 
of the IL-21 Gene by the NF-kappa B Transcription Factor c-Rel', Journal of 
Immunology, vol. 185, no. 4, pp. 2350-2359. 
 
Chen, LF & Greene, WC 2004, 'Shaping the nuclear action of NF-kappa B', Nature 
Reviews Molecular Cell Biology, vol. 5, no. 5, pp. 392-401. 
 
147 
 
Chen, X, Wang, J, Woltring, D, Gerondakis, S & Shannon, MF 2005, 'Histone 
dynamics on the interleukin-2 gene in response to T-Cell activation', Molecular and 
Cellular Biology, vol. 25, no. 8, pp. 3209-3219. 
 
Cheutin, T, McNairn, AJ, Jenuwein, T, Gilbert, DM, Singh, PB & Misteli, T 2003, 
'Maintenance of stable heterochromatin domains by dynamic HP1 binding', Science, 
vol. 299, no. 5607, pp. 721-725. 
 
Chi, TH, Wan, M, Zhao, KJ, Taniuchi, I, Chen, L, Littman, DR & Crabtree, GR 2002, 
'Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes', 
Nature, vol. 418, no. 6894, pp. 195-199. 
 
Chi, TH, Wan, MM, Lee, PP, Akashi, K, Metzger, D, Chambon, P, Wilson, CB & 
Crabtree, GR 2003, 'Sequential roles of Brg, the ATPase subunit of BAF chromatin 
remodeling complexes, in thymocyte development', Immunity, vol. 19, no. 2, pp. 169-
182. 
 
Cockerill, PN 2004, 'Mechanisms of transcriptional regulation of the human IL-3/GM-
CSF locus by inducible tissue-specific promoters and enhancers', Critical Reviews in 
Immunology, vol. 24, no. 6, pp. 385-408. 
 
Cockerill, PN 2011, 'Structure and function of active chromatin and DNase I 
hypersensitive sites', Febs Journal, vol. 278, no. 13, pp. 2182-2210. 
 
Cockerill, PN, Bert, AG, Roberts, D & Vadas, MA 1999, 'The human granulocyte-
macrophage colony-stimulating factor gene is autonomously regulated in vivo by an 
inducible tissue-specific enhancer', Proceedings of the National Academy of Sciences of 
the United States of America, vol. 96, no. 26, pp. 15097-15102. 
 
Cockerill, PN, Shannon, MF, Bert, AG, Ryan, GR & Vadas, MA 1993, 'The 
Granulocyte Macrophage Colony-Stimulating Factor Interleukin-3 Locus Is Regulated 
by an Inducible Cyclosporin A-Sensitive Enhancer', Proceedings of the National 
Academy of Sciences of the United States of America, vol. 90, no. 6, pp. 2466-2470. 
 
Cohen, S, Bigazzi, PE & Yoshida, T 1974, 'Similarities of T-cell function in cell-
mediated-immunity and antibody production ', Cellular Immunology, vol. 12, no. 1, pp. 
150-159. 
 
Couture, JF & Trievel, RC 2006, 'Histone-modifying enzymes: encrypting an enigmatic 
epigenetic code', Current Opinion in Structural Biology, vol. 16, no. 6, pp. 753-760. 
 
Creyghton, MP, Markoulaki, S, Levine, SS, Hanna, J, Lodato, MA, Sha, K, Young, 
RA, Jaenisch, R & Boyer, LA 2008, 'H2AZ Is Enriched at Polycomb Complex Target 
Genes in ES Cells and Is Necessary for Lineage Commitment', Cell, vol. 135, no. 4, pp. 
649-661. 
 
148 
 
Cruickshank, M, Fenwick, E, Abraham, LJ & Ulgiati, D 2008, 'Quantitative differences 
in chromatin accessibility across regulatory regions can be directly compared in distinct 
cell-types', Biochemical and Biophysical Research Communications, vol. 367, no. 2, 
pp. 349-355. 
 
Cuddapah, S, Barski, A & Zhao, KJ 2010, 'Epigenomics of T cell activation, 
differentiation, and memory', Current Opinion in Immunology, vol. 22, no. 3, pp. 341-
347. 
 
Cui, KR, Zang, CZ, Roh, TY, Schones, DE, Childs, RW, Peng, WQ & Zhao, K 2009, 
'Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the 
Fate of Bivalent Genes during Differentiation', Cell Stem Cell, vol. 4, no. 1, pp. 80-93. 
 
de la Cruz, X, Lois, S, Sanchez-Molina, S & Martinez-Balbas, MA 2005, 'Do protein 
motifs read the histone code?', Bioessays, vol. 27, no. 2, pp. 164-175. 
 
de la Serna, IL, Ohkawa, Y & Imbalzano, AN 2006, 'Chromatin remodelling in 
mammalian differentiation: lessons from ATP-dependent remodellers', Nature Reviews 
Genetics, vol. 7, no. 6, pp. 461-473. 
 
De, S, Wurster, AL, Precht, P, Wood, WH, Becker, KG & Pazin, MJ 2011, 'Dynamic 
BRG1 recruitment during T helper differentiation and activation reveals distal 
regulatory elements', Molecular and Cellular Biology. 
 
Dechassa, ML, Sabri, A, Pondugula, S, Kassabov, SR, Chatterjee, N, Kladde, MP & 
Bartholomew, B 2010, 'SWI/SNF Has Intrinsic Nucleosome Disassembly Activity that 
Is Dependent on Adjacent Nucleosomes', Molecular Cell, vol. 38, no. 4, pp. 590-602. 
 
Dhalluin, C, Carlson, JE, Zeng, L, He, C, Aggarwal, AK & Zhou, MM 1999, 'Structure 
and ligand of a histone acetyltransferase bromodomain', Nature, vol. 399, no. 6735, pp. 
491-496. 
 
Donnelly, RP, Freeman, SL & Hayes, MP 1995, 'Inhibition of IL-10 expression by 
IFN-gamma up-regulates transcription of TNF-alpha in human monocytes', Journal of 
Immunology, vol. 155, no. 3, pp. 1420-1427. 
 
Druker, BJ, Neumann, M, Okuda, K, Franza, BR & Griffin, JD 1994, 'Rel is rapidly 
tyrosine-phosphorylated following granulocyte-colony-stimulating factor treatment of 
human neutrophils', Journal of Biological Chemistry, vol. 269, no. 7, pp. 5387-5390. 
 
El Mezayen, R, El Gazzar, M, Myer, R & High, KP 2009, 'Aging-dependent 
upregulation of IL-23p19 gene expression in dendritic cells is associated with 
differential transcription factor binding and histone modifications', Aging Cell, vol. 8, 
no. 5, pp. 553-565. 
 
149 
 
Falvo, JV, Jasenosky, LD, Kruidenier, L & Goldfeld, AE 2013, 'Epigenetic Control of 
Cytokine Gene Expression: Regulation of the TNF/LT Locus and T Helper Cell 
Differentiation', in FW Alt (ed.), Advances in Immunology, Vol 118, vol. 118, pp. 37-
128, DOI 10.1016/b978-0-12-407708-9.00002-9, <<Go to 
ISI>://WOS:000321592300002>. 
 
Fan, CM & Maniatis, T 1991, 'Generation of p50 subunit of NF-kappa-B by processing 
of p105 through an ATP-dependent pathway', Nature, vol. 354, no. 6352, pp. 395-398. 
 
Fiorentino, DF, Bond, MW & Mosmann, TR 1989, '2 types of mouse T-helper cell.4. 
Th2 clones secrete a factor that inhibits cytokine production by the clones', Journal of 
Experimental Medicine, vol. 170, no. 6, pp. 2081-2095. 
 
Fishman, D, Faulds, G, Jeffery, R, Mohamed-Ali, V, Yudkin, JS, Humphries, S & 
Woo, P 1998, 'The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on 
IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset 
juvenile chronic arthritis', Journal of Clinical Investigation, vol. 102, no. 7, pp. 1369-
1376. 
 
Fognani, C, Rondi, R, Romano, A & Blasi, F 2000, 'cRel-TD kinase: a serine/threonine 
kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation 
domain', Oncogene, vol. 19, no. 18, pp. 2224-2232. 
 
Fowler, T, Sen, R & Roy, AL 2011, 'Regulation of Primary Response Genes', 
Molecular Cell, vol. 44, no. 3, pp. 348-360. 
 
Gardner, KE, Allis, CD & Strahl, BD 2011, 'OPERating ON Chromatin, a Colorful 
Language where Context Matters', Journal of Molecular Biology. 
 
Gebuhr, TC, Kovalev, GI, Bultman, S, Godfrey, V, Su, LS & Magnuson, T 2003, 'The 
role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T 
cell development', Journal of Experimental Medicine, vol. 198, no. 12, pp. 1937-1949. 
 
Georgopoulos, K 2002, 'Haematopoietic cell-fate decisions, chromatin regulation and 
ikaros', Nature Reviews Immunology, vol. 2, no. 3, pp. 162-174. 
 
Georgopoulos, K, Moore, DD & Derfler, B 1992, 'Ikaros, an early lymphoid-specific 
transcription factor and putative mediator for T-cell commitment', Science, vol. 258, no. 
5083, pp. 808-812. 
 
Gerondakis, S, Banerjee, A, Grigoriadis, G, Vasanthakumar, A, Gugasyan, R, Sidwell, 
T & Grumont, RJ 2012, 'NF-kappa B subunit specificity in hemopoiesis', 
Immunological Reviews, vol. 246, pp. 272-285. 
 
Gerondakis, S, Strasser, A, Metcalf, D, Grigoriadis, G, Scheerlinck, JPY & Grumont, 
RJ 1996, 'Rel-deficient T cells exhibit defects in production of interleukin 3 and 
150 
 
granulocyte-macrophage colony-stimulating factor', Proceedings of the National 
Academy of Sciences of the United States of America, vol. 93, no. 8, pp. 3405-3409. 
 
Ghosh, G, Vanduyne, G, Ghosh, S & Sigler, PB 1995, 'Structure of NF-kappa-B p50 
homodimer bound to a kappa-B site', Nature, vol. 373, no. 6512, pp. 303-310. 
 
Ghosh, S, May, MJ & Kopp, EB 1998, 'NF-kappa B and rel proteins: Evolutionarily 
conserved mediators of immune responses', Annual Review of Immunology, vol. 16, pp. 
225-260. 
 
Gordon, S 1995, 'The macrophage', Bioessays, vol. 17, no. 11, pp. 977-986. 
 
Gordon, S & Taylor, PR 2005, 'Monocyte and macrophage heterogeneity', Nature 
Reviews Immunology, vol. 5, no. 12, pp. 953-964. 
 
Grigoriadis, G, Zhan, YF, Grumont, RJ, Metcalf, D, Handman, E, Cheers, C & 
Gerondakis, S 1996, 'The Rel subunit of NF-kappa B-like transcription factors is a 
positive and negative regulator of macrophage gene expression: Distinct roles for Rel in 
different macrophage populations', Embo Journal, vol. 15, no. 24, pp. 7099-7107. 
 
Grunstein, M 1997, 'Histone acetylation in chromatin structure and transcription', 
Nature, vol. 389, no. 6649, pp. 349-352. 
 
Hargreaves, DC, Horng, T & Medzhitov, R 2009, 'Control of Inducible Gene 
Expression by Signal-Dependent Transcriptional Elongation', Cell, vol. 138, no. 1, pp. 
129-145. 
 
Hassan, AH, Neely, KE, Vignali, M, Reese, JC & Workman, JL 2001, 'Promoter 
targeting of chromatin-modifying complexes', Frontiers in Bioscience, vol. 6, pp. 
D1054-D1064. 
 
Hawwari, A, Burrows, J, Vadas, MA & Cockerill, PN 2002, 'The human IL-3 locus is 
regulated cooperatively by two NFAT-dependent enhancers that have distinct tissue-
specific activities', Journal of Immunology, vol. 169, no. 4, pp. 1876-1886. 
 
Hayden, MS & Ghosh, S 2008, 'Shared principles in NF-kappa B signaling', Cell, vol. 
132, no. 3, pp. 344-362. 
 
Heinrich, PC, Behrmann, I, Haan, S, Hermanns, HM, Muller-Newen, G & Schaper, F 
2003, 'Principles of interleukin (IL)-6-type cytokine signalling and its regulation', 
Biochemical Journal, vol. 374, pp. 1-20. 
 
Heissmeyer, V, Krappmann, D, Wulczyn, FG & Scheidereit, C 1999, 'NF-kappa B 
p105 is a target of I kappa B kinases and controls signal induction of Bcl-3-p50 
complexes', Embo Journal, vol. 18, no. 17, pp. 4766-4778. 
 
151 
 
Herschman, HR 1991, 'Primary response genes induced by growth-factors and tumor 
promoters ', Annual Review of Biochemistry, vol. 60, pp. 281-319. 
 
Himes, SR, Coles, LS, Reeves, R & Shannon, MF 1996, 'High mobility group protein 
I(Y) is required for function and for c-Rel binding to CD28 response elements within 
the GM-CSF and IL-2 promoters', Immunity, vol. 5, no. 5, pp. 479-489. 
 
Ho, L & Crabtree, GR 2010, 'Chromatin remodelling during development', Nature, vol. 
463, no. 7280, pp. 474-484. 
 
Holloway, AF, Rao, S, Chen, XX & Shannon, MF 2003, 'Changes in chromatin 
accessibility across the GM-CSF promoter upon T cell activation are dependent on 
nuclear factor kappa B proteins', Journal of Experimental Medicine, vol. 197, no. 4, pp. 
413-423. 
 
Holloway, AF, Rao, S & Shannon, MF 2002, 'Regulation of cytokine gene transcription 
in the immune system', Molecular Immunology, vol. 38, no. 8, pp. 567-580. 
 
Iglesias, MJ, Reilly, SJ, Emanuelsson, O, Sennblad, B, Najafabadi, MP, Folkersen, L, 
Malarstig, A, Lagergren, J, Eriksson, P, Hamsten, A & Odeberg, J 2012, 'Combined 
Chromatin and Expression Analysis Reveals Specific Regulatory Mechanisms within 
Cytokine Genes in the Macrophage Early Immune Response', Plos One, vol. 7, no. 2. 
 
Jeong, SW & Stein, A 1994, 'Micrococcal nuclease digestion of nuclei reveals extended 
nucleosome ladders having anomalous DNA lengths for chromatin assembled on 
nonreplicating plasmids in transfected cells', Nucleic Acids Research, vol. 22, no. 3, pp. 
370-375. 
 
Jin, CY, Zang, CZ, Wei, G, Cui, KR, Peng, WQ, Zhao, KJ & Felsenfeld, G 2009, 
'H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of 
active promoters and other regulatory regions', Nature Genetics, vol. 41, no. 8, pp. 941-
U112. 
 
Kadonaga, JT 1998, 'Eukaryotic transcription: An interlaced network of transcription 
factors and chromatin-modifying machines', Cell, vol. 92, no. 3, pp. 307-313. 
 
Kafer, GR, Lehnert, SA, Pantaleon, M, Kaye, PL & Moser, RJ 2010, 'Expression of 
genes coding for histone variants and histone-associated proteins in pluripotent stem 
cells and mouse preimplantation embryos', Gene Expression Patterns, vol. 10, no. 6, 
pp. 299-305. 
 
Karin, M & Ben-Neriah, Y 2000, 'Phosphorylation meets ubiquitination: The control of 
NF-kappa B activity', Annual Review of Immunology, vol. 18, pp. 621-+. 
 
152 
 
Kawamoto, H, Ohmura, K & Katsura, Y 1998, 'Cutting edge: Presence of progenitors 
restricted to T, B, or myeloid lineage, but absence of multipotent stem cells, in the 
murine fetal thymus', Journal of Immunology, vol. 161, no. 8, pp. 3799-3802. 
 
Kireeva, ML, Walter, W, Tchernajenko, V, Bondarenko, V, Kashlev, M & Studitsky, 
VM 2002, 'Nucleosome remodeling induced by RNA polymerase II: Loss of the 
H2A/H2B dimer during transcription', Molecular Cell, vol. 9, no. 3, pp. 541-552. 
 
Kondo, M, Weissman, IL & Akashi, K 1997, 'Identification of clonogenic common 
lymphoid progenitors in mouse bone marrow', Cell, vol. 91, no. 5, pp. 661-672. 
 
Kontgen, F, Grumont, RJ, Strasser, A, Metcalf, D, Li, RL, Tarlinton, D & Gerondakis, 
S 1995, 'Mice lacking the c-rel protooncogene exhibit defects in lymphocyte-
proliferation, humoural immunity, and interleukin-2 expression', Genes & 
Development, vol. 9, no. 16, pp. 1965-1977. 
 
Kornberg, RD 1974, 'Chromatin structure - repeating unit of histones and DNA', 
Science, vol. 184, no. 4139, pp. 868-871. 
 
Kornberg, RD & Lorch, Y 2007, 'Chromatin rules', Nature Structural & Molecular 
Biology, vol. 14, no. 11, pp. 986-988. 
 
Kornberg, RD & Lorch, YL 1999, 'Twenty-five years of the nucleosome, fundamental 
particle of the eukaryote chromosome', Cell, vol. 98, no. 3, pp. 285-294. 
 
Kouzarides, T 2007, 'Chromatin modifications and their function', Cell, vol. 128, no. 4, 
pp. 693-705. 
 
Kunsch, C, Ruben, SM & Rosen, CA 1992, 'Selection of optimal kappa-B/Rel DNA-
binding motifs - interaction of both subunits of NF-kappa-B with DNA is required for 
transcriptional activation', Molecular and Cellular Biology, vol. 12, no. 10, pp. 4412-
4421. 
 
Lacaud, G, Carlsson, L & Keller, G 1998, 'Identification of a fetal hematopoietic 
precursor with B cell, T cell, and macrophage potential', Immunity, vol. 9, no. 6, pp. 
827-838. 
 
Laiosa, CV, Stadtfeld, M & Graf, T 2006, 'Determinants of lymphoid-myeloid lineage 
diversification', in Annual Review of Immunology, vol. 24, pp. 705-738, DOI 
10.1146/annurev.immunol.24.021605.090742, <<Go to 
ISI>://WOS:000237583300023>. 
 
Langrish, CL, Chen, Y, Blumenschein, WM, Mattson, J, Basham, B, Sedgwick, JD, 
McClanahan, T, Kastelein, RA & Cua, DJ 2005, 'IL-23 drives a pathogenic T cell 
population that induces autoimmune inflammation', Journal of Experimental Medicine, 
vol. 201, no. 2, pp. 233-240. 
153 
 
 
Laurenti, E, Doulatov, S, Zandi, S, Plumb, I, Chen, J, April, C, Fan, JB & Dick, JE 
2013, 'The transcriptional architecture of early human hematopoiesis identifies 
multilevel control of lymphoid commitment', Nature Immunology, vol. 14, no. 7, pp. 
756-+. 
 
Lee, HS, Park, JH, Kim, SJ, Kwon, SJ & Kwon, J 2010, 'A cooperative activation loop 
among SWI/SNF, gamma-H2AX and H3 acetylation for DNA double-strand break 
repair', Embo Journal, vol. 29, no. 8, pp. 1434-1445. 
 
Li, B, Carey, M & Workman, JL 2007, 'The role of chromatin during transcription', 
Cell, vol. 128, no. 4, pp. 707-719. 
 
Li, Y, Ohms, SJ, Shannon, FM, Sun, C & Fan, JY 2012, 'IL-2 and GM-CSF are 
regulated by DNA demethylation during activation of T cells, B cells and 
macrophages', Biochemical and Biophysical Research Communications, vol. 419, no. 4, 
pp. 748-753. 
 
Liang, MD, Zhang, Y, McDevit, D, Marecki, S & Nikolajczyk, BS 2006, 'The 
interleukin-1 beta gene is transcribed from a poised promoter architecture in 
monocytes', Journal of Biological Chemistry, vol. 281, no. 14, pp. 9227-9237. 
 
Libermann, TA & Baltimore, D 1990, 'Activation of interleukin-6 gene-expression the 
NF-kappa-B transcription factor', Molecular and Cellular Biology, vol. 10, no. 5, pp. 
2327-2334. 
 
Lim, PS, Hardy, K, Bunting, KL, Ma, L, Peng, KM, Chen, XX & Shannon, MF 2009, 
'Defining the chromatin signature of inducible genes in T cells', Genome Biology, vol. 
10, no. 10. 
 
Lim, PS, Li, J, Holloway, AF & Rao, S 2013, 'Epigenetic regulation of inducible gene 
expression in the immune system', Immunology, vol. 139, no. 3, pp. 285-293. 
 
Limpert, AS, Bai, SJ, Narayan, M, Wu, J, Yoon, SO, Carter, BD & Lu, QR 2013, 'NF-
kappa B Forms a Complex with the Chromatin Remodeler BRG1 to Regulate Schwann 
Cell Differentiation', Journal of Neuroscience, vol. 33, no. 6, pp. 2388-+. 
 
Liou, HC, Jin, Z, Tumang, J, Andjelic, S, Smith, KA & Liou, ML 1999, 'c-Rel is crucial 
for lymphocyte proliferation but dispensable for T cell effector function', International 
Immunology, vol. 11, no. 3, pp. 361-371. 
 
Litterst, CM, Kliem, S, Lodrini, M & Pfitzner, E 2005, 'Coactivators in gene regulation 
by STAT5', in G Litwack (ed.), Vitamins and Hormones, vol. 70, pp. 359-386, DOI 
10.1016/s0083-6729(05)70012-1, <<Go to ISI>://WOS:000228718900012>. 
 
154 
 
Liu, WC, Ouyang, XS, Yang, JJ, Liu, JG, Li, QS, Gu, YP, Fukata, M, Lin, T, He, JC, 
Abreu, M, Unkeless, JC, Mayer, L & Xiong, HB 2009, 'AP-1 Activated by Toll-like 
Receptors Regulates Expression of IL-23 p19', Journal of Biological Chemistry, vol. 
284, no. 36, pp. 24006-24016. 
 
Lorch, Y, Maier-Davis, B & Kornberg, RD 2006, 'Chromatin remodeling by 
nucleosome disassembly in vitro', Proceedings of the National Academy of Sciences of 
the United States of America, vol. 103, no. 9, pp. 3090-3093. 
 
Lucas, M, Zhang, X, Prasanna, V & Mosser, DM 2005, 'ERK activation following 
macrophage Fc gamma R ligation leads to chromatin modifications at the IL-10 locus', 
Journal of Immunology, vol. 175, no. 1, pp. 469-477. 
 
Luger, K, Dechassa, ML & Tremethick, DJ 2012, 'New insights into nucleosome and 
chromatin structure: an ordered state or a disordered affair?', Nature Reviews Molecular 
Cell Biology, vol. 13, no. 7, pp. 436-447. 
 
Lusser, A & Kadonaga, JT 2003, 'Chromatin remodeling by ATP-dependent molecular 
machines', Bioessays, vol. 25, no. 12, pp. 1192-1200. 
 
Martin, AG & Fresno, M 2000, 'Tumor necrosis factor-alpha activation of NF-kappa B 
requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel', Journal 
of Biological Chemistry, vol. 275, no. 32, pp. 24383-24391. 
 
McBryant, SJ, Adams, VH & Hansen, JC 2006, 'Chromatin architectural proteins', 
Chromosome Research, vol. 14, no. 1, pp. 39-51. 
 
Mikkelsen, TS, Ku, MC, Jaffe, DB, Issac, B, Lieberman, E, Giannoukos, G, Alvarez, P, 
Brockman, W, Kim, TK, Koche, RP, Lee, W, Mendenhall, E, O'Donovan, A, Presser, 
A, Russ, C, Xie, XH, Meissner, A, Wernig, M, Jaenisch, R, Nusbaum, C, Lander, ES & 
Bernstein, BE 2007, 'Genome-wide maps of chromatin state in pluripotent and lineage-
committed cells', Nature, vol. 448, no. 7153, pp. 553-U552. 
 
Mirabella, F, Baxter, EW, Boissinot, M, James, SR & Cockerill, PN 2010, 'The Human 
IL-3/Granulocyte-Macrophage Colony-Stimulating Factor Locus Is Epigenetically 
Silent in Immature Thymocytes and Is Progressively Activated during T Cell 
Development', Journal of Immunology, vol. 184, no. 6, pp. 3043-3054. 
 
Mise-Omata, S, Kuroda, E, Niikura, J, Yamashita, U, Obata, Y & Doi, TS 2007, 'A 
proximal kappa B site in the IL-23 p19 promoter is responsible for RelA- and c-rel-
dependent transcription', Journal of Immunology, vol. 179, no. 10, pp. 6596-6603. 
 
Moore, KW, Malefyt, RD, Coffman, RL & O'Garra, A 2001, 'Interleukin-10 and the 
interleukin-10 receptor', Annual Review of Immunology, vol. 19, pp. 683-765. 
 
155 
 
Mosmann, TR & Coffman, RL 1989, 'Th1-cell and Th2-cell - Differnet patterns of 
lymphokine secretion lead to different functional properties', Annual Review of 
Immunology, vol. 7, pp. 145-173. 
 
Mus, AMC, Cornelissen, F, Asmawidjaja, PS, van Hamburg, JP, Boon, L, Hendriks, 
RW & Lubberts, E 2010, 'Interleukin-23 Promotes Th17 Differentiation by Inhibiting 
T-bet and FoxP3 and Is Required for Elevation of Interleukin-22, but Not Interleukin-
21, in Autoimmune Experimental Arthritis', Arthritis and Rheumatism, vol. 62, no. 4, 
pp. 1043-1050. 
 
Naito, T, Tanaka, H, Naoe, Y & Taniuchi, I 2011, 'Transcriptional control of T-cell 
development', International Immunology, vol. 23, no. 11, pp. 661-668. 
 
Natoli, G 2009, 'Control of NF-kappa B-dependent Transcriptional Responses by 
Chromatin Organization', Cold Spring Harbor Perspectives in Biology, vol. 1, no. 4. 
 
Natoli, G, Saccani, S, Bosisio, D & Marazzi, I 2005, 'Interactions of NF-kappa B with 
chromatin: the art of being at the right place at the right time', Nature Immunology, vol. 
6, no. 5, pp. 439-445. 
 
Oeckinghaus, A, Hayden, MS & Ghosh, S 2011, 'Crosstalk in NF-kappa B signaling 
pathways', Nature Immunology, vol. 12, no. 8, pp. 695-708. 
 
Oppmann, B, Lesley, R, Blom, B, Timans, JC, Xu, YM, Hunte, B, Vega, F, Yu, N, 
Wang, J, Singh, K, Zonin, F, Vaisberg, E, Churakova, T, Liu, MR, Gorman, D, 
Wagner, J, Zurawski, S, Liu, YJ, Abrams, JS, Moore, KW, Rennick, D, de Waal-
Malefyt, R, Hannum, C, Bazan, JF & Kastelein, RA 2000, 'Novel p19 protein engages 
IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct 
from IL-12', Immunity, vol. 13, no. 5, pp. 715-725. 
 
Palsson-McDermott, EM & O'Neill, LAJ 2004, 'Signal transduction by the 
lipopolysaccharide receptor, Toll-like receptor-4', Immunology, vol. 113, no. 2, pp. 153-
162. 
 
Pastinen, T & Hudson, TJ 2004, 'Cis-acting regulatory variation in the human genome', 
Science, vol. 306, no. 5696, pp. 647-650. 
 
Perkins, ND 2006, 'Post-translational modifications regulating the activity and function 
of the nuclear factor kappa B pathway', Oncogene, vol. 25, no. 51, pp. 6717-6730. 
 
Poke, FS, Upcher, WR, Sprod, OR, Young, A, Brettingham-Moore, KH & Holloway, 
AF 2012, 'Depletion of c-Rel from Cytokine Gene Promoters Is Required for 
Chromatin Reassembly and Termination of Gene Responses to T Cell Activation', Plos 
One, vol. 7, no. 7. 
 
156 
 
Precht, P, Wurster, AL & Pazin, MJ 2010, 'The SNF2H chromatin remodeling enzyme 
has opposing effects on cytokine gene expression', Molecular Immunology, vol. 47, no. 
11-12, pp. 2038-2046. 
 
Ptashne, M & Gann, A 1997, 'Transcriptional activation by recruitment', Nature, vol. 
386, no. 6625, pp. 569-577. 
 
Ramirez-Carrozzi, VR, Braas, D, Bhatt, DM, Cheng, CS, Hong, C, Doty, KR, Black, 
JC, Hoffmann, A, Carey, M & Smale, ST 2009, 'A Unifying Model for the Selective 
Regulation of Inducible Transcription by CpG Islands and Nucleosome Remodeling', 
Cell, vol. 138, no. 1, pp. 114-128. 
 
Ramirez-Carrozzi, VR, Nazarian, AA, Li, CC, Gore, SL, Sridharan, R, Imbalzano, AN 
& Smale, ST 2006, 'Selective and antagonistic functions of SWI/SNF and Mi-2 beta 
nucleosome remodeling complexes during an inflammatory response', Genes & 
Development, vol. 20, no. 3, pp. 282-296. 
 
Rao, A, Luo, C & Hogan, PG 1997, 'Transcription factors of the NFAT family: 
Regulation and function', Annual Review of Immunology, vol. 15, pp. 707-747. 
 
Rao, S, Gerondakis, S, Woltring, D & Shannon, MF 2003, 'c-Rel is required for 
chromatin remodeling across the IL-2 gene promoter', Journal of Immunology, vol. 170, 
no. 7, pp. 3724-3731. 
 
Rao, SH, Procko, E & Shannon, MF 2001, 'Chromatin remodeling, measured by a 
novel real-time polymerase chain reaction assay, across the proximal promoter region 
of the IL-2 gene', Journal of Immunology, vol. 167, no. 8, pp. 4494-4503. 
 
Reinecker, HC, Steffen, M, Witthoeft, T, Pflueger, I, Schreiber, S, Macdermott, RP & 
Raedler, A 1993, 'Enhanced secretion of tumour-necrosis-factor-alpha, IL-6, and IL-1-
beta by isolated lamina propria mononuclear-cells from patients with ulcerative-colitis 
and crohns-disease', Clinical and Experimental Immunology, vol. 94, no. 1, pp. 174-
181. 
 
Rice, JC, Briggs, SD, Ueberheide, B, Barber, CM, Shabanowitz, J, Hunt, DF, Shinkai, 
Y & Allis, CD 2003, 'Histone methyltransferases direct different degrees of methylation 
to define distinct chromatin domains', Molecular Cell, vol. 12, no. 6, pp. 1591-1598. 
 
Rice, NR, Mackichan, ML & Israel, A 1992, 'The precursor of NF-kappa-B p50 has I-
kappa-B-like functions', Cell, vol. 71, no. 2, pp. 243-253. 
 
Rieger, MA, Hoppe, PS, Smejkal, BM, Eitelhuber, AC & Schroeder, T 2009, 
'Hematopoietic Cytokines Can Instruct Lineage Choice', Science, vol. 325, no. 5937, 
pp. 217-218. 
 
157 
 
Rodriguez, J, Munoz, M, Vives, L, Frangou, CG, Groudine, M & Peinado, MA 2008, 
'Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer 
cells', Proceedings of the National Academy of Sciences of the United States of 
America, vol. 105, no. 50, pp. 19809-19814. 
 
Roger, T, Out, TA, Jansen, HM & Lutter, R 1998, 'Superinduction of interleukin-6 
mRNA in lung epithelial H292 cells depends on transiently increased C/EBP activity 
and durable increased mRNA stability', Biochimica Et Biophysica Acta-Gene Structure 
and Expression, vol. 1398, no. 3, pp. 275-284. 
 
Roger, T, Out, TA, Mukaida, N, Matsushima, K, Jansen, HM & Lutter, R 1998, 
'Enhanced AP-1 and NF-kappa B activities and stability of interleukin 8 (IL-8) 
transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells', 
Biochemical Journal, vol. 330, pp. 429-435. 
 
Roh, TY, Cuddapah, S, Cui, KR & Zhao, KJ 2006, 'The genomic landscape of histone 
modifications in human T cells', Proceedings of the National Academy of Sciences of 
the United States of America, vol. 103, no. 43, pp. 15782-15787. 
 
Roh, TY, Cuddapah, S & Zhao, K 2005, 'Active chromatin domains are defined by 
acetylation islands revealed by genome-wide mapping', Genes & Development, vol. 19, 
no. 5, pp. 542-552. 
 
Ryseck, RP, Bull, P, Takamiya, M, Bours, V, Siebenlist, U, Dobrzanski, P & Bravo, R 
1992, 'RelB, a new Rel family transcription activator that can interact with p50-NF-
kappa-B', Molecular and Cellular Biology, vol. 12, no. 2, pp. 674-684. 
 
Saccani, S, Pantano, S & Natoli, G 2001, 'Two waves of nuclear factor kappa B 
recruitment to target promoters', Journal of Experimental Medicine, vol. 193, no. 12, 
pp. 1351-1359. 
 
Saha, A, Wittmeyer, J & Cairns, BR 2006, 'Chromatin remodelling: the industrial 
revolution of DNA around histones', Nature Reviews Molecular Cell Biology, vol. 7, 
no. 6, pp. 437-447. 
 
Sanjabi, S, Williams, KJ, Saccani, S, Zhou, LN, Hoffmann, A, Ghosh, G, Gerondakis, 
S, Natoli, G & Smale, ST 2005, 'A c-Rel subdomain responsible for enhanced DNA-
binding affinity and selective gene activation', Genes & Development, vol. 19, no. 18, 
pp. 2138-2151. 
 
Santos-Rosa, H, Schneider, R, Bannister, AJ, Sherriff, J, Bernstein, BE, Emre, NCT, 
Schreiber, SL, Mellor, J & Kouzarides, T 2002, 'Active genes are tri-methylated at K4 
of histone H3', Nature, vol. 419, no. 6905, pp. 407-411. 
 
Santos-Rosa, H, Schneider, R, Bernstein, BE, Karabetsou, N, Morillon, A, Weise, C, 
Schreiber, SL, Mellor, J & Kouzarides, T 2003, 'Methylation of histone H3K4 mediates 
158 
 
association of the Isw1p ATPase with chromatin', Molecular Cell, vol. 12, no. 5, pp. 
1325-1332. 
 
Schmitz, ML, Silva, MAD, Altmann, H, Czisch, M, Holak, TA & Baeuerle, PA 1994, 
'Structural and functional-analysis of the NF-kappa-B p65 C-terminus - an acidic and 
modular transactivation domain with the potential to adopt an alpha-helical 
conformation', Journal of Biological Chemistry, vol. 269, no. 41, pp. 25613-25620. 
 
Schones, DE, Cui, KR, Cuddapah, S, Roh, TY, Barski, A, Wang, ZB, Wei, G & Zhao, 
KJ 2008, 'Dynamic regulation of nucleosome positioning in the human genome', Cell, 
vol. 132, no. 5, pp. 887-898. 
 
Schreiber, E, Matthias, P, Muller, MM & Schaffner, W 1989, 'Rapid detection of 
octamer binding-proteins with mini-extracts, prepared from a small number of cells', 
Nucleic Acids Research, vol. 17, no. 15, pp. 6419-6419. 
 
Schreiber, J, Jenner, RG, Murray, HL, Gerber, GK, Gifford, DK & Young, RA 2006, 
'Coordinated binding of NF-kappa B family members in the response of human cells to 
lipopolysaccharide', Proceedings of the National Academy of Sciences of the United 
States of America, vol. 103, no. 15, pp. 5899-5904. 
 
Sen, R & Baltimore, D 1986, 'Multiple nuclear factors interact with the 
immunoglobulin enhancer sequences', Cell, vol. 46, no. 5, pp. 705-716. 
 
Shannon, MF, Coles, LS, Vadas, MA & Cockerill, PN 1997, 'Signals for activation of 
the GM-CSF promoter and enhancer in T cells', Critical Reviews in Immunology, vol. 
17, no. 3-4, pp. 301-323. 
 
Shannon, MF, Himes, SR & Coles, LS 1995, 'GM-CSF and IL-2  share common 
control mechanisms in response to costimulatory signals in T-cells.', Journal of 
Leukocyte Biology, vol. 57, no. 5, pp. 767-773. 
 
Shaw, JP, Utz, PJ, Durand, DB, Toole, JJ, Emmel, EA & Crabtree, GR 1988, 
'Identification of a putative regulator of early T-cell activation genes', Science, vol. 241, 
no. 4862, pp. 202-205. 
 
Shogren-Knaak, M, Ishii, H, Sun, JM, Pazin, MJ, Davie, JR & Peterson, CL 2006, 
'Histone H4-K16 acetylation controls chromatin structure and protein interactions', 
Science, vol. 311, no. 5762, pp. 844-847. 
 
Sims, RJ, Millhouse, S, Chen, CF, Lewis, BA, Erdjument-Bromage, H, Tempst, P, 
Manley, JL & Reinberg, D 2007, 'Recognition of trimethylated histone h3 lysine 4 
facilitates the recruitment of transcription postinitiation factors and pre-mRNA 
splicing', Molecular Cell, vol. 28, no. 4, pp. 665-676. 
 
159 
 
Singh, H, Sen, R, Baltimore, D & Sharp, PA 1986, 'A nuclear factor that binds to a 
conserved sequence motif in transcriptional control elements of immunoglobulin genes', 
Nature, vol. 319, no. 6049, pp. 154-158. 
 
Singh, M, Popowicz, GM, Krajewski, M & Holak, TA 2007, 'Structural ramification for 
acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central 
ATPase of the SWI/SNF remodeling complex', Chembiochem, vol. 8, no. 11, pp. 1308-
1316. 
 
Smale, ST 2010a, 'Selective Transcription in Response to an Inflammatory Stimulus', 
Cell, vol. 140, no. 6, pp. 833-844. 
 
Smale, ST 2010b, 'Transfection by electroporation of RAW 264.7 macrophages', Cold 
Spring Harbor Protocols. 
 
Smale, ST 2012, 'Dimer-specific regulatory mechanisms within the NF-kappa B family 
of transcription factors', Immunological Reviews, vol. 246, pp. 193-204. 
 
Smith, BC & Denu, JM 2009, 'Chemical mechanisms of histone lysine and arginine 
modifications', Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms, vol. 
1789, no. 1, pp. 45-57. 
 
Smith, S, Gabhann, JN, Higgs, R, Stacey, K, Wahren-Herlenius, M, Espinosa, A, 
Totaro, MG, Sica, A, Ball, E, Bell, A, Johnston, J, Browne, P, O'Neill, L, Kearns, G & 
Jefferies, CA 2012, 'Enhanced interferon regulatory factor 3 binding to the interleukin-
23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus 
erythematosus', Arthritis and Rheumatism, vol. 64, no. 5, pp. 1601-1609. 
 
Spangrude, GJ, Heimfeld, S & Weissman, IL 1988, 'Purification and characterization of 
mouse hematopoietic stem-cells', Science, vol. 241, no. 4861, pp. 58-62. 
 
Sprod, OR 2011, 'Differential Expression of the GM-CSF Gene in the Immune System 
is Regulated by Epigenetic Factors', PhD thesis, University of Tasmania. 
 
Strahl, BD & Allis, CD 2000, 'The language of covalent histone modifications', Nature, 
vol. 403, no. 6765, pp. 41-45. 
 
Sutcliffe, EL, Parish, IA, He, YQ, Juelich, T, Tierney, ML, Rangasamy, D, Milburn, PJ, 
Parish, CR, Tremethick, DJ & Rao, S 2009, 'Dynamic Histone Variant Exchange 
Accompanies Gene Induction in T Cells', Molecular and Cellular Biology, vol. 29, no. 
7, pp. 1972-1986. 
 
Sweet, MJ & Hume, DA 1996, 'Endotoxin signal transduction in macrophages', Journal 
of Leukocyte Biology, vol. 60, no. 1, pp. 8-26. 
 
160 
 
Szenker, E, Ray-Gallet, D & Almouzni, G 2011, 'The double face of the histone variant 
H3.3', Cell Research, vol. 21, no. 3, pp. 421-434. 
 
Takahama, Y & Nakauchi, H 1996, 'Phorbol ester and calcium ionophore can replace 
TCR signals that induce positive selection of CD4 T cells', Journal of Immunology, vol. 
157, no. 4, pp. 1508-1513. 
 
Takemoto, N, Kamogawa, Y, Lee, HJ, Kurata, H, Arai, K, O'Garra, A, Arai, N & 
Miyatake, S 2000, 'Cutting edge: Chromatin remodeling at the IL-4/IL-13 intergenic 
regulatory region for Th2-specific cytokine gene cluster', Journal of Immunology, vol. 
165, no. 12, pp. 6687-6691. 
 
Tamaru, H 2010, 'Confining euchromatin/heterochromatin territory: jumonji crosses the 
line', Genes & Development, vol. 24, no. 14, pp. 1465-1478. 
 
Tan, MJ, Luo, H, Lee, S, Jin, FL, Yang, JS, Montellier, E, Buchou, T, Cheng, ZY, 
Rousseaux, S, Rajagopal, N, Lu, ZK, Ye, Z, Zhu, Q, Wysocka, J, Ye, Y, Khochbin, S, 
Ren, B & Zhao, YM 2011, 'Identification of 67 Histone Marks and Histone Lysine 
Crotonylation as a New Type of Histone Modification', Cell, vol. 146, no. 6, pp. 1015-
1027. 
 
Thanos, D & Maniatis, T 1995, 'Identification of the Rel family members required for 
virus induction of the human beta-interferon gene', Molecular and Cellular Biology, 
vol. 15, no. 1, pp. 152-164. 
 
Thorens, B, Mermod, JJ & Vassalli, P 1987, 'Phagocytosis and inflammatory stimuli 
induce GM-CSF messenger-RNA in macrophages through posttranscriptional 
regulation', Cell, vol. 48, no. 4, pp. 671-679. 
 
Tremethick, DJ 2007, 'Higher-order structures of chromatin: The elusive 30 nm fiber', 
Cell, vol. 128, no. 4, pp. 651-654. 
 
Tsuboi, A, Muramatsu, M, Tsutsumi, A, Arai, K & Arai, N 1994, 'Calcineurin activates 
transcription from the GM-CSF promoter in synergy with either protein-kinase-C or 
NF-kappa-B/AP-1 in T-cells.', Biochemical and Biophysical Research 
Communications, vol. 199, no. 2, pp. 1064-1072. 
 
Tullai, JW, Schaffer, ME, Mullenbrock, S, Sholder, G, Kasif, S & Cooper, GM 2007, 
'Immediate-early and delayed primary response genes are distinct in function and 
genomic architecture', Journal of Biological Chemistry, vol. 282, no. 33, pp. 23981-
23995. 
 
Ulevitch, RJ & Tobias, PS 1995, 'Receptor-dependent mechanisms of cell stimulation 
by bacterial-endotoxin', Annual Review of Immunology, vol. 13, pp. 437-457. 
 
161 
 
Vahedi, G, Takahashi, H, Nakayamada, S, Sun, HW, Sartorelli, V, Kanno, Y & O'Shea, 
JJ 2012, 'STATs Shape the Active Enhancer Landscape of T Cell Populations', Cell, 
vol. 151, no. 5, pp. 981-993. 
 
Venters, BJ & Pugh, BF 2009, 'How eukaryotic genes are transcribed', Critical Reviews 
in Biochemistry and Molecular Biology, vol. 44, no. 2-3, pp. 117-141. 
 
Wada, H, Masuda, K, Satoh, R, Kakugawa, K, Ikawa, T, Katsura, Y & Kawamoto, H 
2008, 'Adult T-cell progenitors retain myeloid potential', Nature, vol. 452, no. 7188, pp. 
768-U710. 
 
Wada, Y 2008, 'IL-12/IL-23 inhibitors: a promising approach to the treatment of 
inflammatory disorders', Drugs of the Future, vol. 33, no. 1, pp. 49-63. 
 
Wada, Y, Cardinale, I, Khatcherian, A, Chu, J, Kantor, AB, Gottlieb, AB, Tatsuta, N, 
Jacobson, E, Barsoum, J & Krueger, JG 2012, 'Apilimod Inhibits the Production of IL-
12 and IL-23 and Reduces Dendritic Cell Infiltration in Psoriasis', Plos One, vol. 7, no. 
4. 
 
Wada, Y, Lu, RZ, Zhou, D, Chu, J, Przewloka, T, Zhang, SJ, Li, L, Wu, YM, Qin, J, 
Balasubramanyam, V, Barsoum, J & Ono, M 2007, 'Selective abrogation of Th1 
response by STA-5326, a potent IL-12/IL-23 inhibitor', Blood, vol. 109, no. 3, pp. 
1156-1164. 
 
Wang, WH, Tam, WF, Hughes, CCW, Rath, S & Sen, R 1997, 'c-Rel is a target of 
pentoxifylline-mediated inhibition of T lymphocyte activation', Immunity, vol. 6, no. 2, 
pp. 165-174. 
 
Wang, ZB, Zang, CZ, Cui, KR, Schones, DE, Barski, A, Peng, WQ & Zhao, KJ 2009, 
'Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active 
and Inactive Genes', Cell, vol. 138, no. 5, pp. 1019-1031. 
 
Wang, ZB, Zang, CZ, Rosenfeld, JA, Schones, DE, Barski, A, Cuddapah, S, Cui, KR, 
Roh, TY, Peng, WQ, Zhang, MQ & Zhao, KJ 2008, 'Combinatorial patterns of histone 
acetylations and methylations in the human genome', Nature Genetics, vol. 40, no. 7, 
pp. 897-903. 
 
Ward, SB, Hernandez-Hoyos, G, Chen, F, Waterman, M, Reeves, R & Rothenberg, EV 
1998, 'Chromatin remodeling of the interleukin-2 gene: distinct alterations in the 
proximal versus distal enhancer regions', Nucleic Acids Research, vol. 26, no. 12, pp. 
2923-2934. 
 
Wei, G, Wei, L, Zhu, J, Zang, C, Hu-Li, J, Yao, Z, Cui, K, Kanno, Y, Roh, T-Y, 
Watford, WT, Schones, DE, Peng, W, Sun, H-w, Paul, WE, O'Shea, JJ & Zhao, K 
2009, 'Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity 
162 
 
in Lineage Fate Determination of Differentiating CD4(+) T Cells', Immunity, vol. 30, 
no. 1, pp. 155-167. 
 
Weih, F, Carrasco, D & Bravo, R 1994, 'Constitutive and inducible Rel NF-kappa-B 
activities in mouse thymus and spleen', Oncogene, vol. 9, no. 11, pp. 3289-3297. 
 
Weinmann, AS, Plevy, SE & Smale, ST 1999, 'Rapid and selective remodeling of a 
positioned nucleosome during the induction of IL-12 p40 transcription', Immunity, vol. 
11, no. 6, pp. 665-675. 
 
Wills-Karp, M, Luyimbazi, J, Xu, XY, Schofield, B, Neben, TY, Karp, CL & 
Donaldson, DD 1998, 'Interleukin-13: Central mediator of allergic asthma', Science, 
vol. 282, no. 5397, pp. 2258-2261. 
 
Wilson, CB, Rowell, E & Sekimata, M 2009, 'Epigenetic control of T-helper-cell 
differentiation', Nature Reviews Immunology, vol. 9, no. 2, pp. 91-105. 
 
Wongchana, W & Palaga, T 2012, 'Direct regulation of interleukin-6 expression by 
Notch signaling in macrophages', Cellular & Molecular Immunology, vol. 9, no. 2, pp. 
155-162. 
 
Workman, JL 2006, 'Nucleosome displacement in transcription', Genes & Development, 
vol. 20, no. 15, pp. 2009-2017. 
 
Wurster, AL & Pazin, MJ 2008, 'BRG1-Mediated Chromatin Remodeling Regulates 
Differentiation and Gene Expression of T Helper Cells', Molecular and Cellular 
Biology, vol. 28, no. 24, pp. 7274-7285. 
 
Wurster, AL, Precht, P & Pazin, MJ 2011, 'NF-kappa B and BRG1 bind a distal 
regulatory element in the IL-3/GM-CSF locus', Molecular Immunology, vol. 48, no. 15-
16, pp. 2178-2188. 
 
Wysocka, J, Swigut, T, Xiao, H, Milne, TA, Kwon, SY, Landry, J, Kauer, M, Tackett, 
AJ, Chait, BT, Badenhorst, P, Wu, C & Allis, CD 2006, 'A PHD finger of NURF 
couples histone H3 lysine 4 trimethylation with chromatin remodelling', Nature, vol. 
442, no. 7098, pp. 86-90. 
 
Xu, C, Bian, CB, Yang, W, Galka, M, Hui, OY, Chen, C, Qiu, W, Liu, HD, Jones, AE, 
MacKenzie, F, Pan, P, Li, SSC, Wang, HB & Min, JR 2010, 'Binding of different 
histone marks differentially regulates the activity and specificity of polycomb 
repressive complex 2 (PRC2)', Proceedings of the National Academy of Sciences of the 
United States of America, vol. 107, no. 45, pp. 19266-19271. 
 
Yamamoto, KR & Alberts, BM 1976, 'Steroid receptors - Elements for modulation of 
eukaryotic transcription ', Annual Review of Biochemistry, vol. 45, pp. 721-746. 
 
163 
 
Yamaoka, S, Courtois, G, Bessia, C, Whiteside, ST, Weil, R, Agou, F, Kirk, HE, Kay, 
RJ & Israel, A 1998, 'Complementation cloning of NEMO, a component of the I kappa 
B kinase complex essential for NF-kappa B activation', Cell, vol. 93, no. 7, pp. 1231-
1240. 
 
Yang, Q, Bell, JJ & Bhandoola, A 2010, 'T-cell lineage determination', Immunological 
Reviews, vol. 238, pp. 12-22. 
 
Young, DC & Griffin, JD 1986, 'Autocrine secretion of GM-CSF in acute myeloblastic-
leukemia ', Blood, vol. 68, no. 5, pp. 1178-1181. 
 
Yudkovsky, N, Logie, C, Hahn, S & Peterson, CL 1999, 'Recruitment of the SWI/SNF 
chromatin remodeling complex by transcriptional activators', Genes & Development, 
vol. 13, no. 18, pp. 2369-2374. 
 
Zhang, JLA, Mortazavi, A, Williams, BA, Wold, BJ & Rothenberg, EV 2012, 
'Dynamic Transformations of Genome-wide Epigenetic Marking and Transcriptional 
Control Establish T Cell Identity', Cell, vol. 149, no. 2, pp. 467-482. 
 
Zhang, X, Edwards, JP & Mosser, DM 2006, 'Dynamic and transient remodeling of the 
macrophage IL-10 promoter during transcription', Journal of Immunology, vol. 177, no. 
2, pp. 1282-1288. 
 
Zhao, KJ, Wang, WD, Rando, OJ, Xue, YT, Swiderek, K, Kuo, A & Crabtree, GR 
1998, 'Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF 
complex to chromatin after T lymphocyte receptor signaling', Cell, vol. 95, no. 5, pp. 
625-636. 
 
Zhou, LA, Ivanov, II, Spolski, R, Min, R, Shenderov, K, Egawa, T, Levy, DE, Leonard, 
WJ & Littman, DR 2007, 'IL-6 programs TH-17 cell differentiation by promoting 
sequential engagement of the IL-21 and IL-23 pathways', Nature Immunology, vol. 8, 
no. 9, pp. 967-974. 
 
Ziegler-Heitbrock, L, Lotzerich, M, Schaefer, A, Werner, T, Frankenberger, M & 
Benkhart, E 2003, 'IFN-alpha induces the human IL-10 gene by recruiting both IFN 
regulatory factor 1 and Stat3', Journal of Immunology, vol. 171, no. 1, pp. 285-290. 
 
 
 
164 
 
APPENDIX A – c-Rel dependent genes 
 
 
NM_024253    Nkg7    natural killer cell group 7 
NM_009917   Ccr5   chemokine (C-C motif) receptor  
M11024       hypothetical protein LOC641050  
NM_031395   Sytl3   synaptotagmin-like3  
NM_010370   Gzma   granzyme A  
NM_010288   Gja1   gap junction protein, alpha 1 
BC083101   C87414  expressed sequence C87414 
NM_008607   Mmp13  matrix metallopeptidase 13 
NM_134066   Akr1c18  aldo-keto reductase family 1,  
       member c18 
NM_008147    Gp49a   glycoprotein 49A 
ENSMUST00000020067 Lilrb4       leukocyte immunoglobulin-like  
       receptor, subfamily B, member 4  
NM_001044384  Timp1    tissue inhibitor of  
       metalloproteinase  
NM_008510   Xcl1   chemokine (C motif) ligand 1 
NM_010548   Il10   interleukin 10  
NM_019770   Tmed2  transmembrane emp24 domain 
trafficking protein 2 
NM_011636   Plscr1    phospholipid scramblase  
NM_001025602  Il1rl1   interleukin 1 receptor-like 1 
NM_010590   Jub   ajuba  
ENSMUST00000101675 Gm14636  predicted gene 14636/100038616 
NM_011454   Serpinb6b  serine (or cysteine) peptidase  
       inhibitor, clade B, member 6b  
NM_028044    Cnn3   calponin 3, acidic 
165 
 
NM_028849   Cldnd2   claudin domain containing 2 
NM_010554    Il1a    interleukin 1 alpha  
NM_009255    Serpine2   serine (or cysteine) peptidase  
        inhibitor, clade E, member 2  
XM_621704   Gm5301   predicted gene 5301  
NM_153529    Nrn1    neuritin 1  
NM_026075   Sfrs12ip1   SFRS12-interacting protein 1 
NM_001081287  Mpp7    membrane protein,  
        palmitoylated 7  
NM_146218    Rfwd3    ring finger and WD repeat  
        domain 3  
NM_029341   Capsl    calcyphosine-like 
ENSMUST00000114898 Zc3hav1   zinc finger CCCH type, antiviral 
 1  
ENSMUST00000099550  Gm10786   predicted gene 10786 
NM_001033415   Shisa3   shisa homolog 3 
NM_019656    Tspan6   tetraspanin 6  
NM_025677    Tsen15   tRNA splicing endonuclease 15  
        homolog (S. cerevisiae)  
NM_010242    Fut4    fucosyltransferase 4  
NM_013754    Insl6     insulin-like  
NM_027091     Nup35   nucleoporin  
NM_029249     RIKEN     RICKEN cDNA  
NM_019549     Plek     pleckstrin  
NM_026122     Hmgn3    high mobility group  
         nucleosomal binding domain 3  
NM_001161515    Dctd     dCMP deaminase 
NM_027154     Tmbim1    transmembrane BAX inhibitor 
  motif containing 1  
ENSMUST00000079237   Zfp125    zinc finger protein 125 
NM_015829    Slc25a13   solute carrier family 25  
166 
 
       (mitochondrial carrier, adenine  
       nucleotide translocator), member 
 13  
NM_010104    Edn1    endothelin 1  
NM_172301    Ccnb1   cyclin B1  
NM_011369    Shcbp1   Shc SH2-domain binding  
        protein 1  
NM_009004    Kif20a   kinesin family member 20A 
NM_011347     Selp    selectin, platelet  
NM_023645     Kdelc1   KDEL (Lys-Asp-Glu-Leu) 
 containing 1  
NM_019425     Gnpnat1   glucosamine-phosphate N- 
        acetyltransferase 1  
NM_010371     Gzmc   granzyme C  
XR_032134     Gm2889   predicted gene 2889 
ENSMUST00000058104   Zfp719   zinc finger protein 719 
NM_180600     Ube2q2   ubiquitin-conjugating enzyme 
 E2Q (putative) 2  
NM_153116     Gtpbp10   GTP-binding protein 10 
NM_001039251    Gm7265   predicted gene 7265  
XR_031404     Gm3148   predicted gene 3148  
NM_145483     Zfp160   zinc finger protein 160 
NM_026053     Gemin6   gem (nuclear organelle)  
        associated protein 6  
NM_009758     Bmpr1a  bone morphogenetic protein  
       receptor, type 1A  
NM_025664     Snx9   sorting nexin 9  
NM_001004140    Ckap2             cytoskeleton associated protein 2 
NM_016960     Ccl20  chemokine (C-C motif) ligand 20 
NM_145618     Narg2  NMDA receptor-regulated gene  
       2  
167 
 
NM_001040699  Mtmr7   myotubularin related protein 7 
NM_011207   Ptpn3   protein tyrosine phosphatase,  
       non-receptor type 3  
NM_145938   Rpp40     ribonuclease P 40 subunit  
NM_001081680  Zfp72   zinc finger protein 72 
NM_001008427  Gm5595  predicted gene  
NM_026958    RIKEN   neural regeneration protein 
NM_030710   Slamf6  SLAM family member 6 
NM_016971   Il22   interleukin 22  
NM_054079   Iltifb   interleukin 10-related T cell- 
       derived inducible factor beta  
BC116235   Il22   interleukin 22  
NM_011990   Slc7a11  solute carrier family 7 (cationic  
       amino acid transporter, y+  
       system), member 11  
ENSMUST00000099328      Gm6843  predicted gene 6843  
NM_028334   Nup37   nucleoporin 37  
NM_030690   Rai14   retinoic acid induced 14 
NM_013898   Timm8a1  translocase of inner  
       mitochondrial membrane 8  
       homolog a1 (yeast)  
NM_146231   Zfp825  zinc finger protein 825 
XR_032234   LOC675534  similar to Importin alpha-2  
       subunit  
NM_144895    Spg20   spastic paraplegia 20, spartin  
       (Troyer syndrome)  
NM_021397   Zbtb32  zinc finger and BTB domain 
containing  
NM_026507   Zwilch  Zwilch, kinetochore associated,  
       homolog (Drosophila)  
NM_134080   Flnb   filamin, beta  
168 
 
XR_034872   Gm7239   predicted gene 7239  
NM_011289   Rpl27    ribosomal protein L27 
NM_012012   Exo1    exonuclease 1  
NM_001128096  Atp13a3   ATPase type 13A3  
NM_031252   Il23a    interleukin 23, alpha subunit 
 p19  
NM_080448    Srgap3  SLIT-ROBO Rho GTPase 
 activating protein 3  
NM_009657    Aldoc    aldolase C, fructose- 
        bisphosphate  
NM_026560    Cdca8   cell division cycle associated 8 
NM_009773    Bub1b   budding uninhibited by  
        benzimidazoles 1 homolog, beta  
        (S. cerevisiae)  
NM_027695     Oxsm   3-oxoacyl-ACP synthase,  
        mitochondrial  
NM_001001495    Tnip3   TNFAIP3 interacting protein 3 
NM_176996     Smo    smoothened homolog  
         (Drosophila)  
NM_021782     Il21    interleukin 21  
NM_175406    Atp6v0d2   ATPase, H+ transporting,  
        lysosomal V0 subunit  
NM_013532     Lilrb4   leukocyte immunoglobulin-like 
receptor, subfamily B, member   
4  
NM_009969    Csf2   colony stimulating factor 2  
       (granulocyte-macrophage)  
NM_019465    Crtam  cytotoxic and regulatory T cell  
       molecule  
NM_007609   Casp4   caspase 4, apoptosis-related  
       cysteine peptidase  
169 
 
NM_015728    Slc33a1   solute carrier family 33 (acetyl- 
        CoA transporter), member 1  
NM_001142916    Plod2   procollagen lysine, 2- 
        oxoglutarate 5-dioxygenase 2  
NM_013552     Hmmr   hyaluronan mediated motility  
        receptor (RHAMM) 
NM_145825     Cetn4   centrin 4  
NM_015736     Galnt3   UDP-N-acetyl-alpha-D- 
 galactosamine:polypeptide N- 
acetylgalactosaminyltransferase 
3  
NM_011636    Plscr1  phospholipid scramblase 1 
NM_001145953   Lgals3  lectin, galactose binding, soluble  
       3  
NM_026023    Nudcd2  NudC domain containing 2 
NM_175443    Etnk2   ethanolamine kinase 2 
NM_010818    Cd200  CD200 antigen  
NM_013542    Gzmb    granzyme B  
NM_145535    Sdcbp2   syndecan binding protein  
        (syntenin) 2  
NM_053095     Il24   interleukin 24  
NM_011068     Pex11a  peroxisomal biogenesis factor 11 
 alpha  
NM_001040026    Sco1   SCO cytochrome oxidase  
       deficient homolog 1 (yeast)  
NM_001005421   Amica1  adhesion molecule, interacts with 
 CXADR antigen 1  
NM_134250    Havcr2   hepatitis A virus cellular  
        receptor 2  
NM_172587    Cdc14b  CDC14 cell division cycle 14  
       homolog B (S. cerevisiae)  
170 
 
NM_031374   Tex15   testis expressed gene 15 
NM_007759   Crabp2  cellular retinoic acid binding 
 protein II  
NM_033524   Spred1  sprouty protein with EVH-1  
       domain 1, related sequence  
NM_010287   Gpr83   G protein-coupled receptor 
NM_008737    Nrp1   neuropilin 1  
NM_009012    Rad50  RAD50 homolog (S. cerevisiae) 
NM_023670    Igf2bp3  insulin-like growth factor 2 
mRNA binding protein 3  
NM_001033331   Gas2l3  growth arrest-specific 2 like 3 
NM_145706    Nup43  nucleoporin 43  
NM_010128    Emp1   epithelial membrane protein 1 
NM_029797    Mnd1   meiotic nuclear divisions 1  
       homolog (S. cerevisiae) 
NM_008871    Serpine1  serine (or cysteine) peptidase  
       inhibitor, clade E, member 1  
NM_007962     Mpzl2  myelin protein zero-like 2 
NM_010683     Lamc1  laminin, gamma 1  
NM_011627     Tpbg   trophoblast glycoprotein 
NM_025676     Mcm8  minichromosome maintenance  
       deficient 8 (S. cerevisiae)  
NM_019507     Tbx21  T-box 21  
NM_145381     Lactb2  lactamase, beta 2  
NM_026412     D2Ertd750e  DNA segment 
NM_001045513    Raph1  Ras association (RalGDS/AF-6) 
and pleckstrin homology 
domains 1  
NM_010634     Fabp5   fatty acid binding protein 5, 
epidermal  
NM_013565     Itga3   integrin alpha 3  
171 
 
NM_008921    Prim1   DNA primase, p49 subunit 
NM_029998    RIKEN    cDNA 6030458C11 gene 
NM_009128     Scd2    stearoyl-Coenzyme A desaturase 
 2  
NM_027533     Tspan2   tetraspanin 2  
NM_019438     Ncapg    non-SMC condensin I complex,  
         subunit G  
NM_011121      Plk1     polo-like kinase 1 (Drosophila) 
NM_025879      RIKEN     cDNA 2410002O22 gene 
NM_001146081     Fancb    Fanconi anemia,  
         complementation group B  
NM_018782      Calcrl    calcitonin receptor-like  
NM_181542      Slfn10    schlafen 10  
NM_134471      Kif2c    kinesin family member 2C 
NM_011173      Pros1    protein S (alpha)  
NM_212445       Kdelc2    KDEL (Lys-Asp-Glu-Leu)  
         containing 2  
NM_172723      Adap1    ArfGAP with dual PH domains  
         1  
NM_148933      Slco4a1    solute carrier organic anion  
         transporter family, member 4a1  
NM_027342      Fam162a    family with sequence similarity  
         162, member A  
NM_008337       Ifng     interferon gamma  
NM_019699       Fads2    fatty acid desaturase 2  
NM_028760       Cep55    centrosomal protein 55 
NM_177884       AW146020    expressed sequence AW146020  
NM_008991       Abcd3    ATP-binding cassette, sub- 
         family D (ALD), member 3  
NM_009445        Ttk     Ttk protein kinase  
172 
 
NM_027896     Coasy   Coenzyme A synthase 
NM_010790     Melk    maternal embryonic leucine 
 zipper kinase  
NM_026558     Fam92a   family with sequence similarity  
        92, member A  
NM_027400     Lman1   lectin, mannose-binding,  
NM_026656     Mcoln2   mucolipin 2  
NM_019425     Gnpnat1   glucosamine-phosphate N- 
        acetyltransferase 1  
NM_028986      Gzf1    GDNF-inducible zinc finger 
        protein 1  
NM_008354      Il12rb2   interleukin 12 receptor, beta 
NM_009404      Tnfsf9   tumor necrosis factor (ligand)  
        superfamily, member 9  
NM_028133       Egln3   EGL nine homolog 3 (C.  
         elegans) 
NM_009256       Serpinb9   serine (or cysteine) peptidase 
  inhibitor, clade B, member 9  
NM_018763       Chst2   carbohydrate sulfotransferase 2 
NM_023059       Sigirr   single immunoglobulin and toll- 
        interleukin 1 receptor (TIR)  
        domain  
NM_027838       Senp8   SUMO/sentrin specific peptidase  
        8  
NM_134133         RIKEN    cDNA 2010002N04 gene 
NM_009977        Cst7   cystatin F (leukocystatin)  
NM_011232        Rad1   RAD1 homolog (S. pombe) 
NM_007457        Ap1s1   adaptor protein complex AP-1,  
        sigma 1  
NM_025518        Dus2l    dihydrouridine synthase 2-like  
        (SMM1, S. cerevisiae)  
173 
 
NM_011937     Gnpda1  glucosamine-6-phosphate 
 deaminase 1  
NM_011399     Slc25a17  solute carrier family 25  
       (mitochondrial carrier,  
        peroxisomal membrane protein),  
       member 17  
NM_023284      Nuf2    NUF2, NDC80 kinetochore  
       complex component, homolog  
       (S. cerevisiae)  
NM_008495       Lgals1   lectin, galactose binding, soluble 
1  
NM_008364       Il1rap  interleukin 1 receptor accessory  
       protein  
NM_029578       Tgds  TDP-glucose 4,6- 
 NM_172616       RIKEN   cDNA C330027C09 gene  
NM_007585       Anxa2   annexin A2  
NM_011170       Prnp   prion protein  
NM_175001       Mrpl22   mitochondrial ribosomal protein  
        L22  
NM_021886      Cenph   centromere protein H  
NM_029942      Prelid2   PRELI domain containing 2  
NM_010892      Nek2   NIMA (never in mitosis gene a)- 
        related expressed kinase 2  
NM_198127      Abi2    abl-interactor 2  
NM_025384      Dnajc15   DnaJ (Hsp40) homolog,  
        subfamily C, member 15  
NM_177684       Zfp637   zinc finger protein  
NM_028006       Tube1   epsilon-tubulin 1  
NM_028304       Pus10   pseudouridylate synthase 
BC158017       Cdc42bpa   CDC42 binding protein kinase  
        alpha  
174 
 
NM_176993    Mpzl3   myelin protein zero-like 3 
NM_148928    Gtf3c5  general transcription factor IIIC, 
polypeptide 5  
NM_020559    Alas1              aminolevulinic acid synthase 1 
NM_010720    Lipg   lipase, endothelial  
NM_015804    Atp11a  ATPase, class VI, type 11A  
NM_199007    Sgol2   shugoshin-like 2 (S. pombe) 
NM_030013    Cyp20a1  cytochrome P450, family 20,  
       subfamily A, polypeptide 1  
NM_026644    Agpat4  1-acylglycerol-3-phosphate O- 
       acyltransferase 4  
      (lysophosphatidic acid  
      acyltransferase, delta)  
NM_008445    Kif3c   kinesin family member 3C 
NM_173762    Cenpe  centromere protein E  
NM_145480    Rfc4    replication factor C (activator 1)  
        4  
NM_016965    Nckap1   NCK-associated protein 1 
NM_009015    Rad54l   RAD54 like (S. cerevisiae 
NM_145924    Cenpi    centromere protein I  
NM_173750    RIKEN   cDNA 2700007P21 gene 
NM_026053    Gemin6   gem (nuclear organelle) 
 associated protein 6  
NM_175193    Golim4    golgi integral membrane protein  
        4  
NM_016918      Nudt5   nudix (nucleoside diphosphate  
        linked moiety X)-type motif 5  
NM_024261      RIKEN     cDNA 1700052N19 gene 
NM_012048     Polk     polymerase (DNA directed),  
         kappa  
175 
 
NM_133838   Ehd4    EH-domain containing 4 
NM_176982   Fbxo48   F-box protein 48  
NM_009517   Zmat3    zinc finger matrin type 3  
NM_026221   Ppfibp1   PTPRF interacting protein,  
        binding protein 1 (liprin beta 1) 
 
NM_198605    RIKEN    cDNA F630043A04 gene  
NM_027346   Ccdc44   coiled-coil domain containing 44 
NM_173757   Mrps27   mitochondrial ribosomal protein  
        S27  
NM_181410   Gtf2h3   general transcription factor IIH,  
       polypeptide 3  
NM_018861   Slc1a4    solute carrier family 1  
        (glutamate/neutral amino acid  
         transporter), member 4  
NM_007796   Ctla2a     cytotoxic T lymphocyte- 
         associated protein 2 alpha  
NM_025979   Mastl     microtubule associated  
         serine/threonine kinase-like  
NM_028232    Sgol1    shugoshin-like 1 (S. pombe) 
NM_026178    Mmd    monocyte to macrophage 
 differentiation-associated  
NM_001127338  Aldh7a1   aldehyde dehydrogenase family  
        7, member A1  
NM_183046   Kif20b   kinesin family member 20B 
NM_025935   Tbc1d7   TBC1 domain family, member 7 
NM_001080995   RIKEN    cDNA 4632434I11 gene 
NM_145460   Oxnad1   oxidoreductase NAD-binding  
        domain containing 1  
NM_153780    RIKEN    cDNA 2610044O15 gene 
NM_009811   Casp6    caspase 6  
176 
 
NM_022324    Sdf2l1   stromal cell-derived factor 2-like  
        1  
NM_001113179   Bub1    budding uninhibited by  
        benzimidazoles 1 homolog (S.  
        cerevisiae)  
NM_001114663    Plcl1    phospholipase C-like 1 
NM_001135149    Slc39a8   solute carrier family 39 (metal  
        ion transporter), member 8  
NM_010260     Gbp2    guanylate binding protein 2 // 3 
NM_008925     Prkcsh   protein kinase C substrate 80K- 
 H  
NM_010049     Dhfr    dihydrofolate reductase 
NM_029720    Creld2   cysteine-rich with EGF-like  
        domains 2  
NM_029017     Mrpl47   mitochondrial ribosomal protein 
  L47  
NM_175002     Mmgt2   membrane magnesium  
        transporter 2  
NM_172653     Slc39a10   solute carrier family 39 (zinc 
  transporter), member 10  
NM_173763     Ccbl2    cysteine conjugate-beta lyase 2 
NM_146097     Cbwd1    COBW domain containing 1  
NM_173745     Dusp18    dual specificity phosphatase 18 
NM_175563     Prr11    proline rich 11  
NM_011849     Nek4     NIMA (never in mitosis gene a)- 
         related expressed kinase 4  
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APPENDIX B – Gene expression time course data relative 
to GAPDH  
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